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Norepinephrine (NE) is a neurotransmitter involved in learning and 
memory.  NE activates adrenergic receptors (ARs) and stimulating the α1A-AR 
subtype has been known to increase adult neurogenesis (ANG).  We 
hypothesized that α1A-AR-induced ANG would enhance learning and memory.  
Constitutively active mutant (CAM) α1A-AR, α1A-AR knock-out (KO), normal wild 
type (WT) mice, and mice treated with the α1A-AR selective agonist cirazoline 
(CRZ) were tested on the Barnes maze.  CAM α1A-AR and CRZ-treated mice 
performed better and α1A-AR KO mice performed poorer than WT.  Long-term 
potentiation (LTP) experiments on aged CAM α1A-AR mice revealed enhanced 
LTP in CAM α1A-AR mice versus WT.  Therefore, we hypothesized that α1A-AR-
induced ANG underlies enhanced learning, memory and synaptic function.  We 
used CRZ to activate α1A-ARs and the anti-mitotic agent cytosine arabinoside 
(Ara-C) to impair ANG in CRZ-treated and WT mice, and tested mice on novel 
object recognition (NOR), Morris water maze (MWM), and open field (OF).  No 
difference was found in NOR and OF.  MWM revealed that CRZ-treated mice 
were protected from Ara-C-induced learning and memory impairments, and 
surgery-induced learning impairments.   
We observed that Ara-C treatment was causing weight gain and 
hypothesized that Ara-C inhibits cellular proliferation in the hypothalamus, the 




stereological investigation revealed that Ara-C treated mice gained significantly 
more weight and had significantly fewer dividing cells and immature neurons than 
WT mice.  We concluded stem cells and immature neurons in the hypothalamus 
are important in metabolism and normal weight gain.  We launched a pilot study 
investigating the α1A-AR in exercise-induced neurogenesis using WT and α1A-AR 
KO mice and running wheels.  We measured anxiety-like behavior and 
neurogenesis and found enhanced anxiety and less neurogenesis in running α1A-
AR KO mice.  Results from this study are ambiguous; therefore we cannot 
dismiss α1A-AR involvement in exercise-induced neurogenesis.  In conclusion, 
activating α1A-ARs increases neurogenesis, enhances learning and memory, and 
has neuroprotective effects against brain injury.  These insights may lead to 
therapeutic interventions for patients suffering from chemotherapy’s negative 
effects on memory and other neurodegenerative diseases, as Ara-C (also known 






1.1 Discovery, history, and categorization 
Adrenalin (a.k.a. epinephrin) was discovered by Oliver and Schafer in 
1894-1895, though it would not receive this name until two other scientists, 
Jokichi Takamine and John Jacob Abel, tried and successfully purified the 
compound in 1899-1900 (Davenport, 1982).  Adrenergic “receptors” were a 
hypothetical concept, thought to exist somewhere near or inside a cell, and 
responsive only to epinephrine (EPI) or adrenaline in the body, and 
norepinephrine (NE) or noradrenaline in the brain, thus the term “adrenergic” 
(Ahlquist, 1948).  Then in 1948, Raymond Ahlquist defined two categories for 
adrenergic receptors (ARs), the α- and β-ARs. Ahlquist based this categorization 
on a series of experiments using varying concentrations of epinephrine and 
several other adrenergic receptor agonists in the blood vessels, uterus, heart, 
pupils and gut. His results showed striking contrast in the agonists potency and 
effect (constriction or dilation) depending on the tissue in question.  Then, an 
excellent study clarifying the role of EPI (also known as “sympathin” at the time) 
in the body was published shortly after Ahlquist’s discovery (Von Euler, 1951).  
Von Euler and Ahlquist were beginning the characterization and classification of 




After Ahlquist’s landmark study, Lands reported that having only a single 
set of receptors in each α- and β-AR group was too simplified.  Using a similar 
approach with various adrenergic agonists and making observations in several 
different tissues, Lands’ results showed an even more diverse response, and he 
concluded that at least two receptor types existed within the β-AR category 
(Lands, Arnold, McAuliff, Luduena, & Brown, 1967).   Shortly after this discovery, 
Langer (1974) hypothesized that there may be an α-adrenergic auto-receptor, 
which works by causing “presynaptic inhibition of transmitter release through a 
negative feedback mechanism which is mediated through the neurotransmitter 
itself.”  Finally, based on mounting evidence from these experiments, it was 
proposed that the α-AR family be split into two groups: the α1- and the α2-AR 
(Berthelsen & Pettinger, 1977).  As a result, the categorization of ARs was 
almost complete by the late 1970’s (Fig. 1).  And twenty years after Langer 
proposed the auto-receptor hypothesis, the α2-AR would be classified into one of 
the main three categories of ARs: the α2- (auto-receptor), the α1-, and the β 
(Bylund, 1985).   
 
Figure 1.  Diagram of the historical categorization of adrenergic receptors.  Scientists responsible 
for each category are above.  All subclasses of receptors (except the β3-AR) were classified 




A third subtype of the β-AR class, the β3, was added in the mid to late 1980’s 
(Arch et al., 1984; Emorine et al., 1989).  The α2-AR was discovered to have 
several different subtypes of its own by the late 1980’s – the α2A, α2B, and α2C 
(Bylund, 1988; Kobilka et al., 1987; Minneman, Han, & Abel, 1988; Regan et al., 
1988; Zeng et al., 1990).  Finally, the α1-AR was thought to have 4 subtypes – 
the α1A, α1B, (Minneman et al., 1988; Morrow & Creese, 1986) α1C, and the α1D 
(Ford, Williams, Blue, & Clarke, 1994; Lomasney et al., 1991; Perez, Piascik, & 
Graham, 1991).  Then in 1994, investigators studied the binding profiles of both 
the α1C-AR and α1A-AR and found them the same. Furthermore, in situ 
hybridization showed the α1C-AR receptor localized to α1A-AR rich tissue 
(hippocampus, vas deferens, aorta, and the submaxillary gland).  It was 
concluded that the α1C-AR was actually the same as the α1A-AR subtype (Perez, 
Piascik, Malik, Gaivin, & Graham, 1994).  Thus, the α1C-AR was removed from 
the classification chart, leaving a curious gap in the naming convention (Fig. 2). 
 
Figure 2.  Complete categorization of the adrenergic receptors and their subtypes. Scientists that 
discovered each subtype with corresponding year can be seen above.  As noted in figure 1, 
Lands discovered the β1- and β2-AR subtypes in the late 1960’s and Bylund discovered all three 
of the α2-AR subtypes in the 1980’s.  This figure is a modified version of the diagram appearing in 




Then again in the late 1990’s, a tentative fourth receptor subtype was 
again identified for the α1-AR class, the α1L-AR (Ford et al., 1997; Kava, Blue, 
Vimont, Clarke, & Ford, 1998). However, it is not included in traditional 
classification charts because it has properties that are very similar to the α1A-AR, 
and it is only located in the bladder, prostate and urethra. 
Highlighted here are the historical points relevant to the classification of 
ARs.  A more detailed summary of work in the AR field during the 20th century 
can be found in Table 1.  However, the focus of this introduction will be on the α1-
















































 Langley proposes that cells have “receptive substances” 
 Dale refers to “receptive mechanisms for adrenalin” 
 Abel isolates epinephrine from the adrenal medulla, the first hormone 




 Ahlquist defines α— and β-types of adrenergic receptors 
 von Euler demonstrates that norepinephrine is the sympathetic 
neurotransmitter 
 Sutherland discovers cyclic AMP, leading to the second messenger 
concept 
 Sir James Black develops propranolol, the first clinically useful beta-
antagonists 
 Lands defines β1- and β2-subtypes 
 
 Langer defines α1 as postsynaptic and α2 as presynaptic 
 Pettinger defines α1- and α2-receptors functionally 
 Snyder and Lefkowitz develop radioligand binding assays for the most 
adrenergic receptors 
 Lefkowitz develops the ternary complex model for G protein-coupled 
receptors 
 Khorana clones bacteriorhodopsin, the first of the seven 
transmembrane receptors 
 Nathans and Hogness clone rhodopsin, the first of the G protein-
coupled receptors 
 Arch defines the β3-receptor using pharmacological criteria 
 Bylund defines α1, α2, and β as the three types of adrenergic receptors 
 Dixon, Strader, and Lefkowitz clone the β2-adrenergic receptor 
 Creese proposes α1A- and α1B-subtypes based on radioligand binding 
 Bylund defines α2A-, α2B-, α2A-, α1A-, and α1B-receptors 
 Strosberg clones the β3-receptor 
 Strader’s laboratory and other laboratories use site-directed 
mutagenesis to define ligand-binding site and signaling mechanisms 
 Graham and Perez clone α1D 
 Transgenic mice developed by several laboratories 
 Lefkowitz works out desensitization mechanism involving β-adrenergic 
receptor kinase and beta-arrestin 
 Lowell generates β3-knockout mice 
 Kobilka generates β1-, β2-, α2A-, α2B-, and α2C-knockout mice 
 Cotecchia generates α1B-knockout mice 
 Liggett describes clinically relevant polymorphisms in α2- and β-
receptors 
 Crystal structure of rhodopsin, a G protein-coupled receptor, 
determined 











1.2. Structure and second messenger pathway 
 Adrenergic receptors belong to one of the largest classes of receptors 
called G protein-coupled receptors.  Structurally, ARs are heptahelical 
transmembrane receptors coupled to a specific G protein.  These G proteins 
have an α subunit with intrinsic enzymatic activity.  The difference in α subunits 
between G proteins confers specificity to the G protein function and ultimate 
pharmacological response.  Each AR subtype is coupled to a different G protein.  
The β-ARs are couple to the Gαs; the α2-ARs are coupled to the Gαi/o; and the α1-
ARs are coupled to the Gαq/11 (Wess, 1998).  In turn, these G proteins lead to 
different second messenger pathways and, therefore, a different physiological 
response (Fig. 3). 
Figure 3.  The adrenergic receptor family and corresponding G-proteins.   Also seen above is 
the second messenger effects, and the physiological effects of receptor activation. Adapted 




The G protein-coupled AR binds EPI in the peripheral nervous system 
(PNS) and NE in the central nervous system (CNS).  EPI binds to the AR through 
four key interactions during the binding process (Perez, 2006).  First, ionic 
bonding occurs between the catechol and the third helical transmembrane of the 
receptor.  Second, hydrogen bonding occurs between the hydroxyl groups on the 
catechol and the serine residues in the fifth helical transmembrane.  Third, the 
aromatic residues in the sixth helical transmembrane interact with the aromatic 
catechol of NE. Fourth, and finally, hydrogen bonding occurs between the chiral 
β-hydroxyl group and another residue in the sixth helical transmembrane (Fig. 4, 
left).  Structural differences between agonists (e.g., EPI vs. NE; Fig 4, right) 
cause slightly different binding in the receptor’s binding pocket, and therefore 
different responses. For example, the methyl group present on the amine in EPI 
may interfere with binding slightly more than when methyl is not present on the 
amine, as in NE. 
Figure 4. Adrenergic receptor binding epinephrine.  Shown here is the binding of epinephrine to 
the adrenergic receptor, showing the key interactions of the agonist with each transmembrane 
(left). Norepinephrine (right), showing the absence of a methyl group on the amine, in contrast to 




 Each receptor subtype (β, α1 or α2) activates a different second 
messenger pathway.  The α1-AR second messenger pathway activates several 
different proteins, enzymes, and receptors within the cell.  All of the α1-AR 
subtypes activate pathways that lead to increases in calcium via the Gαq/11 
subunit and the activation of phospholipase C (PLC) and protein kinase C (PKC), 
leading to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) increases 
(Offermanns & Simon, 1998).  However, activation of the α1-AR has also been 
shown to lead to a number of different outcomes such as increases in 
arachidonic acid (Burch et al., 1986; Insel et al., 1991; Perez, DeYoung, & 
Graham, 1993), which is thought to occur because of the activation of  
phospholipase A2 (PLA2; Xing & Insel, 1996).  Additionally, activation of the α1-
AR (Fig. 5) leads to growth factor regulation (Zhong & Minneman, 1999), such as 
the mitogen-activated protein kinase (MAPK) pathway (Gutkind, 1998).  MAPKs 
are serine/threonine kinases and for the α1-AR include the subfamilies 
extracellular signal-regulated kinase, ERK (Liu et al., 2011), c-Jun N-terminal 
Kinase, JNK, and p38 kinase.  There is speculation as to how specificity for the 
subtypes of each main class of ARs is gained (Dianqing Wu, Katz, Lee, & Simon, 
1992).  One hypothesis is that specificity is at least somewhat dependent on the 
intracellular loops of the G protein coupling – specifically the i3 loop (Wess, 
1998).  For example, the Gαq/11 family of α-subunits (which includes α-subunits q, 
11, 14, 15 and 16), are shown to interact with a specific sequence of residues in 




the α1A- and α1B-AR, does not need this segment to function (Wu, Jiang, & 
Simon, 1995).  
Figure 5.  Second-messenger pathway for α1-AR activation. The above diagram shows PIP2, 
DAG, IP3, PKC and ERK activation followed by increases in [Ca
2+]i. PIP2, phosphatidylinositol 4,5-
bisphosphate; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate; PKC, protein kinase C; ERK, 
extracellular signal-regulated kinase;  [Ca2+]i, internal calcium concentration.  Adapted from figure 






1.3 Pharmacological characterization 
The natural, endogenous agonists of the ARs system are EPI and NE.  As 
mentioned, NE is the main AR agonist in the brain and is released from the locus 
coeruleus.  However, each AR subtype has a different potency (the amount of 
ligand compared to the intensity of cellular response), affinity (how well the ligand 
binds to the receptor), and efficacy (or efficiency of cellular response).  Affinity 
measures how well a ligand binds to the receptor and efficacy measures how 
well the ligand elicits a response after receptor activation.   Just like endogenous 
and natural agonists, synthetic agonists and antagonists have been produced for 
each AR class and subtypes within each class.  For the sake of brevity, the α1-
AR class affinity (Table 2) alone and efficacy of the agonist cirazoline (CRZ, Fig. 
6) alone will be highlighted here, as they are most relevant to these studies 
(Horie, Obika, Foglar, & Tsujimoto, 1995).  This study used human receptors 
transfected into Chinease hamster ovary cells.  Paired with radioligand binding 
and tracking [Ca2+]i levels, agonist potency and efficacy were determined.  
Additional information about the pharmacological characterization of the other AR 
classes and subtypes can be found in the International Union of Basic Clinical 












Pharmacological profile of the cloned human α1-adrenergic receptor subtypes 
Ki (nM) 
Drugs α1A-AR α1B-AR α1D-AR 
Agonists    
(-)-Adrenaline 600 ± 250 400 ± 35 56 ± 12 
(+)-Adrenaline 8,100 ± 560 7,600 ± 600 920 ± 90 
(-)-Noradrenaline 990 ± 100 680 ± 90 42 ± 8.8 
Methoxamine 4,400 ± 200 110,000 ± 6,000 11,000 ± 1,300 
Cirazoline 120 ± 18 960 ± 130 660 ± 160 
Oxymetazoline 6.0 ± 0.60 320 ± 15 390 ± 100 
    
Antagonist     
Prazosin 0.17 ± 0.020 0.26 ± 0.032 0.070 ± 0.0010 
Phentolamine 2.5 ± 0.10 30 ± 3.0 7.0 ± 0.83 
Yohimbine 400 ± 50 520 ± 5.0 240 ± 25 
5-Methylurapidil 0.89 ± 0.081 39 ± 3.1 10 ± 1.4 
WB-4101 0.20 ± 0.030 3.4 ± 0.30 0.25 ± 0.012 
Dose response curves determined the -log EC50 values, and Emax (the maximum response 






Figure 6.  Full and partial agonists for the α1-AR after external calcium removal; (a) noradrenaline 
responses with the α1A-AR, α1B-AR, and α1C-AR; (b) cirazoline responses with the α1A-AR, α1B-AR, 
and α1C-AR.  Cirazoline acts as a full agonist for the α1A-AR but as only a partial in the α1B-AR, 
and little to know response in the α1D-AR. Figure from Horie et al., 1995. AR, adrenergic receptor. 
1.4. Localization and physiological function  
Adrenergic receptors are located throughout the body, in the PNS as well 
as the CNS.  In the PNS, ARs are located in the heart, blood vessels, lung, liver, 
gut, pancreatic islet cells, adipocytes, leukocytes, platelets, skeletal muscles, 




CNS, NE is involved in sleep, arousal, attention, mood, cardiovascular regulation, 
appetite, pain, motor output, and learning and memory (Pupo & Minneman, 
2001).  NE is supplied to the CNS through efferent output from the locus 
coeruleus (Berridge & Waterhouse, 2003).  ARs receiving this output from the 
locus coeruleus are present in the cerebral cortex, hippocampus, basal ganglia, 
cerebellum, olfactory, amygdaloid (amygdala), thalamus, hypothalamus, 
midbrain, brain stem, pons, pineal gland, spinal cord and pituitary gland (Papay 
et al., 2006).  It stands to reason, then, that these receptors will influence the 
particular function of each organ or system they are expressed in, be it in the 
PNS or the CNS (table 3).   
Table 3* 
Distribution of Adrenergic Receptor Subtypes in the Brain Via In Situ or Autoradiography 
Tissue α1A α1B α1D α2A α2B α2C β1 β2 β3 
Cerebral cortex ++r +++r ++r ++m,r +h ++m,r ++r ++r ND 
Hippocampus          
Dentate Gyrus ++r +h ++r +h +m,h ++r,h +r +r ND 
Basal Ganglia          
Caudate/putamen -- +r -- -- +m ++m,r ++r +r ND 
Cerebellum          
Granule cell layer -- ND ND ++m,r -- -- ND ND ND 
Olfactory          
Anterior olfactory nuclei +r ND ND ++m,r -- ++m,r ++r ND ND 
Amygdaloid ++r ND ND ++m,r -- +m,r ++r +r ND 
Thalamus          
Dorsal lateral geniculate  -- +++r +r +m ++m,r +m +r +r ND 
Hypothalamus          
Lateral ++r ND ND ++m,r -- +m ND ND ND 
Midbrain          
Dorsal raphe nuclei +r +++r -- +m,r -- +r -- -- ND 
Brain stem and pons          
Lateral reticular nuclei ++r ND ND ++m,r -- ++r ND ND ND 
Pineal gland +++r +r -- -- +r +++r +r ND  
Spinal cord ++r ++r ++r ++r -- +r +r +r ND 
Pituitary ND ND ND ND ND ND +r,h,rb ++r,h,rb ND 
gp, guinea pig; h, human; m, mouse; ND, not determined; r, rat; rb, rabbit; --, not detected; +, low expression; ++medium 
expression; +++, high expression. *Table adapted from table 1 in Perez, 2006, p. 176-177.  
 
The AR subtypes are found in varying amounts throughout the 




been shown to be involved in memory formation (Sirviö & MacDonald, 1999), and 
is present in high concentrations in one of the main areas for learning and 
memory, the hippocampus.  In fact, a few studies have gone on to show the 
specific localization of the α1A- and α1B-AR in the brain using a more accurate 
technique using transgenic mice expressing enhanced green fluorescent protein 
with each of these receptor subtypes.  Results from this study can be found in 
Table 4 below (Papay et al., 2006). 
Table 4* 
Distribution of the α1A- and α1B-adrenergic receptors in the brain 
Tissue α1A-AR α1B-AR 
Amygdaloid +++ +++ 
Basal ganglia   
Caudate putamen + + 
Cerebellum   
Granule cell layer + + 
Cerebral cortex ++ +++ 
Corpus callosum - - 
Hindbrain   
Dorsal raphe nuclei ++ + 
Hippocampus   
Dentate gyrus +++ + 
CA1 field +++ + 
CA3 field +++ + 
Hypothalamus   
Hypothalamic nuclei +++ ++ 
Hypothalamic area +++ ++ 
Interpeduncular nucleus +++  
Midbrain   
Raphe cap ++ + 
Olfactory +++ ++ 
Pituitary ++ ++ 
Spinal cord ++ ++ 
Thalamus + + 
Relative levels of expression based on intensity of label within each mouse model.  
*Adaptation of table 3 in Papay et al., 2006. 
 
On a cellular level, each main category of ARs are located either pre- or 




ARs are autoreceptors and are the exception as they are located pre-
synaptically; Hein, Altman, & Kobilka, 1999), and α1-ARs are also mostly post-
synaptic (Perez, 2006).  Additionally, the α2-AR may be extrasynaptic while the 
α1-AR may be intrasynaptic (Curet & de Montigny, 1988).  The β1- and β3-ARs 
are located post-synaptically, and the β2-ARs located pre-synaptically (Lakhlani, 
Amenta, Napoleone, Felici, & Eikenburg, 1994). 
 The AR has been studied for nearly 100 years.  Each subtype, and sub-
subtype, has been classified and characterized with regards to its natural 
activator, NE, as well as a variety of synthetic agonists and antagonists that have 
further helped to characterize each receptors function.  Each receptor is unique 
in its physiological effects in the body.  The following chapter highlights the 






LEARNING, MEMORY & THE α1-ADRENERGIC RECEPTOR 
2.1 Learning and memory 
Learning and memory take place in several different brain regions 
depending on the type of learning and memory.  For instance, fear-based and 
emotional learning and memory is associated with the amygdala – one of the 
emotional centers of the brain (Cahill & McGaugh, 1995; Costafreda, 
Brammer, David, & Fu, 2008).  Other areas of learning and memory in the 
brain include the prefrontal cortex (PFC), or “neocortex” (Goldman-Rakic, 
1987; Jacobsen & Nissen, 1937), the striatum, the cerebellum, and the 
hippocampus in the medial temporal lobe (Pergola & Suchan, 2013).  Each 
area is responsible for a different type of learning and memory (Fig. 7).  
Interestingly, the prefrontal cortex is directly and indirectly connected to 
several other structures that also play important roles in learning and memory 
– most notably, the hippocampus – through the anterior and posterior 
cingulate cortices (Goldman-Rakic, 1987).  This area also receives input from 
the parietal lobe of the brain.  As previously mentioned, these areas of the 
brain process different types of learning and memory (Fig. 7) and spatial 




ventral striatum – with the processing of these memories done in the 
hippocampus (Floresco, Seamans, & Phillips, 1997).   
Figure 7. Types of memory.  The hippocampus (in the medial temporal lobe) is involved in 
explicit or declarative memory (facts and events).  The prefrontal cortex/neocortex, the 
striatum, amygdala, cerebellum and other reflex pathways are involved in implicit (non-
declarative) memory.  Under the implicit memory category, the prefrontal cortex controls 
memory priming while the striatum controls skills and habits (procedural learning).  The 
amygdala controls emotional memory, and the cerebellum controls skeletal musculature 
memory. Adapted from figure 62-4, Kandel, Schwartz, Jessell (2000), p. 1231. 
It has been known for quite some time that the hippocampus is 
important for learning and memory, evident from a patient in the 1950’s 
known as H.M. (Neylan, Scoville, & Milner, 2000) who’s hippocampus was 
removed to alleviate the severe seizures the patient was suffering.  To what 
extent the hippocampus was important, however, was unclear.  Since H.M., 
experiments have discovered that other brain regions such as the caudate 
nucleus and parts of the cortex have a much smaller role in spatial learning 
and memory than the hippocampus (Olton & Papas, 1979).  Additionally, the 




topographical memory) over other important memory structures, like the 
amygdala (Sutherland & McDonald, 1990).  The type of memory processed in 
the medial temporal lobe and hippocampus is declarative memory, which 
includes facts (semantic) and events (episodic) (Squire, 1992).  Because the 
hippocampus is also an important region for neurogenesis (discussed in 
chapter 3.1), this research described herein focused mainly on the 
involvement of the hippocampus in memory and its relationship to the α1-AR 
(specifically, the α1A-AR).  
2.2 History of the α1-adrenergic receptors, learning & memory 
Several neuromodulatory systems have been implicated in learning 
and memory such as the opioid peptidergic, -aminobutyric acid (GABA)-
ergic, and cholinergic systems.  In fact, a synergistic interaction exists 
between the cholinergic system and adrenergic system in enhancing learning 
and memory performance in rodents – though mainly mediated through the β-
adrenergic receptor system with a minor to negligible role for the α1-AR 
(Puumala, Sirviö, Ruotsalainen, & Riekkinen, 1996).  Individually, NE and EPI 
have been shown to be important in retention and enhancement of memory – 
both of these ligands are released when animals are learning (McGaugh & 
Cahill, 1997).  Furthermore, there is a large number of noradrenergic inputs 
into the mammalian hippocampus from the locus coeruleus (Blackstad, Fuxe, 
& Hökfelt, 1967) and a very high expression of α1A- and α1B-ARs in this same 
region (Tables 3 and 4).  However, it is not clear which AR is mediating these 




areas of the brain.  For instance, if we look at Table 4 (section 1.4), the gray 
rows are areas in the brain with high α1A- and α1B-AR expression, and are 
also key brain areas for learning and memory, namely the basal ganglia, 
cerebral cortex, hippocampus and amygdala.  There are also high levels of all 
three of the α1-ARs in the cerebral cortex, despite the use of less optimal 
expression techniques (Table 3, section 1.4).   
High hippocampal input from the locus coeruleus hints at the 
importance of the α1-AR in this key learning and memory area of the brain.  
However, what role the α1-AR plays in learning and memory is still 
controversial.  For instance, some studies show that α1-AR stimulation inhibits 
memory consolidation in chicks (Gibbs & Summers, 2001) and impairs spatial 
working memory in monkeys (Arnsten & Jentsch, 1997; Mao, Arnsten, & Li, 
1999) and rats (Arnsten, Mathew, Ubriani, Taylor, & Li, 1999).  Additionally, 
another study shows that the AR system is altered after traumatic brain 
injuries (TBIs) and contributes to PFC-controlled working memory 
dysfunction.  Here, blocking the α1-ARs after TBI improves working memory, 
and expression of the α1-AR is down-regulated in the medial-PFC of brain-
injured rats (Kobori, Hu, & Dash, 2011).  Yet other studies have suggested 
that activating the α1-AR facilitates spatial learning and memory in rodents 
(Pussinen et al., 1997; Puumala et al., 1998) – and this facilitation, especially 
in aged animals, may be through a synergistic relationship with the N-methyl-
D-aspartate (NMDA) receptor (Riekkinen, Kemppainen, & Riekkinen, 1997; 




2.3 Synaptic plasticity and the α1-adrenergic receptor 
Long term potentiation (LTP) is a form of synaptic plasticity that is 
thought to be the underlying mechanism of learning and memory (Deupree, 
Turner, & Watters, 1991; Squire, 1992).  LTP is defined as potentiation of the 
synapse that is both NMDA and receptor-dependent and lasts for longer than 
one hour (Bliss & Collingridge, 1993).  This definition is based on 
hippocampal LTP, and is measured by an increase in the amplitude of the 
evoked excitatory post-synaptic potential (EPSP) from a single neuron or a 
population, which is typically induced by quick injections of current, also 
called a tetanus.  The tetanus varies from study to study, but generally 
involves several short bursts of 50-100 stimuli at about 100 Hz. Theta-bursts 
are a popular technique to induce LTP and includes 4 current injections, 
separated by 200 ms each (called interburst intervals) at a rate of 100 Hz. 
This sequence of bursts mimics the frequency of input during the actual 
process of learning (Otto, Eichenbaum, Wiener, & Wible, 1991).  Inducing 
LTP is dependent on the intensity of these bursts as well as the frequency.  If 
the intensity is not high enough or the frequency not right, short-term 
potentiation (STP) or even post-tetanic potentiation (PTP) can be induced – 
each lasting for a shorter amount of time than LTP, with PTP lasting the 
shortest amount of time (Lovinger, Routtenbergt, Lovinger, & Routtenberg, 
1988; Malenka, 1991).   
The induction of LTP involves a few key components on a molecular 




needs to be large enough to eject the Mg2+-blocks of NMDA receptors while 
in the presence of glutamate.  If the depolarization is too weak or stimulus too 
infrequent, not all of the Mg2+-blocks will be ejected, resulting in either STP or 
PTP.  The NMDA receptors have been shown to be essential in the induction 
of LTP, although their activation alone is not usually enough to induce LTP 
(Bashir, Tam, & Collingridge, 1990) and may sometimes inhibit LTP (Coan, 
Irving, & Collingridge, 1989; Izumi, Clifford, & Zorumski, 1992).  Second, Ca2+ 
plays a very important and critical role in the induction of LTP; this is evident 
when the use of a Ca2+ chelator, like ethylene glycol tetraacetic acid (EGTA), 
inhibits the induction of LTP (Lynch, Larson, Kelso, Barrionuevo, & Schottler, 
1983).  However, NMDA receptors are permeable to Ca2+.  This feature of 
NMDA receptors, as well as the intracellular release of Ca2+, is thought to 
synergistically induce LTP (Bliss & Collingridge, 1993) since  LTP is inhibited 
when intracellular stores of Ca2+ are blocked or depleted (Bortolotto & 
Collingridge, 1993; Harvey & Collingridge, 1992; Obenaus, Mody, & 
Baimbridge, 1989).  Ca2+ is also thought to play an important role in the 
recruitment of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors– the second key component in LTP (Malinow & Malenka, 2002).  
Recruitment of AMPA receptors to the synapse after LTP induction is thought 
to be involved in the maintenance of LTP – as blocking exocytosis of these 
receptors to the synapse inhibits LTP (Maletic-Savatic, Koothan, & Malinow, 
1998).   Interestingly, blocking the NMDA receptor alone does not necessarily 




enough IP3 to increase internal concentrations of Ca
2+ (Bortolotto & 
Collingridge, 1993).   The NMDA receptor function is also known to be 
enhanced by PKC activation (Lovinger et al., 1988), and one of the ways to 




Figure 8. Induction of long-term potentiation. Normal synaptic transmission, which is low-
frequency, involves several types of glutamate receptors, including NMDA and non-
NMDA (metabotropic glutamate receptors, and AMPA) receptors. Glutamate activates 
non-NMDA receptors during normal transmission (and Na+ and K+ flow through) as 
NMDA-receptor have an additional Mg2+ block, requiring significant depolarization of the 
membrane to remove (top). When long-term potentiation is induced, the membrane is 
depolarized by non-NMDA receptors, removing the Mg2+ block, causing Ca2+ to flow 
through NMDA-receptors, increasing intercellular calcium concentrations and further 
depolarizing the cell. This action of the NMDA-receptor and the subsequent actions of 
calcium, and recruitment of AMPA receptors to the synapse is linked to LTP maintenance 
(bottom). Adapted from figure 63-10, Kandel et al. (2000), p. 1261. AMPA, α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid; Ca2+, calcium; Glu, glutamate; K+, 
potassium; Mg2+, magnesium; Na+, sodium; NO, nitric oxide; NMDA, N-methyl-D-





The α1-AR is important in promoting LTP and long-term depression 
(LTD) in the rat hippocampus – modulators of synaptic plasticity in the adult 
rodent (Scheiderer, Dobrunz, & McMahon, 2004).  Compared to other 
neurotransmitters like serotonin (5-HT) depleting NE reduces LTP (Stanton & 
Sarvey, 1985), and it is thought β-ARs mediate the induction and early 
maintenance of LTP (Pussinen & Sirviö, 1998).  It is unclear what role the α1-
AR plays in either LTP or LTD.  Several studies showed that NE mediates 
inhibition of excitatory transmission through the α1-AR, whereas the β-AR 
increases excitation (Mynlieff & Dunwiddie, 1988; Scanziani, Gähwiler, & 
Thompson, 1993); another found that activating the α1-AR suppressed 
endogenous LC output of NE onto pyramidal cells of the hippocampus, while 
NE activation of β-ARs excited pyramidal cells (Curet & de Montigny, 1988; 
Pang & Rose, 1987).  Despite there being a lack of evidence for an important 
role of α1-ARs in the initial induction or maintenance of LTP, a study by Izumi 
et al. (1992) showed that when LTP was inhibited, applying NE overcame this 
block. Additionally, this study showed that using α1-AR agonists specifically 
were responsible for overcoming the LTP inhibition and that using an α1-AR 
antagonist blocked the effect of NE (β- and α2-AR agonists and antagonists 
had no effect).  And as previously mentioned, the α1-AR pathway activates 
PKC and directly affects internal Ca2+ levels in the cell – which are both key 





2.4 Learning & memory testing paradigms 
 Multiple methods exist for testing cognition in animals, specifically 
learning and memory.  These methods can be adjusted for the species in 
question, for instance, mazes for rats are larger than those that accommodate 
a smaller rodent such as a mouse.  Careful attention is usually paid to the 
ratio of the maze to the size of the animal being tested so that this ratio 
remains the same between species.  One of the first behavioral tests to be 
designed for learning and memory was the Barnes maze (Barnes, 1979).  
The Barnes maze is a large circular platform with holes around the perimeter 
and spatial cues within the environment (section 5.2.2).  Beneath one of these 
holes is an escape box that the animal will eventually find and disappear into 
–based on an evolutionary instinct to escape open, bright areas and avoid 
predation.  Additional aversive stimuli besides bright lights, such as sounds 
and fans, can also be added to the test to increase the animal’s drive  to 
escape the open area.  This test relies on hippocampal-dependent spatial 
reference memory and the animals natural instinct to escape open areas 
(Harrison, Reiserer, Tomarken, & McDonald, 2006).  It was originally made 
for rats but has since been converted into a maze for mice as well.  Over 
time, mice learn the location of an escape box based on spatial cues set in 
the surrounding environment.  Thus after several days of training, they are 
able to remember where the escape box is and solve the maze more 
efficiently (with fewer errors) and quickly.  Barnes maze assesses errors 




assesses the amount of time taken to solve the maze, generally stopping at 
300 s or 5 min.  Training times can vary anywhere from 4-5 days, with testing 
occurring once or multiple times after training.  For more details concerning 
this maze, see section 5.2.2. 
 The Morris water maze (MWM) (Morris, 1984) is another behavioral 
test for hippocampal-dependent spatial learning and memory, though it is 
more stressful for animals than the Barnes maze (Harrison, Hosseini, & 
McDonald, 2009).  The MWM uses a large tub filled with water, visual cues, 
and a hidden platform to test memory (section 6.2.5).  This test may induce 
hypothermia because of the water component (Iivonen, Nurminen, Harri, 
Tanila, & Puoliväli, 2003) that can be offset with heat lamps and/or slightly 
longer inter-trial intervals (the time in between each training trial for each 
animal).  The advantage of using this maze is that it is faster to conduct 
experiments, as each training trial takes 1-2 min (depending on the protocol 
used) versus 5 min in the Barnes maze.  The MWM test is also thought to be 
neurogenesis-dependent (Dupret et al., 2008), making this test ideal for use 
in this research.  Procedures for this test can vary, but typically, it consists of 
3-5 days of training, with 4-6 trials per day per animal.  Each trial consists of 
1-2 min of swimming in the maze and searching for the hidden platform.  After 
the time is up, animals that did not successfully find the platform are placed 
on the platform for 15-30 s and allowed to observe the spatial cues in the 
area to better associate the location of the platform with the cues.  Probe 




platform is removed.  Then the animal is allowed to explore the maze for 1-2 
min.  Additionally, experimenters may add a reversal day, where 24 h after 
the probe test, the platform is placed in the opposite quadrant of where it was 
for the probe test.  How long it takes the animal to learn the new position is 
measured.  Typical data analyzed include distance travelled to platform, 
latency to the platform, and swim speed, but several other parameters may 
be assessed depending on the study (Vorhees & Williams, 2006; Wenk, 
2004).  For more information on the testing paradigm used in this dissertation, 
see section 6.2.5. 
 The novel object recognition (NOR) task was first developed to assess 
working memory (Ennaceur & Delacour, 1988).  In this task, animals are 
shown two identical objects and, a designated amount of time later, are 
shown one of the old objects and a new object (section 6.2.4).  Animals that 
remember the old object will spend more time exploring the new object.  The 
amount of time in between showing the animals the old objects and then 
adding the new object will assess different aspects of memory.  For instance, 
it was later found that NOR task also assesses spatial and non-spatial 
memory (Ennaceur & Meliani, 1992) and is hippocampal-dependent (Clark, 
Zola, & Squire, 2000).  NOR task can also be used to assess shorter 
retention periods, or short-term memory, if necessary (Hammond, Tull, & 
Stackman, 2004).  In fact, rats had intact retention times (i.e. remembering 
the old object and exploring the new more) up to 60 min after being shown 




24 h (Ennaceur & Meliani, 1992).  Therefore, depending on the procedural 
set-up, NOR task can be used to assess diverse aspects of memory.  
Typically, NOR task data is analyzed as the amount of time spent with the 
novel object over the familiar object, and preference of the novel object over 
the familiar object (percent time spent with the novel object versus the familiar 
object).  For more information about the procedural set-up used in this 







HIPPOCAMPAL NEUROGENESIS, LEARNING, MEMORY, & THE α1-
ADRENERGIC RECEPTOR  
3.1 Adult neurogenesis 
 In 1965, Joseph Altman and Gopal Das showed evidence of dividing 
neurons in the post-natal hippocampus – a process known as neurogenesis 
(Altman & Das, 1965).  They also unknowingly identified neural stem cells in 
the brain – those cells that could continually divide and give rise to new 
neurons.  Neurogenesis was only thought to occur during prenatal 
development at the time. Adult neurogenesis was undiscovered: the general 
consensus, up until the mid-twentieth century, was that mammals were born 
with a fixed number of neurons.  This perspective began to waiver as more 
evidence became available to support Joseph Altman’s initial evidence of 
postnatal neurogenesis (Eckenhoff & Rakic, 1988; Reynolds & Weiss, 1992).  
Eventually, by the late 1990’s, the “fixed-neuron” dogma finally came to an 
end.  When a landmark study done with humans showed neurogenesis 
occurring in adults as old as 72 (Eriksson et al., 1998), the paradigm shift 




Neurogenesis has been discovered in many areas of the brain since 
the initial discovery in the mid-twentieth century.  They include, but are not 
limited to, the striatum (Eckenhoff & Rakic, 1988), the olfactory bulb (Bédard 
& Parent, 2004), the amygdala and cortex (Bernier, Bedard, Vinet, Levesque, 
& Parent, 2002), the substantia nigra (Zhao et al., 2003), the hypothalamus 
(Kokoeva, Yin, & Flier, 2005), and the spinal cord (Fernández, Radmilovich, & 
Trujillo-Cenóz, 2002).  Since then, several areas of the brain have been 
identified as neurogenic niches, or areas where neurogenesis is occurring at 
a higher rate than other areas.  These neurogenic niches also have neural 
stem cells, or constitutively dividing cells that give rise to progenitor cells with 
limited self-renewal properties.  A controversial area, the subcallosal zone 
(Seri et al., 2006) and possibly another area in the hypothalamus (Kokoeva, 
Yin, & Flier, 2007) may contain these neural stem cells. The two widely 
accepted main areas are known as the subventricular zone (SVZ) of the 
lateral ventricle and the subgranular zone (SGZ) of the dentate gyrus (DG).  
Newborn cells from the SVZ travel via the rostral migratory stream to the 
olfactory bulb (Alvarez-Buylla & Garcia-Verdugo, 2002; Lois & Alvarez-Buylla, 
1994).  Newborn cells from the SGZ populate the hippocampus (Fig. 9) 
(Cameron & McKay, 2001; Lledo, Alonso, & Grubb, 2006; Ming & Song, 




Figure 9. The progressive discovery of neurogenic regions in the brain.  Pre-1990’s (upper 
left), late 1990’s (lower left) and present day (lower right).  Grey regions represent areas of no 
neurogenesis, red represents high neurogenic areas, and pink represent low neurogenic 
areas. Figure adapted from Gould, 2007. 
As previously discussed, the hippocampus is an important region for 
learning, memory, and neurogenesis.  Thus, hippocampal neurogenesis in 
the SGZ will be the focus and main example of neurogenesis referred to 
throughout the rest of this dissertation.  Hippocampal neurogenesis has five 
key stages of development, and six different cell types are expressed during 
those stages.  These are based on morphology, specific proteins expressed 
during development, and whether cells are mitotic or post mitotic as follows 
(Kempermann, Jessberger, Steiner, & Kronenberg, 2004; von Bohlen und 
Halbach, 2007): 
 Stage 1, mitotic – type-1 cell: dividing stem cells  
 Stage 2, mitotic – type-2a:  dividing progenitor cell without certain 
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3.2 Detecting and modifying adult neurogenesis 
 One of the most important immunohistological discoveries in detecting 
newborn cells was 5-bromo-2’-deoxyuridine (BrdU), a synthetic nucleotide 
that is incorporated into any dividing cell (Miller & Nowakowski, 1988) during 
the S-phase of the cell cycle.  BrdU is typically delivered by an intraperitoneal 
injection. The age of the animal at the time of injection and the amount 
injected can greatly affect the number of dividing neurons that are labeled 
(Cameron & McKay, 2001).  Depending on the amount injected, BrdU can 
also label events such as DNA repair, abortive cell cycle re-entry, and gene 
duplication (Bauer & Patterson, 2005; Nowakowski & Hayes, 2000; Taupin, 
2007).  In general, concentrations of BrdU given in neurogenesis studies are 
typically low enough to only mark mitotic cells in the S-phase (Bauer & 






Figure 11.  The stages of neurogenesis with coinciding markers. GFAP and nestin are widely 
used for the identification of neural stem cells (usually with another marker like Ki67 or BrdU), 
while DCX is popular for immature neurons, and NeuN for mature neurons. Figure from von 
Bohlen und Halbach, 2007. BrdU, 5-bromo-2’-deoxyuridine; DCX, doublecortin; GFAP, glial 
fibrillary acidic protein; Ki67, Kiel 67; NeuN, neuron-specific nuclear protein; NeuroD, 
neurogenic differentiation factor; Pax-6, Paired box protein; PSA-NCAM, polysialylated -
neural cell adhesion molecule; TUC-4, TOAD, Turned On After Division, Ulip/CRMP-4; Tuj-1, 
neuron-specific class III beta-tubulin. 
 Another important marker for detecting neurogenesis is a microtubule 
binding protein called doublecortin (DCX).  DCX is an important protein that 
aids the newborn cell in migrating (Gleeson, Lin, Flanagan, & Walsh, 1999) 
and is heavily expressed in the dendrites of new neurons, making it useful to 
study dendrite growth as well (Rao & Shetty, 2004).  Because DCX 
coexpresses with nearly 90% of BrdU-positive cells (Fig. 12, Brown et al., 
2003), it has been suggested that DCX detection alone is enough to 
determine levels of neurogenesis (Couillard-Despres et al., 2005).  Using 
DCX alone would bypass the need for intraperitoneal injections of BrdU and 






Figure 12.  Expression of DCX, NeuN and BrdU in the adult female rat dentate gyrus of the 
hippocampus.  In the above diagram from Brown et al., 2003, up to 90% of BrdU-positive 
cells (y-axis) are also colabeled with DCX-positive labeling.  This peak occurs from day 4 - 7 
after BrdU injection (x-axis). DCX- and BrdU-positive cells drop sharply after 14 days, 
disappearing almost entirely at 30 days.  Other markers, like NeuN, show a sharp increase 
after 14 days as this marker typically denotes mature neurons (n = 4 mice per group, mean ± 
SEM).  DCX, doublecortin; NeuN, neuron-specific neuronal peptide; BrdU, 5-bromo-2’-
deoxyuridine. 
Other important markers of neurogenesis include nestin, 
polysialylated-neural cell adhesion molecule (PSA-NCAM), and neuron 
differentiation protein (NeuroD).  Nestin is an intermediate filament protein 
expressed through stages 1 and 2 of neurogenesis in stem and progenitor 
cells (Messam, Hou, & Major, 2000).  PSA-NCAM is an important molecule 
for neuroblast migration and is expressed mainly in stage 2 of neurogenesis 
(Seki, 2002).  NeuroD is a basic helix-loop-helix protein that is expressed 
during differentiation from progenitor to immature neuron (Lee et al., 1995).    
An excellent review by von Bohlen und Halbach (2007) summarizes in 
detail several markers for all of the adult neurogenesis stages, and includes 




neurons and even glial cells.  Some of this marker information is summarized 
in Table 5. 
Table 5 
Markers of Stages in Adult Neurogenesis 







HMG-box gene 2 
Glial fibrillary 
acidic  protein 
(GFAP) 
Neuron-specific class 
III beta-tubulin (Tuj-1) 
Calretinin 
Kiel 67 (Ki-67) Musashi-1 Vimentin T-box brain gene 2 Calbindin 
Phosphohistone 3 
(PhisH3) 












Doublecortin (DCX)  
 
These common markers of neurogenesis help scientists determine the 
stage of neurogenesis a neuron is in, and also helps determine levels of 
neurogenesis.  Normal physiological levels of neurogenesis can be influenced 
by environmental, pharmacological, and genetic manipulations.  Beneficial 
environmental influences that increase neurogenesis in the brain include 
estrogen, (Fowler, Liu, & Wang, 2008; Tanapat, Hastings, Reeves, & Gould, 
1999), voluntary exercise (van Praag, Christie, Sejnowski, & Gage, 1999), 
environmental enrichment (Bekinschtein, Oomen, Saksida, & Bussey, 2011), 
and electroconvulsive therapy (Madsen et al., 2000) which all increase cell 
proliferation in the dentate gyrus. Detrimental environmental influences that 
decrease neurogenesis include factors such as the adrenal hormone 
corticosterone (Gould, Cameron, Daniels, Woolley, & McEwen, 1992), stress 




Barrot, Schad, Self, & Nestler, 2000), all of which decrease cell proliferation in 
the dentate gyrus. 
In order to assess what purpose neurogenesis serves in the brain, 
scientists can deplete or even knock out neurogenesis and then observe the 
subsequent behavioral, cellular, or molecular result.  Several pharmacological 
approaches to depleting neurogenesis in the hippocampus exist.  Two of the 
most common are by using methylaoxymethanol acetate (MAM) and cytosine 
arabinoside (Ara-C), which are both anti-mitotic agents (Ko et al., 2009; van 
Pelt, de Haan, Vellenga, & Daenen, 2005).  However, one of the advantages 
to using Ara-C is that it is a common chemotherapy agent and therefore has 
more translational relevance (Li et al., 2008).  Ara-C is thought to work by 
interfering with cell cycle kinetics, causing cell cycle arrest just 2 h after 
administration of BrdU (van Pelt et al., 2005).  After Ara-C treatment ceases, 
however, the cell cycle resumes and regular incorporation of BrdU occurs in 
6-12 h (Doetsch, García-Verdugo, & Alvarez-Buylla, 1999).  Several 
mechanisms of action have been proposed to explain how Ara-C works to 
stop cellular proliferation by interrupting the cell cycle.  Among them include a 
Bax-dependent apoptosis hypothesis (Besirli, Deckwerth, Crowder, Freeman, 
& Johnson, 2003), incorporation into DNA and RNA causing inhibition of 
polymerase α and β, and impairment of DNA repair mechanisms (Braess et 
al., 1999).  The exact mechanism of action of Ara-C is controversial and 




Genetic manipulations of neurogenesis enable scientists to more 
specifically examine the purpose of neurogenesis and how it works, without 
having to interrupt other cellular processes.  Therefore, multiple genetic 
manipulations have been produced to influence adult neurogenesis 
expression.  A few of these are listed in table 6 (Filipkowski, Kiryk, Kowalczyk, 
& Kaczmarek, 2005) below. 
Table 6* 
Effects of KO mutations on adult neurogenesis 
Gene/Protein Name/Function Effects on ANGE Site Reference 
Cyclin D2 Cell cycle reg. protein Complete reduction DG, OB Kowalczyk et al., 1994 
Tlx (tailless)/Tlx Transcription factor Complete reduction DG, SVZ Shi et al., 2004 
nNOS Neuronal NO synthase Enhancement SVZ, OB, DG Packer et al., 2003 
BDNF Growth factor Reduction DG Lee et al., 2002 
IGF1 Insulin-like growth factor Enhancement DG Cheng et al., 2001 
CB1R Cannabinoid receptor Reduction DG, SVZ Jin et al., 2004 
VR1 Vanilloid receptor Enhancement DG, SVZ Jin et al., 2004 
GIPR GIP receptor Reduction DG Nyberg et al., 2005 
MR Mineralocorticoid receptor Reduction DG Gass et al., 2000 
NK1R Neurokinin-1 receptor Enhancement DG Morcuende et al., 2003 
mCD24 Membrane-assoc. molecule Enhancement DG, SVZ Belvindrah et al., 2002 
Sox2 Transcription factor Reduction DG, SVZ Ferri et al., 2004 
Naglu α-N-acetylglucosaminidase Reduction DG, SVZ Li et al., 2002 
Cystatin Cysteine protease inhibitor Reduction DG Pirttila et al., 2004 
Bax Proapoptotic Bcl-2 Enhancement DG Sun et al., 2004 
*This table is adapted from table 1 in Filipkowski et al., 2005, and includes all manipulations that affect the DG.  
Note that references listed in this table do not necessarily appear in the “References” section. For further 
information on each manipulation, please refer to Filipkowski et al., 2005. DG, dentate gyrus; SVZ, subventricular 
zone; OB, olfactory bulb. 
 Other conditional genetic manipulations – meaning the manipulation 
can be turned on and off – have since been developed (table 7).  These 
genetic manipulations are often referred to as “Cre/loxP” and “Flp” 
recombinase systems. Developed in the early 2000’s, these manipulations 
are helpful in ascertaining a neuron’s current developmental stage (also 
known as fate-mapping).  They work by using a promoter common only to 




specific ligand, usually tamoxifen and sometimes tetracycline, is introduced, 
cells recombine their genes, or mutate, so that the promoter that usually 
signals cell proliferation is skipped (Feil et al., 1996). 
Table 7* 
Neural stem cell-promotor tamoxifen-inducible and tetracycline-regulated mice 
Name Promotor Type Reference 
Tamoxifen-inducible    
GRAP-CreERT2 huGFAP Cre-ERT2 Hirrlinger et al., 2006 
GLAST::CreERT2 Knockin to endogenous GLAST locus Cre-ERT2 Mori et al., 2006 
Nestin-CreER Nestin second intron/Hsp-68 minimal Cre-ERT1 Burns et al., 2007 
Nes-CreER(T2) Nestin/Nestin second intron Cre-ERT2 Imayoshi et al., 2006 
Nestin-creERtm Nestin promoter and second intron Cre-ERT1 Kuo et al., 2006 
Ngn2-CreERTM Knockin to endogenous Ngn2 locus Cre-ERT1 Raineteau et al., 2006 
    
Tetracycline-regulated    
Nestin-rtTA-M2 Nestin/Nestin second intron rtTA-M2 Yu et al., 2005 
Nestin-tTA Xh5 plasmid (large fragment including 
Nestin promoter/introns/exons) 
tTA Beech et al., 2005 
    
*Table adapted from table 2 in Gage, Kempermann, Song (2008), p. 62. Note that references within this table 
do not necessarily appear in the “Reference” section of this dissertation.  
3.3 Learning, memory and adult neurogenesis 
Though adult neurogenesis was discovered nearly 50 years ago, 
controversy still exists over whether or not adult neurogenesis is important to 
cognition – specifically learning and memory.  Several studies have shown 
that neurogenesis is important for hippocampal-dependent learning and 
memory tasks (Bruel-Jungerman, Laroche, & Rampon, 2005; Dupret et al., 
2008; Gould, Beylin, Tanapat, Reeves, & Shors, 1999; Snyder, Hong, 
McDonald, & Wojtowicz, 2005) while another shows that neurogenesis may 
only be important for some hippocampal-dependent learning tasks (Shors, 
Townsend, Zhao, Kozorovitskiy, & Gould, 2002).  Additionally, a recent review 




times in their development, may contribute to different aspects of learning and 
memory – such as pattern separation (Deng, Aimone, & Gage, 2010).   
It has been shown that higher levels of cell proliferation and numbers 
of new neurons correlated with better spatial memory, whereas lower levels of 
neurogenesis correlated with poorer memory in aged rats (Drapeau et al., 
2003).  In addition, inhibiting neurogenesis negatively affects learning and 
memory.  For instance, mice that underwent low-dose x-irradiation to focally 
ablate hippocampal neurogenesis performed poorly in a behavioral test for 
spatial discrimination, compared to those with intact neurogenesis (Clelland et 
al., 2009).  Neurogenesis is important for the formation of hippocampal-
dependent memories and when neurogenesis is knocked-down with a toxin 
specific to proliferating cells (methylazoxymethanol acetate) this formation is 
impaired (Shors et al., 2001).  Additionally, prenatal stress-induced learning 
deficits are also associated with inhibition of neurogenesis in the 
hippocampus (Lemaire, Koehl, Le Moal, & Abrous, 2000). 
Adult neurogenesis is also implicated in the enhancement of 
hippocampal synaptic plasticity – the underlying mechanism for learning and 
memory (see chapter 2.3).  Adult born hippocampal granule cells have a 
lower threshold to induce LTP (Ge, Yang, Hsu, Ming, & Song, 2007) and are 
more sensitive to excitatory input (Couillard-Despres et al., 2006; Schmidt-
Hieber, Jonas, & Bischofberger, 2004).  Furthermore, young neurons 
generated in the adult mouse have been shown to play a significant role in 




2001).  NMDA receptors have a significant role in the induction of LTP (see 
chapter 2.3) and have also been shown to be important in the process of 
neurogenesis (Nacher & McEwen, 2006). Blocking NMDA receptors 
increases neurogenesis in the DG and also the density of neurons in the 
granule cell layer of the DG – showing the regulatory effects of excitatory 
amino acids on neurogenesis (Cameron, McEwen, & Gould, 1995).  
Additionally, NMDA receptor levels have been shown to positively correlate 
with hippocampal dependent learning abilities (Adams et al., 2001), further 
strengthening the connection between neurogenesis, learning and memory, 
and synaptic plasticity. 
3.4 Adult neurogenesis and the α1-adrenergic receptor 
As previously mentioned, a substantial amount of efferent NE 
projections from the locus coeruleus synapse onto the mammalian 
hippocampus (Blackstad et al., 1967).  The SGZ of the DG has more of these 
NE-innervations than other regions of the hippocampus (Loy, Koziell, Lindsey, 
& Moore, 1980).  It is easy to see that the AR system may have an important 
role in adult neurogenesis, especially in the SGZ of the DG. In fact, depleting 
catecholamines in the brain, such as NE, with reserpine caused drastic 
decreases in neurogenesis (Lewis, Patel, Béndek, & Balázs, 1977).  
Furthermore, selectively depleting NE with a noradrenergic neurotoxin (N-(2-
chloroethyl)-N-ethyl-2-bromo-benzylamine hydrochloride) reduced neural 
stem cell proliferation, specifically, but did not affect survival and 




serotonin, activated precursor cell populations from the adult hippocampus 
(Jhaveri et al., 2010).  However, the AR subtype mediating this response is 
controversial. 
The α1-, α2-, β1- and β2-ARs are all present in the DG of the 
hippocampus (see table 2, section 1.4) in varying amounts.  One study found 
that directly activating the β2-ARs led to an increase in type-2A progenitor 
neurons, and increases neurogenesis both in cell culture and in the 
hippocampus (Masuda et al., 2012).  Surprisingly, the β3-AR was not detected 
in the DG (see table 2), but another study showed that proliferation of neural 
precursors in the DG was specifically mediated by the β3-AR (Jhaveri et al., 
2010).  The opposite was found with agonizing α2-AR, where activating this 
subtype caused a decrease (Yanpallewar et al., 2010) in hippocampal 
neurogenesis and blocking it caused an increase (Veyrac, Didier, Colpaert, 
Jourdan, & Marien, 2005; Yanpallewar et al., 2010).  However, there is still 
controversy over whether blocking the α2-AR causes an increase in 
neurogenesis by a selective effect that increases proliferation via α2-AR 
directly located on neural stem and progenitor cells (Yanpallewar et al., 2010) 
or by increasing the long-term survival by reducing apoptosis in newborn 
neurons (Rizk et al., 2006). 
There are significant concentrations of the α1D-AR in the DG, but 
interestingly, this receptor may mediate a stress response in the 
hippocampus (Campeau et al., 2010), and has not been shown to be linked to 




the α1B-AR has a slightly lower concentration in this area (see table 3, section 
1.4), comparable to α1D-AR levels.  The α1A- and α1B-AR have both been 
shown to regulate gliogenesis and neurogenesis in the subventricular zone of 
the brain – the other highly neurogenic region besides the SGZ (Gupta et al., 
2009). This study also found α1A-ARs present on stem cells and early 
progenitor cells.   Therefore, it is highly possible that α1A-AR activation in the 








NEUROGENESIS, METABOLISM, & EXERCISE 
4.1 The role of adrenergic receptors in metabolism 
Norepinephrine plays an important role in metabolism via the 
hypothalamus.  It is known that noradrenergic projections into the ventral medial 
hypothalamus (VMH) convey important information to the CNS regarding the 
tissue in the PNS, and also serve as part of the communication pathway between 
the brain and the periphery for fatty acid oxidation during exercise (Miyaki et al., 
2011).  Several subtypes of ARs are expressed in the hypothalamus of the brain 
(tables 2 and 3, sect 1.4).  Research shows a high density of α1A-ARs, a 
moderate density of α1B-ARs and α2A-ARs, and low amounts of α2C-ARs in the 
mouse hypothalamus (Papay et al., 2006).  And according to table 2, no β-AR 
subtypes were detected in the hypothalamus, but the β1- and β2-AR seem to play 
a role in conjunction with the α1-AR as their activation causes inhibition of food 
intake (Racotta & Soto-Mora, 1993).  In contrast, activating the α2-AR causes an 
increase in food intake (Goldman, Marino, & Leibowitz, 1985; Leibowitz, 1988).  
Taking a closer look at the α1-AR, and specifically the α1A-AR, this receptor may 




The α1-AR agonist, cirazoline (CRZ), causes acute activation of these 
receptors in the paraventricular hypothalamic nucleus (PVN) affecting feeding 
behavior by decreasing food intake and appetite (Davies & Wellman, 1992; Rossi 
& Scharrer, 1994; Wellman & Davies, 1992).  Though several subtypes of the AR 
family are implicated in metabolism, the α1-AR is most relevant to these studies 
and therefore will be emphasized throughout this chapter.  
4.2 Neurogenesis and metabolism 
Typically, studies have connected the brain to obesity and metabolism by 
focusing on hormonal regulators of appetite and satiation, such as appetite-
suppressing leptin and appetite-stimulating ghrelin (Elmquist, Elias, & Saper, 
1999; Nakazato et al., 2001).  Both leptin and ghrelin have receptors located on 
neurons in the hypothalamus – a metabolic center – in the central nervous 
system (Guan et al., 1997; Hâkansson, Brown, Ghilardi, Skoda, & Meister, 1998).  
More recently, neurogenesis in the hypothalamus became the new connection 
between the brain and obesity (Park, Baum, Paredes, & Tobet, 1996; Pencea, 
Bingaman, Wiegand, & Luskin, 2001).  Within the last decade, studies of 
neurogenesis in the hypothalamus revealed that new hypothalamic neurons play 
a role in energy balance and weight maintenance (Kokoeva et al., 2005; Pierce & 






Figure 13. Diagram of the hypothalamus.  Hypothalamic nuclei, the neurogenic region of the 
hypothalamus, and the third ventricle (A; figure from Morton, Cummings, Baskin, Barsh, & 
Schwartz, 2006); Median eminence revealing hypothalamic neurogenesis (B; figure from Bennett, 
Yang, Enikolopov, & Iacovitti, 2009). DMN, dorsal medial nucleus; VMC, ventral medial nucleus; 
ARC, arcuate nucleus; ME, median eminence;  PFA, parafornical area; FX, fornix. 
Hypothalamic neurogenesis appears to influence normal weight 
maintenance, metabolism, and energy balance (Lee & Blackshaw, 2012).  
Hypothalmic neurons that seem to play a role include the orexigenic 
neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons and the 
anorexigenic proopiomelanocortin (POMC) neuron.  NPY/AgRP neurons in 
newborn mice have no impact on feeding, yet in adult mice they are essential 
(Luquet, Perez, Hnasko, & Palmiter, 2005).  A sudden loss of AgRP neurons 
causes severe anorexia in adult mice (Gropp et al., 2005).  However, a gradual 
loss of AgRP neurons had no effect on weight or fat deposits until a proliferation-
blocking drug was added (cytosine arabinoside, Ara-C), which induced significant 
fat loss (Pierce & Xu, 2010).  These results suggest that neurogenesis in the 





Figure 14.   The satiety and reward circuits of the hypothalamus.  Arrows show the connections 
between the different neurons (blue circles) located there (Morton et al., 2006).  PVN, 
paraventricular nucleus; LHA, lateral hypothalamic area; PFA, parafornical area; ARC, arcuate 
nucleus; NTS, nucleus of the solitary tract; 3V, third ventricle; Npy/AgRP GABA, neuropeptide Y/ 
agouti-related peptide –aminobutyric acid; POMC, proopiomelanocortin. 
4.3 Norepinephrine, adrenergic receptors and exercise 
 The fight or flight response of the sympathetic nervous system activates 
our EPI and NE systems in the body.  Naturally, it would be logical to assume 
that when running, or exercising, EPI levels rise in the periphery, and NE levels 
rise in the brain.  Experimentally, this was confirmed, as NE brain levels in 
running rats were compared to their sedentary counterparts, and the levels in the 
running group were significantly higher than the sedentary group (Brown & Huss, 
1973; Brown, Payne, & Kim, 1979).  This result was confirmed again nearly 20 
years later with a more sophisticated test for NE metabolites in the brain after 
exercise, again finding that exercise increased NE metabolites in areas of the 
brain containing NE cell bodies and NE terminals (Dunn & Reigle, 1996).  




hippocampus (Chen & Russo-Neustadt, 2005).  And as previously mentioned in 
section 1.2, PI3 is part of the α1-AR second-messenger pathway (Fig. 5).  
Therefore, it is possible that the α1-AR is a key mediating receptor between 
increased NE levels and exercise.  
4.4 Exercise-induced neurogenesis 
 As adult neurogenesis became a burgeoning field in the late 1990’s, 
studies began to surface observing increases in neurogenesis correlated with 
running (van Praag, Kempermann, & Gage, 1999), while physical activity 
appeared to have the opposite effect on microglia cell populations (Kohman, 
DeYoung, Bhattacharya, Peterson, & Rhodes, 2012).  Upon further investigation, 
exercise-induced neurogenesis was shown to enhance learning and memory in 
mice (van Praag, Christie, et al., 1999).  Other studies echoed these results 
(Snyder, Glover, Sanzone, Kamhi, & Cameron, 2009), and even showed that the 
usual learning and memory impairments accompanying aging can be offset by 
voluntary exercise (van Praag, Shubert, Zhao, & Gage, 2005).  However, 
whether or not neurogenesis is important for enhancing learning and memory is 
still controversial (Rhodes, Gammie, & Garland, 2005).  
As investigations into exercise-induced neurogenesis increased, 
complications arose.  For instance, different strains of mice respond much 
differently to exercise-induced neurogenesis (Clark et al., 2011).  For instance, 
the C57BL/6J mice showed the least difference in running-mice versus 




which showed the greatest difference.  Another confounding factor was that 
many exercise-induced neurogenesis studies were not tracking how far mice 
were running, which generally correlates with the amount of neurogenesis 
induced (Castilla-Ortega et al., 2013).  The type of running can also affect the 
amount of neurogenesis induced from exercise. For instance, one study found 
that voluntary resistance running induced significantly higher levels of 
neurogenesis in mice compared to regular “free-load” running (Lee et al., 2013).  
And running in wild rodents induces little to no effect on neurogenesis levels 
(Klaus & Amrein, 2012) further complicating the question of what the relationship 
is between exercise and neurogenesis, if any.  This nascent field has many 
questions left to address, especially regarding which receptors may be mediating 
exercise-induced neurogenesis.  Many studies show links between exercise 
induced neurogenesis and several different neurotransmitters (e.g., NE, 
serotonin, acetylcholine, and γ-aminobutyric acid), as well as brain-derived 
neurotrophic factor (Ma, 2008), but receptors mediating this response remain 
elusive. 
There are many similarities between the consequences of exercising and 
the consequences of activating the α1A-AR.  Exercising increases NE levels in 
the brain (Brown & Huss, 1973), increases heart mass (Brown & Huss, 1973), 
increases neurogenesis (van Praag, Kempermann, et al., 1999), and decreases 
anxiety-like behavior (Duman & Schlesinger, 2008).  Activating the α1A-AR with 
NE increases heart mass (when chronically activated) (Papay, Shi, Piascik, Naga 




decreases anxiety-like behavior (Doze et al., 2011).  These similarities lead to 
the question of whether or not exercise-induced neurogenesis, along with the 




















LONG TERM α1A-ADRENERGIC RECEPTOR STIMULATION ENHANCES 
COGNITIVE FUNCTION AND SYNAPTIC PLASTICITY 
5.1.  Introduction 
In this study, transgenic mice engineered to express a constitutively 
activated mutant-α1AAR and normal mice treated with an α1A-AR-selective 
agonist, cirazoline (CRZ), were used to determine the effects of chronic α1A-AR 
stimulation on learning, memory and synaptic plasticity.  We used the Barnes 
maze to test cognitive function and electrophysiology to test for enhanced 
synaptic plasticity to determine whether chronically or transgenically activating or 
knocking out the α1A-AR enhances these functions.  Our results may afford a 
potential new strategy for treating the decline in cognitive function with aging and 
other neurological disorders.  
5.2.  Methods 
5.2.1.  Transgenic mice 
This study utilized 26 male and female transgenic CAM-α1AAR mice (on a 
B6/CBA background) and 34 wild type (WT) littermate controls, along with 12 
male and female α1A-AR KO mice. CAM-α1Aadrenergic receptors were mutated 




the G-protein inside of the cell to continually signal (Hwa, Graham, & Perez, 
1996).  For α1A-AR KO mice, the α1A-AR exon was replaced with the LacZ exon 
(Papay et al., 2006).  Mice were bred and genotyped at the Cleveland Clinic 
Foundation and then transferred to the University of North Dakota’s AAALAC-
accredited animal care facility.  Mice were maintained on a 12 h light/dark cycle 
(lights on 0500) and housed in 17 x 28 x 13-cm translucent, polycarbonate boxes 
attached to an automatic watering system (Edstrom Industries, Inc, Waterford, 
WI, USA), and were provided ad libitum access to pelleted food with 5% fat 
(Teklad 22/5 Rodent Diet (W) 8640, Harlan, Indianapolis, IN, USA).  Room air 
was 100% exchanged 12-40 times per h with no recirculation, the temperature 
was 22°C, and the humidity was 23-27%.  Mice were identified by ear tags 
placed at the Cleveland Clinic.  The experimental protocols employed in this 
study conform to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health and were approved by the 
Animal Care and Use Committees at both institutions.    
5.2.2.  Barnes maze 
Mice were aged 3-6 mo, except for mice treated long-term with cirazoline, 
which were aged 6-11 mo.  Mice were acclimated in separate cages in the 
testing room for 30 min prior to Barnes maze testing, and deprived of food and 
water for the duration of the test.  The Barnes maze (Fig. 15) was performed 
between 0800 and 1200 h. The Barnes maze was used to assess spatial 
learning and memory in mice with a modified protocol (Harrison et al., 2006).  




elevated 140 cm above ground (Med Associates, St. Albans, VT, USA).  An 
escape box (21 x 5.5 x 5 cm), not visible from the top of the maze, was located 
under one of 40 holes (5 cm in diameter) evenly spaced, 3.5 cm apart, around 
the perimeter.  Three visual cues were placed on a black curtain surrounding the 
maze, and their locations in relation to the escape box remained the same 
throughout the experiment.  Two flood lights (1700 total lux) and four evenly 
spaced fans, above the maze, provided aversion (Hong et al., 2007).  Between 
trials, the apparatus was cleaned with alcohol.  All testing was video captured, 
performed, and analyzed blind to mouse type. 
The first four days consisted of four learning trials with 30 min intervals 
between trials.  At the start of each trial, a mouse was placed in the center of the 
maze under a holding chamber for 30 s.  When the chamber was lifted, timing of 
the trial began and the mouse was allowed up to 300 s to enter the escape box.  
If a mouse failed to enter after the allowed time, it was gently placed into the hole 
containing the escape box for 30 s.  Memory trials were conducted on days 1, 4, 
5, and 8 (transgenic mice) and days 1, 4, and 6 (cirazoline-treated mice) after the 
four days of training.  The procedure for the memory trials was the same as 
learning, except the mice were allowed only one attempt to solve the maze each 
day.  Later analysis included the time to solve, number of errors made, and 
distance traveled on the maze.  Errors were defined as when a mouse poked 
more than three-quarters of its head into any hole other than the appropriate 
escape hole.  Distance traveled was measured using ANY-maze software 




Figure 15.  Barnes maze apparatus. (Top left) Mouse navigating the Barnes maze based on 
spatial cues shown in bright pink and black. (Top right) Aversive stimulus was produced with 
bright flood lights and fans. (Bottom left) Barnes maze on raised pedestal, showing a large 
black curtain draped around the apparatus to block distractions. (Bottom right) Mouse in red 
mouse house moments after being placed on the maze (house will be removed once mouse 
exits the house). 
5.2.3.  Hippocampal slice preparation 
The effects of long-term chronic α1AAR stimulation on synaptic 
transmission and plasticity were examined in aged mice.  Hippocampal slices 
were prepared from 22-24 mo old mice as follows.  Mice were weighed, deeply 
anesthetized with isoflurane, and then immediately decapitated.  The brain was 
removed quickly and placed in ice cold oxygenated choline chloride solution (110 




mM C3H3NaO3, 2.50 mM KCl, 1.25 mM NaH2PO4, 0.50 mM CaCl2).  While 
submersed, hippocampi were removed and placed on a tissue chopper.  Coronal 
brain slices were cut 400 m thick and immediately transferred to an oxygenated 
holding chamber filled with aCSF (119 mM NaCl, 5.0 mM KCl, 1.3 mM MgSO4, 
2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3) warmed to 32 ± 1C in a 
water bath for approximately 30 min.  Slices were then removed from the water 
bath and allowed to cool to room temperature (22 ± 1C).  After 15 min, the 
entorhinal cortex and CA3 region of each slice were quickly removed.  Slices 
were then returned to the holding chamber and allowed an acclimation period of 
approximately 2 h.  Slices were transferred to recording chambers in preparation 
for electrophysiological recordings, where they were constantly perfused with 
oxygenated aCSF at a rate of 1.5 mL/min at 22 ± 1C.   
5.2.4.  Electrophysiology recordings 
Recording electrodes were made from glass micropipettes backfilled with 
3 M NaCl solution.  The electrodes were placed in the stratum radiatum of the 
hippocampal cornu ammonis (CA) 1 region.  Evoked field excitatory post-
synaptic potentials (fEPSPs) were recorded and measured using a BVC-700A 
Cornerstone amplifier (Dagan Corporation, Minneapolis, MN, USA) in current 
clamp mode with 100X gain.  An ISO-flex stimulator (A.M.P.I., Jerusalem, Israel) 
paired with a 7.5 cm bipolar tungsten stimulating electrode (World Precision 
Instruments, Sarasota, FL, USA) was used for presynaptic stimulation of the 




region and the recording electrode (Fig. 16).  Signals were converted from 
analog to digital using Axon Digidata1440A Data Acquisition System (Molecular 
Devices Inc., Sunnyvale, CA, USA), and electronic cycling and noise was filtered 
using a HumBug 50/60 Hz noise eliminator (Quest Scientific, Vancouver, BC, 
Canada).  Recordings were made using Axon Instruments Clampex v10.2.  Basal 
synaptic transmission was assessed using input-output (I/O) curves, generated 
by applying a stepwise increase in stimulation intensity with a range of 5-80 A, 
using increments of 5 A.  Responses were elicited every 20 s with a duration of 
100 s per pulse.  For subsequent experiments, the stimulus was set to 
approximately 50% of the maximal response.  Short-term plasticity was 
investigated by assessing paired-pulse facilitation (PPF) by applying two pulses 
with inter-pulse intervals of 35, 50, 75, 100, 150, 200, and 300 ms.  A baseline 
response of 30 min was recorded immediately after PPF, which was followed by 
theta burst stimulation (TBS = 10 trains, each train of 4 pulses at 100 Hz, inter-
train interval of 200 ms, total train duration of 40 ms) given at 80% maximal 
response to induce LTP.  fEPSPs were then recorded at 50% maximal response 





Figure 16.  Stimulating LTP in the CA1 region of the hippocampus.  The stimulating electrode 
(left) injects a stimulus to the Schaffer collaterals that synapse on neurons in the CA1 region of 
the hippocampus.  The recording electrode (right) records the response of the neurons there. CA, 
cornu ammonis; LTP, long-term potentiation. 
5.2.5.  Cirazoline treatment 
Normal, non-transgenic WT mice received bottled water containing 
cirazoline at 10 mg/L for 2 - 9 mo.  This concentration was chosen based on the 
binding values of the α1A-AR versus the α1B-AR (Hwa et al., 1996).  The water 
was changed weekly or biweekly as needed.  Food was provided ad libitum.  No 
adverse side effects were observed during treatment, or in CAM-α1AAR mice. 
5.2.6.  Statistical analysis 
All results were analyzed using GraphPad Prism 5.0 (La Jolla, CA, USA).  
Statistical comparisons were performed between both male and female CAM α1A-
AR mice and their WT littermate controls using a Student's unpaired t-test.  
Electrophysiological data was analyzed using Clampfit v10.2 (Molecular Devices, 
Sunnyvale, CA, USA) and Prism 5.0 (GraphPad, La Jolla, CA, USA).  Analysis of 




A increments.  PPF analysis compared the slope of the second elicited fEPSP 
to the first elicited fEPSP.  Fiber volley amplitude was also analyzed to assess 
basal synaptic transmission.  Pre- and post-TBS baselines were analyzed by 
measuring fEPSP slope every 20 s, and comparing the average pre-TBS 
baseline slope to the average post-TBS baseline slope for both CAM α1A-AR and 
WT mice.  fEPSP slopes were expressed as a ratio of the pre-TBS baseline and 
normalized to the pre-TBS baseline. Data are presented as mean ± SEM.  
Significance levels were taken as * p < .05, ** p < .01, or *** p < .001. 
5.3.  Results 
5.3.1.  Chronic stimulation of the α1AAR enhances learning and memory 
 Learning and memory were assessed using the Barnes mazes – widely 
accepted as a hippocampal-dependent task of spatial learning and memory.  The 
time to solve, number of errors, and distance traveled are inversely correlated 
with learning and memory.  As shown in Fig. 17, CAM α1A-AR mice (n = 15) 
showed enhanced cognition when compared to WT mice (n = 17).  During 
learning trials, CAM α1A-AR mice took less time to solve the maze (56 ± 8.9 s) 
(inset, Fig. 17A1) when compared to WT mice (87 ± 9.8 s) [t(30) = 2.26,  p < .05].  
CAM α1A-AR mice also made fewer errors during learning trials (9.7 ± 1.1) (inset, 
Fig. 17A2) than the WT mice (18.0 ± 2.0) [t(30) = 3.46,  p < .001].  During 
memory trials, the CAM α1A-AR mice remembered the location of the escape box 
better than the WT mice, shown by a decreased mean solve time (21 ± 3.5 s) 




CAM α1A-AR mice also made fewer errors (5.2 ± 0.6) (inset, Fig. 2B2) than the 
WT mice (10.7 ± 1.3) [t(30) = 3.56,  p < .001]. 
 
Figure 17.  Chronic α1A-AR stimulation improves cognitive performance in the Barnes maze.  
During learning trials, CAM α1A-AR mice (n = 17) took less time to solve the maze (A1) and made 
fewer errors (A2) when compared to the WT mice (n = 15).  During memory trials, CAM α1A-AR 
mice took less time to solve the maze (B1) and made fewer errors (B2) compared to WT mice.  
Schematic drawings represent paths traveled during learning (C1) and memory (C2) trials of the 
WT and CAM α1A-AR mice.  The bar graph insets show the mean solve time and errors during 
learning and memory trials.  Statistically significant at * p < .05, ** p < .01 or *** p < .001.  CAM, 




5.3.2.  Aged CAM α1A-AR mice have enhanced synaptic plasticity 
To assess whether the cognitive behavioral gains seen in CAM α1A-AR 
mice correlated with enhanced hippocampal plasticity, several cellular properties 
were investigated using electrophysiology, including basal synaptic transmission, 
short-term plasticity as assessed by PPF, and long-term plasticity (i.e., LTP).   
Basal synaptic transmission was investigated by analyzing the fEPSP 
slope at various stimulus intensity intervals (10-80 μA) and plotting it against fiber 
volley amplitude.  As illustrated in Fig. 18A, a significant difference was observed 
in the mean I/O slopes of basal synaptic transmission between CAM α1A-AR mice 
(2.92 ± 0.48, n = 8) and WT mice (1.11 ± 0.07, n = 9; p < 0.001) (Fig. 3A, inset).  
These findings suggest that basal synaptic transmission is enhanced in CAM α1A-
AR mice compared to WT. 
The slope ratio of fEPSP was calculated by taking the slope of the second 
elicited fEPSP and dividing it by the first elicited fEPSP in PPF experiments.  
Inter-pulse intervals were then set at 35, 50, 75, 100, 150, 200, or 300 ms.  As 
shown in Fig. 18B, significant difference was found between CAM α1A-AR and 
WT mice at 35 ms (1.28 ± 0.037, n = 23 vs. 1.59 ± 0.052, n = 21, p < 0.001), 50 
ms (1.27 ± 0.035, n = 23 vs. 1.56 ± 0.049, n = 21, p < 0.001), 75 ms (1.28 ± 
0.043, n = 13 vs. 1.51 ± 0.047, n = 17, p < 0.001), 100 ms (1.23 ± 0.027, n = 23 
vs. 1.45 ± 0.037, n = 21, p < 0.001), 150 ms (1.17 ± 0.039, n = 13 vs. 1.37 ± 




4, p < 0.05).  These results indicate that short-term plasticity is enhanced in CAM 
α1A-AR mice compared to WT.  
Synaptic plasticity, particularly LTP, is thought to underlie learning and 
memory.  LTP was measured in the apical dendrites of the hippocampal CA1 
region of very old (age 22 to 24-mo) CAM α1A-AR and WT mice induced by TBS 
(10 trains of 4 pulses at 100 Hz) of the Schaeffer collateral pathway (Fig. 18C1).  
These recordings showed a significant enhancement of normalized LTP in CAM 
α1A-AR compared to WT mice at 15 min (1.45 ± 0.073 vs. 1.22 ± 0.036, p < 0.01), 
30 min (1.37 ± 0.053 vs. 1.17 ± 0.036, p < 0.01) and 60 min (1.31 ± 0.052 vs. 
1.11 ± 0.041, p < 0.01) after TBS (Fig. 3C2) (n = 9 animals for each comparison).  
In a finding consistent with the observations of enhanced basal synaptic 
transmission and PPF in CAM α1A-AR mice compared to WT mice, the above 
results demonstrate that CAM α1A-AR mice have increased LTP relative to WT 














Figure 18.  Hippocampal synaptic plasticity is enhanced with chronic α1A-AR activation.  (A) Basal 
synaptic transmission, as determined by the I/O relation between fiber volley amplitude and 
fEPSP slope, is increased in CAM α1A-AR (n = 11 slices from 3 mice) compared to WT mice (n = 
23 slices from 7 animals).  The bar graph inset shows the mean I/O slopes.  (B) PPF is enhanced 
in the CAM α1A-AR mice (n = 21 slices from 3 mice) compared to the WT mice (n = 23 slices from 
7 mice).  The facilitation was plotted as a function of interpulse interval of 35, 50, 75, 100, 150, 
200, and 300 ms.  Superimposed representative fEPSPs were recorded at 150 ms intervals.  (C1)  
Chronic α1A-AR activation enhances LTP in the hippocampal CA1 region, shown by cumulative 
data of the normalized changes in field potential slope in CAM α1A-AR mice (n = 23 slices from 9 
mice) and WT mice (n = 27 slices from 9 mice).  Superimposed representative fEPSPs were 
recorded 15 min before and 60 min after LTP induction.  (C2)  Multiple LTP recordings for each 
mouse were grouped and averaged, giving a single fEPSP slope ratio per animal at different time 
points before or after TBS (-15, 15, 30, 60 min).  CAM α1A-AR mice (n = 9) showed enhanced 
mean LTP when compared to WT mice (n = 9) at each post-TBS time point.  Statistically 
significant at * p < .05, * p < .01 or *** p < .001.  CAM, constitutively active mutant; fEPSP, field 







5.3.3. Chronic treatment with an α1A-AR selective agonist improves 
cognitive function 
To determine whether exogenous α1A-AR stimulation mimics the cognitive 
effects observed in CAM α1A-AR mice, we treated normal WT mice with the α1A-
AR selective agonist, cirazoline.  We assessed learning and memory using the 
Barnes (Fig. 19).  During learning, cirazoline-treated mice solved the Barnes 
maze in less time (16  3.4 s, n =14) (Fig. 19A1) than control mice (49  13 s, n = 
11) [t(23) = 2.1,  p < .05] while making fewer errors (2.9  1.0) (Fig. 19A2) than 
control (7.1  2.0) [t(23) = 1.7,  p < .05].  During memory trials for the Barnes 
maze (Fig. 19B1), cirazoline-treated mice solved the maze in less time (24.5  3.6 
s) (inset, Fig. 19B1) than control mice (43.7  7.3 s) [t(23) = 2.2,  p < .05], while 
making fewer errors (3.0  0.7) (inset, Fig. 19B2) than control (7.3  1.7) [t(23) = 
2.1,  p < .05].  The improved performance observed in the CRZ-treated mice 
suggests that activating the α1A-AR by a subtype selective agonist improves 





Figure 19.  Chronic treatment with an α1A-AR-selective agonist improves cognitive function.  
Normal WT mice treated for 9 mo with the α1A-AR selective agonist cirazoline (n = 11) solved the 
Barnes maze in less time (A1) and made fewer errors (A2) than the control WT mice (n = 14) on 
the last day (day 4) of learning trials. During memory trials, cirazoline-treated WT mice required 
less time to solve (B1) and made fewer errors (B2) than the control WT mice in the Barnes maze.  
The bar graph insets show the mean solve time and errors during memory testing.  Statistically 
significant at * p < 0.05 or ** p < 0.01. AR, adrenergic receptor; WT, wild type. 
5.3.4.  α1A-AR KO mice display poor cognitive function   
To further define the role of α1A-ARs in learning and memory, we next 
examined the effects of blocking α1A-ARs on cognitive function.  Because α1-AR 
antagonists can cause sedation, which would affect behavior testing, we studied 
α1A-AR KO mice using the Barnes maze.  The Barnes maze was chosen 
because it creates a less stressful environment than the water maze and is safer 
for the α1A-AR KO mice which are prone to seizures under stressful conditions.  
As shown in Fig. 20, α1A-AR KO mice (n=12) displayed impaired learning and 
memory compared with WT mice (n = 10). During learning trials, α1A-AR KO mice 
took more time to solve the maze (120  27 s) (Fig. 20A1, inset) than control mice 
(54  9.6 s) [t(20) = 1.9, p < 0.05].  α1A-AR KO mice also made more errors (36  
9.8) (Fig. 20A2, inset) than control mice (16  1.8) [t(20) = 1.8, p , 0.05]. During 
memory trials, the α1A-AR KO mice displayed a poorer recollection of the escape 




inset) compared with WT mice (19  4.8 s) [t(20) = 1.9, p < 0.05].  α1A-AR KO 
mice also made more errors (35  15) (Fig. 20B2, inset) than the WT mice (6.3  
1.0) [t(20) = 3.6, p < 0.001].  The poor performance of α1A-AR KO mice in 
learning and memory tasks indicates that this particular transgenic mouse has 






Figure 20.  Cognitive performance in the Barnes maze is reduced in mice lacking the α1A-ARs. 
During learning trials, α1A-AR KO mice (n = 12) took more time to solve the maze (A1) and made 
more errors (A2) compared with the WT mice (n = 10).  During memory trials, α1A-AR KO mice 
took more time to solve the maze (B1) and made more errors (B2) compared with WT mice. 
Schematic drawings represent paths traveled during learning (C1) and memory (C2) trials of the 
WT and α1A-AR KO mice.  The bar graph insets show the mean solve time and errors during 
learning and memory trials.  Statistically significant at *, p < 0.05. AR, adrenergic receptor; KO, 





ACTIVATING THE α1A-AR RESCUES THE NEGATIVE EFFECTS THAT 
INHIBITING NEUROGENESIS HAS ON LEARNING AND MEMORY IN MICE 
 
6.1.  Introduction 
 Activating the α1A-AR subtype increases neurogenesis in the SGZ of the 
hippocampus (Gupta et al., 2009) and enhances learning, memory, and synaptic 
plasticity in mice (Doze et al., 2011) as was previously discussed.  However, it is 
unclear whether activating the α1A receptor enhances cognition directly or 
whether it enhances cognition by increasing neurogenesis.  In this study, it was 
hypothesized that α1A-AR induced neurogenesis is responsible for the learning 
and memory improvements shown previously, but that activating the α1A-AR is 
not solely responsible for this improvement.  
 The aforementioned hypothesis was tested by first using a common anti-
mitotic agent, cytosine arabinoside (Ara-C) along with the α1A-AR agonist, 
cirazoline (Horie et al., 1995; Ruffolo & Waddell, 1982) delivered via osmotic 
pump (Azlet, Cupertino, CA, USA).  Second, learning and memory were tested 
with novel object recognition and Morris water maze during Ara-C and cirazoline 
treatment.  This novel approach, one of activating the α1A-AR while inhibiting 
neurogenesis, helped to reveal how the α1A-AR enhances learning and memory.  




learning and memory.  Investigation of the α1A-AR mechanism may lead to new 
therapeutic strategies targeting the α1A-AR and improving learning and memory 
deficits, along with other cognitive impairments. 
6.2.  Methods 
6.2.1.  Mouse husbandry  
4-wk old B6/CBA strain mice of both sexes (32 male and 45 female) were 
transferred to the University of North Dakota’s Association for Assessment and 
Accreditation of Laboratory Animal Care-accredited animal care facility from Dr. 
Dianne Perez of the Cleveland Clinic Foundation.  Mice were housed in groups 
of 3-4 until one day prior to surgery (see 6.2.3.), then singly in 17 x 28 x 13-cm 
transparent, polycarbonate boxes containing one red mouse house, an individual 
water bottle filled with pH-adjusted water (Edstrom Industries, Inc., Waterford, 
WI), or water containing the treatment drug Cirazoline (see “Cirazoline 
Treatment” below for further details).  Pelleted food with 5% fat was provided ad 
libitum (Teklad 22/5 Rodent Diet (W) 8640, Harlan, Indianapolis, IN). Mice were 
maintained on a 12-h light/dark cycle (lights on at 0600) and room air was 100% 
exchanged 12 to 40 times per hour with no recirculation and a constant 
temperature of 22°C and humidity of 23% to 27%.  Mice were ear tagged and 
identified in this way at the Cleveland Clinic. The experimental protocol employed 
in this study conform to the Guide for the Care and Use of Laboratory Animals 




Animal Care and Use Committee at the University of North Dakota (protocol no. 
1012-1). 
6.2.2.  Cirazoline treatment   
4-wk old mice received bottled pH-adjusted water with (16 male, 14 
female) or without (8 male, 16 female) 10 mg/L of the α1Aadrenergic receptor 
agonist, cirazoline hydrochloride (CRZ, Tocris Bioscience, Bristol, UK).  
Treatment duration was 8.5 wks and water was changed weekly.  
6.2.3.  Stereotaxic surgery   
For this study, a separate cohort of mice (n = 6) were also treated with 
increasing concentrations of 2%, 3% and 4% Ara-C or vehicle alone to serve as 
a short pilot study.  Qualitative results were analyzed to assess the effect of Ara-





Figure 21.  Increasing concentrations of anti-mitotic agent Ara-C induces neuronal toxicity at 3-
4%. (A) Mice treated with aCSF (n=2, vehicle-control) or (B) 2% Ara-C (n=2) showed no neuronal 
toxicity as opposed to mice treated with (C) 3% Ara-C (n=2) and (D) 4% Ara-C (n=2) that show 
significant losses, particularly in the CA3 region of the hippocampus. (E-H) 10x magnification of 
CA1 and (I-L) of CA3 in each treatment group.  Sections stained with cresyl violet for qualitative 
analysis. Ara-C, cytosine arabinoside; aCSF, artificial cerebral science fluid; CA, cornu ammonis. 
10-wk old mice were prepared for stereotaxic implantation of cannulas 
(PlasticsOne, Roanoke, VA, USA) and micro-osmotic pumps (flow rate of 0.25 
µl/h for 14 d; ALZET, model 1002) with a fill capacity of 100 µL.  One day prior to 
surgery, mice were separated into individual cages, one mouse per cage (to 
ensure no suture-tampering by other mice), with one red mouse house, pelleted 
food ad libitum, and pH-adjusted water containing 0.2 mg/mL oral suspension of 
ibuprofen as an analgesic (Children’s Ibuprofen Oral Suspension, Grape, 




suspension of ibuprofen for 24 h pre- and post-surgery (total of 48 h), after which 
the oral suspension was replaced with either plain pH-adjusted water, or water 
containing CRZ.  
 The micro-osmotic pumps were prepared according to the manufacturer’s 
instructions.  Briefly, each pump was weighed with its plastic flange (“flow 
moderator”) and steel tube, and recorded.  This base weight helped determine 
the total amount of fluid inside the pump after filling was complete.  Then, a 
sterile 3 mL syringe (Beckton Dickinson & Co, Franklin Lakes, NJ, USA), a sterile 
0.22 µm Millipore Express PES membrane filter unit (Millipore, Billerica, MA, 
USA) and a filling tube attachment was assembled and inserted into the pump, 
keeping the pump perpendicular to the bench.  A syringe was attached to a 
sterile filter with a micro-osmotic pump, and either aCSF (123 mM NaCl, 25 mM 
NaHCO3, 15 mM C6H12O6, 2.5 mM KCl, 1.5 mM CaCl2, 2.0 mM MgSO4, and 1.2 
mM NaH2PO4), or aCSF with 2% Cytosine β-D-arabinofuranoside hydrochloride, 
Ara-C (20µg Ara-C/1µl aCSF; Fisher Bioreagents, Loughborough, UK) was 
filtered into the pump.  The flow moderator (small, steel tube) was inserted into 
the micro-osmotic pump.  The filled pump was weighed and post-filling weight 
was recorded to deduce total fill amount.  If the fill amount was less than 90% of 
the reservoir volume (indicative of air bubbles), the pump was refilled.  If the fill 
amount was greater than 90% of the reservoir volume, the plastic flange was 
removed from the steel tube using a small scissors.  Approximately 35 mm of 
polyethylene tubing (OD: 1.22 mm; ID: 0.72mm) was cut and attached to the 




super glue (Loctite) was used to secure the tubing to the cannula.  A 20 µL 
pipette tip, syringe, and filter was used to fill cannula with aCSF or aCSF + 2% 
AraC.  The tubing was attached to the flow moderator, and secured with a small 
amount of adhesive. The whole apparatus (Fig. 22) was weighed and recorded in 
order to subtract pump weight from the total weight of the mouse (for accurate 
BrdU injections and weight monitoring).  After weighing, the apparatus was 
placed in a 15 mL scintillation vial filled with sterile saline, and placed in an 
incubator at 40°C for approximately 60 min or until needed for surgery. 
 
Figure 22.  Complete pump apparatus. (Left) Alzet micro-osmotic pump with flow moderator and 
attached to polyethylene tubing (i.e. catheter tube in the above diagram).  (Right) The cannula 
attached via catheter tubing to the micro-osmotic pump.  The removable tab served to attached 
the entire pump apparatus to the stereotaxic equipment. Once inserted into the mouse, the tab 
was removed with a small cauterizing tool.  Spacers were not used in this study design but serve 
to correct the depth of the cannula into the brain. 
Mice were brought into a sterile surgical room and weighed. A surgical 
mask, gloves and a laboratory coat were worn at all times during surgery, and 
gloves were changed between mice. Mice were given an injection of ketamine 




an anesthetic/analgesic and paralytic, respectively (0.775 mL sterile saline, 0.125 
mL 100mg/mL ketamine, 0.10 mL 20mg/1mL xylazine) at 0.09 mL cocktail per 
gram of body weight.  After the mouse was no longer responding to a toe pinch, 
the mouse’s head was shaved for the incision area and cleaned thoroughly with 
alcohol and iodine. Lidocaine was applied with a swab and allowed to soak into 
the skin for proper numbing. The mouse was mounted onto the stereotaxic 
equipment and the head secured with ear bars and a nose clamp.  Ophthalmic 
ointment was applied to both eyes to prevent drying of the corneas (I-Drop Vet 
Plus Eye Lubricant, IMED Pharma Inc., Dollard-des Ormeaux, QC, Canada).  
Using a scalpel, an incision was made down the middle of the skull, from just 
posterior to the eyes to just posterior to the ears (about 1.5 cm).  A pocket was 
created for the pump using a small surgical scissors, reaching to the anterior side 
of the left, hind hip (to insure minimal interfere with movement and respiration).  
After the pump pocket was made, the incision on the skull was fitted with, and 
held open by, a skin retractor.  The surface of the skull was then cleaned with a 
sterile Q-tip (Kendall, Mansfield, MA) to remove the superficial fascia, and the 
surface was allowed to dry, briefly.  Bregma was then located and marked with a 
permanent marker (Fig. 23).  The stereotaxic instrument (Stoelting, Wood Dale, 
IL, USA) was fitted with the cannula and pump apparatus, and the cannula was 
aligned with bregma.  The instrument was zeroed and positioned to the following 
coordinates, corresponding to the right lateral ventricle:  Anterior/posterior -0.30, 
medial/lateral +1.00, dorsal/ventral -2.20 (Breton-Provencher, Lemasson, 




made on the skull with a permanent marker.  A hole was drilled (diameter 0.37 
mm) where the mark was made, and a sterile Q-tip was placed over the hole to 
clean any fluid released from the brain.  
Figure 23.  Stereotaxic surgery showing bregma on a mouse. Mouse mounted on stereotaxic 
equipment with arrow pointing to a drilled hole near bregma, denoted with B. The coronal suture 
just left of bregma is also visible, along with lambda, located posterior to bregma (stereotaxic 
coordinates: Anterior/posterior -0.30, medial/lateral +1.00, dorsal/ventral -2.20). B, bregma; CS, 
coronal suture; L, lambda. 
 
A small hole was drilled lateral to lambda (near the posterior portion of the 
brain) for a surgical screw.  A sterile Q-tip was used to remove fluid and the 
surgical screw was positioned.  The screw served to secure the cannula to the 
skull once cement was applied.  The skin retractor was removed and the pump 
placed into the pocket.  The cannula was then positioned over the hole and the 
tip of the cannula aligned with the top of the skull.  The stereotaxic coordinates 




cannula was partially inserted into the brain and dental cement (Stoelting, Wood 
Dale, IL, USA) was mixed, drawn into a small 1 mL syringe, and placed between 
the cannula holder and the skull.  The cannula was lowered completely into the 
brain, and cement was placed around the top of the cannula and around the 
surgical screw.  The cement dried for 5-6 min, the connection between the 
cannula and the stereotaxic instrument was severed with a cauterizer (Bovie, 
Melville, NY, USA), and the mouse dismounted from the ear bars and nose 
clamp.  The mouse was placed on a 40°C warming pad and covered with a 
paper towel to maintain heat while suturing.  Suturing was done with a small 
surgical needle (Roboz Surgical Instrument Co, Gaithersburg, MD, USA) and 
suturing thread (Harvard Apparatus, Holliston, MA, USA).  A total of 7-8 sutures 
was applied to the incision to ensure proper healing of the wound.  New skin 
liquid band-aid (Medtech Products, Inc, Irvington, NY, USA) was applied over the 
top of the sutures along the incision to disinfect and further seal the incision.  The 
mouse was placed in a paper-towel-lined, polycarbonate cage with no bedding. 
The cage was placed on top of a pet bed warmer (K&H Manufacturing, Colorado 
Springs, CO, USA) to ensure the core temperature would remain elevated (as 
anesthesia can cause a drop in core temperature).  After each surgery, the 
stereotaxic equipment and surgical instruments were thoroughly cleaned with 
Clorox disinfectant wipes (The Clorox Company, Oakland, CA, USA), and new 
sterile Q-tips were made available.  The ibuprofen water was made available, but 
no food, until the mouse was fully conscious, or about 1-2 h after surgery.  Once 




bedding, food, and the ibuprofen water.  Ibuprofen water was removed the next 
day (approximately 24-h after surgery) and replaced with plain pH-adjusted water 
or pH-adjusted water containing CRZ.  Mice were allowed 7 days to recover from 
surgery before beginning behavioral testing.  10 L of methylene blue was 
injected into cannulas and pump volumes were measured post-mortem to verify 
cannula placement and pump function, respectively. 
6.2.4.  Novel object recognition  
The novel object recognition task (Fig. 24, Ennaceur & Delacour, 1988) 
measures the ability of a mouse to remember old objects and recognize new 
objects, a behavior thought to be dependent on the medial temporal lobe, or 
hippocampus (Squire & Zola, 1996).  Novel object recognition task was used on 
day 8 of the testing protocol (Fig. 27).  Between 800 h – 1200 h, mice were 
allowed to acclimate in acclimation cages for 30 min.  Then, each mouse was 
placed in the 41.3 x 41.3 x 34.3 cm empty experiment box (Stoelting, Wood Dale, 
IL, USA) for 5 min, the acclimation phase.  After an hour, the mouse was placed 
in the box with two identical objects (black spheres or white cylinders with cone-
tops, Stoelting/Custom-made) for 5 min, the familiarization phase.  After another 
hour, the mouse was place in the box with one old object (used during the 
familiarization phase) and one new object for 5 min, the testing phase.  After, 
mice were returned to their home cages, and objects and the experiment box 
were thoroughly cleaned with 70% ethyl alcohol before the next mouse was 
placed in the experiment box. Experiments were recorded using a computer 




analyzed for the amount of time spent with the old object, compared to the new 
object (data presented in seconds) using Excel (Microsoft, Redmond, WA, USA) 
and Prism (see “statistical analysis”).  
Figure 24. Novel object recognition test.  View from camera suspended over the novel object 
recognition box while a test is in progress. One old object and one new object can be seen 
alongside a mouse actively exploring the objects.  The mouse’s cage and identifying numbers 
can be seen on the left side of the photograph. 
6.2.5.  Morris water maze  
The Morris water maze is a hippocampal- and neurogenesis-dependent 
assay that tests learning and long-term spatial memory (Fig. 25, Morris, 1984). 
The maze uses water as the aversive stimuli that motivates the mouse to solve 
the maze by finding the non-visible platform based on spatial cues (Vorhees & 
Williams, 2006).  Between 800 h – 1200 h, each mouse was placed in an 
acclimation cage with a heat lamp (Petco, San Diego, CA) suspended above for 




cm diameter and 76.2 cm high) divided into four quadrants, surrounded by a tent.  
An invisible platform (32.4 cm high, Stoelting Co., Wood Dale, IL, USA) was 
placed in one of the quadrants (each quadrant had the platform for 25% of the 
trials and 25% of the total mouse population) and covered by 1-1.5 cm of water.  
Visual cues were placed on the tent walls inside and outside of the maze to help 
mice navigate.  Mice were allowed to swim in the maze for 1 min or until they 
found the hidden platform.  Mice were removed from the maze with a dry towel 
and allowed to completely dry off under the heat lamp for a minimum of 5 min to 
prevent hypothermia.  Mice had a total of six learning trials each day for four 
learning days (Fig. 27, days 9 – 12).  Mice were then tested with a probe trial 
(Fig. 27, day 13).  The platform was removed from the maze and mice were 
placed in the quadrant 180° opposite of where the platform used to be.  
Pathways for learning and probe trials were tracked using ANY Maze Software 
(Stoelting Co., Wood Dale, IL, USA) and later analyzed for latency to platform, 




Figure 25.  Morris water maze. View from the camera suspended over the maze. Visual cues are 
on both the tent walls and on the walls of the maze.  Outlined in orange is the area of ANY Maze 
tracking potential platform positions in each quadrant.   
6.2.5.  Open field  
Open field is a test of motor movement in mice (Jähkel, Rilke, Koch, & 
Oehler, 2000; Wilson, Vacek, Lanier, & Dewsbury, 1976) and is now commonly 
performed in a specialized apparatus that measures movement in real-time 
based on laser-beam breaks. Mice motor movement was tested for 20 min in the 
open field (Fig. 26, 43.2 x 43.2 cm, MedAssociates, St. Albans, VT, USA), 
between 1100 h and 1400 h (Fig. 27, day 13).  Data was automatically collected 




Figure 26.  Open field apparatus.  The mouse, visible in the box above, is allowed to explore the 
box (measuring motor movement) freely for 20 min and then removed and returned to its home 
cage. 
6.2.6.  BrdU injection & cardiac perfusion   
Mice were intraperitoneally injected (Fig. 27, day 11) once with 5-bromo-
2’-deoxyuridine (BrdU, 50 mg/kg, Sigma-Aldrich, St. Louis, MO, USA).  Three 
days after BrdU injections (Fig. 27, day 14), mice were lethally injected with 
pentobarbital (150 mg/kg, Euthasol, Virbac Animal Health, Fortworth, TX, USA) 
and perfused transcardially with heparinized saline for approximately 20 min, or 
until 30 mL of saline had perfused through the mouse.  Brains were removed and 
cut in half along the central fissure (into left and right hemispheres) and were 
fixed with 4% paraformaldehyde in normal buffered PBS.  After 48 h, the right 




section placed in cryoprotectant solution of a 96-well plate. Sections were labeled 
and placed in -20 C until immunohistochemical staining was conducted.  
Figure 27.  Timeline of experiments. Day 0, stereotaxic surgery was conducted osmotic pumps 
were given 24 h to begin working.  Days 1-7, recovery.  Day 8, novel object recognition (NOR). 
Days 9-12, Morris water maze (MWM) training. Day 11, BrdU injections.  Day 13, MWM testing 
and open field testing.  Day 14, cardiac perfusions and removal of brain for immunohistochemical 
analysis. BrdU, 5-bromo-2’-deoxyuridine; OF, open field; MWM, Morris water maze; NOR, novel 
object recognition.  
6.2.7.  Immunohistochemistry  
For BrdU-DCX labeling, PBS was used to wash sections 3 times for 5 min 
in between the following incubations: (1) 0.3% H2O2 was used for 5 min; (2) 2 N 
HCl, 30 min at 37° C; (3) 0.1M borate buffer, 10 min; (4) 5% goat serum (Jackson 
ImmunoResearch, West Grove, PA, USA) and 10% BSA in PBS block, 1 h at 
room temperature (RT); (5) rat monoclonal to BrdU antibody (Abcam, 
Cambridge, England; 6326, 1:10,000) at 4C, 24 h; (6) biotinylated goat anti-rat 
(1:2,000), 1 h at RT; (7) avidin/biotin enzyme complex conjugated to horseradish 
peroxidase (Vector Laboratories, Burlingame, CA, USA), 1 h at RT; (8) 
Diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA, USA) 10 min.  
TBS was used for washes between the following incubations – (9) 0.2 N HCl for 




Cambridge, England; 77450, 1:500) at 4C, 24 h; (12) biotinylated goat anti-
rabbit at 1:1500 dilution, 1 h at RT; (13) avidin/biotin enzyme complex conjugated 
to alkaline phosphatase (Vector Laboratories, Burlingame, CA, USA) for 1 h at 
RT; (14) chromagen solution (Vector Laboratories, Burlingame, CA, USA) for 15 
min.  BrdU/DCX sections were mounted and coverslipped using polyvinyl alcohol 
mounting medium (Evans, Janson, & Nyengaard, 2004).   
6.2.8.  Stereology   
DCX+ and BrdU+/ DCX+ cells were counted in the DG at a selected 1 in 12 
series.  The optical fractionator method (West, Slomianka, & Gundersen, 1991) 
was used in combination with StereoInvestigator 9.0 (Microbrightfield Bioscience, 
Williston, VT, USA) to quantify cells, and every other site (or counting frame) was 
counted.  First, using Stereoinvestigator, the microscope stage and slide was 
synchronized with the program.  After locating the DG, a picture was taken at 10x 
magnification.  Second, the region of interest was traced (Fig. 28, left panel).  
Next, the high magnification was set to 60x to identify the labeled cells (Fig. 28, 
right panel).  Mounted thickness was variable depending on each mouse 
(sections were cut at 40 m but individually assessed for thickness, usually 
ranging from 28-34 m).  The counting frame was set at 100m x 100m.  Grid 
size, determining sites counted, was set at 100m x 200m for this study.  
Parameters were optimized to achieve the lowest mean coefficient of error (CE) 
possible (with less than 10% being ideal).  The experimenter was blinded to 




and count cells.  StereoInvestigator software was then able to estimate counts for 
each cell marker delineated based on the following: 
Equation 1 
. . .  ∑ - 
Equation 1: ssf, section sampling fraction; asf, area sampling fraction; hsf, height sampling fraction; ∑ -, total count of 
particles sampled.   
Figure 28. Outline of dentate gyrus and visible neurogenesis. (Left) The dentate gyrus of the 
hippocampus, shown here outlined with a red line. (Right) High magnification of the subgranular 
zone in the dentate gyrus, stained with BrdU (brown) and DCX (blue) in order to identify dividing 
neurons, or neurogenesis. BrdU, 5-bromo-2’-deoxyuridine; DCX, doublecortin. 
6.2.9.  Statistical Analysis   
Prism Software (ver. 5.01; GraphPad, La Jolla, CA, USA) was used to 
employ two-way analysis of variance (ANOVA) and determine interactions 
between groups of three or more.  If significance was found, one-way ANOVA 
was used with a Tukey post hoc test when analyzing groups of three or more. If 
variance was not normal, Kruskal-Wallis non-parametric test was used for groups 
of three or more.  Unpaired two-tailed t-test, with or without Welch’s correction for 
unequal variance, was used as required. Sex differences were not investigated. 






6.3.1.  Ara-C treatment is toxic to neurons at increasing concentrations 
A short pilot study was conducted to test increasing concentrations of Ara-
C and used qualitative analysis to assess the results (Fig. 21).  Mice that 
received 4% Ara-C (n = 2) showed neuronal toxicity (Fig. 21D) in both the CA1 
(Fig. 21H) and (more visibly) in the CA3 (Fig. 21L) when compared with the 
vehicle control (n = 2, Fig. 21A, E, I).  However, mice that received 2% (n = 2, 
Fig. 21B, F, J) or 3% (n = 2, Fig. 21C, G, K) Ara-C showed little neuronal toxicity.  
Treatment with 2% Ara-C was chosen for the study because it was it was non-
toxic at this concentration and was the most common concentration reportedly 
used in the literature.  
6.3.2.  Ara-C significantly reduced immature and dividing neuron 
populations in the hippocampus   
To determine whether treatment with the anti-mitotic agent, Ara-C, was 
successful in disrupting neurogenesis, stereology was used to count the number 
of immature (DCX+) and dividing neurons (DCX+/BrdU+).  Mice treated with Ara-C 
showed significantly reduced populations of immature neurons regardless of 
CRZ pretreatment (No CRZ, n = 8; CRZ, n = 12, F (5, 45) = 32.96, p < 0.001) 
when compared with vehicle (No CRZ, n = 9; CRZ, n = 12).  Dividing neurons 
were also significantly reduced in mice treated with Ara-C (n =20, F (5, 45) = 
18.18, p < 0.001) when compared to vehicle.  Representative images of the DG 




Figure 29. Treatment with Ara-C significantly decreases the number of immature and dividing 
neurons in the hippocampus. (A) Doublecortin+ (DCX+) cells, labeling immature neurons, are 
significantly decreased in mice treated with Ara-C (No CRZ, n = 8; CRZ, n = 12) compared to 
vehicle-control mice (No CRZ, n = 9; CRZ, n = 12).  (B) Ara-C treatment significantly inhibited 
dividing neurons (labeled with both BrdU and DCX) compared with vehicle.  Representative 
figures of vehicle-control mice at 10x (C) and 60x (D) and Ara-C treated mice (D, F). Error bars 
represent SEM; *** p < 0.001. Ara-C, cytosine arabinoside; BrdU, 5-bromo-2’-deoxyuridine; CRZ, 
cirazoline; DCX, doublecortin; SEM, standard error of the mean. 
 
6.3.3.  Motor activity in CRZ-Ara-C treated mice is significantly increased 
compared to CRZ-vehicle-controls 
To determine if motor activity was influenced by CRZ or Ara-C treatment, 
mice were tested in an open field test (Fig. 30).  CRZ-Ara-C treated mice (n = 14) 




8.343, p < 0.01).  Mice that had no surgery and no CRZ treatment did not show a 
difference in movement when compared to their control.  Mice treated with CRZ 
in combination with Ara-C have increased motor movement.  
 
Figure 30. Motor activity of mice in each experiment group. Total distance travelled (cm) was 
measured for each mouse in no surgery, vehicle, and 2% Ara-C treated group and the average 
distance travelled was measured. Motor activity is significantly increased in CRZ-Ara-C treated 
mice compared to their CRZ-vehicle-controls. There was no difference between any groups 
except CRZ-vehicle-control (n=16) and CRZ-Ara-C treated (n=14) mice. Error bars represent 
SEM; ** p < 0.01. Ara-C, cytosine arabinoside; CRZ, cirazoline; SEM, standard error of the mean. 
6.3.4.  All mice recognized and spent more time with the novel object 
Mice were tested in novel object recognition to determine whether short-
term memory was interrupted or enhanced.  All groups, regardless of treatment, 
spent more time with the novel object (Fig. 31A-C).  The percentage of time 
spent with the novel object was considered and whether this time was greater 
than chance (50%).  Findings indicate that all groups, regardless of treatment, 




31D). All mice tested in the novel object recognition test spent more time with the 
novel object over the old object, showing that short-term, hippocampal 
dependent memory was still intact in all groups. 
Figure 31. Novel object recognition test results. All groups of mice successfully identified the new 
(novel) object over the old object at greater than chance. (A) No surgery mice, both no CRZ 
(n=12) and CRZ-treated groups (n=13), (B) no CRZ-vehicle (n=12) and CRZ-vehicle groups 
(n=16), and (C) no CRZ-Ara-C treated (n=11) and CRZ-Ara-C treated (n=15) groups, spent 
significantly more time with the new object over the old object.  All groups spent more time (D) 
with the novel object over the old object at greater than chance (50% of the time).  Error bars 
represent SEM; ** p < 0.01, *** p < 0.001. Ara-C, cytosine arabinoside; CRZ, cirazoline. 
6.3.5.  Performance was similar for all groups during training in the Morris 
water maze   
Mice were trained in Morris water maze to determine the effects of CRZ 
and Ara-C treatment on long-term learning and memory.  All groups of mice 
solved the maze faster (Fig. 32A1-C1), travelled less (Fig. 32A2-C2, with the 
exception of CRZ-Ara-C-treated mice) and swam slower (Fig. 32A3-C3) by day 2 




speed on day 2 of learning between no surgery mice treated with CRZ and those 
without CRZ treatment.  This is likely due to the slight difference in distance and 





Figure 32. Morris water maze learning results. All groups of mice solved the maze faster, 
travelled less and swam slower by day 2 or 3 of the Morris water maze. (A1) No surgery (n=12) 
and CRZ-no surgery (n=13); (B1) vehicle (n=12) and CRZ-vehicle (n=16); and (C1) Ara-C (n=10) 
and CRZ-Ara-C treated (n=14) groups all solved the maze significantly faster by day 2 of MWM 
learning.  (A2) No surgery and CRZ-no surgery mice travelled less by day 2; (B2) vehicle mice 
travelled less by day 3 and CRZ- vehicle mice by day 2; (C2) Ara-C mice travelled less by day 4 
and CRZ-Ara-C treated mice travelled less by day 2.   (A3) No surgery mice were slower by day 3 
and CRZ-no surgery treated were slower by day 3; (B3) vehicle and CRZ-vehicle treated were 
slower by day 3; (C3) Ara-C and CRZ-Ara-C treated mice were slower by day 2.  Error bars 
represent SEM; * p < 0.05, ** p < 0.01, *** p < 0.001. Ara-C, cytosine arabinoside; CRZ, 






6.3.6. Mice treated with CRZ solved the maze faster during training; CRZ-
Ara-C-treated mice solved the maze significantly faster than Ara-C treated 
mice that did not receive CRZ   
To better understand the potential progression of memory loss induced by 
Ara-C, the average time to solve for only the first trial of each training day (9-12) 
for Morris water maze was measured (Fig. 33 A-B).  Mice treated with CRZ, 
regardless of surgery (vehicle, Fig. 33 B2) or Ara-C treatment (Fig. 33 B3) 
remembered where the hidden platform was and were solving the maze 
significantly faster on day 2 compared to day 1. Mice without CRZ treatment that 
had surgery, either with vehicle (Fig. 33A2) or Ara-C (Fig. 33A3) treatment, did not 
remember where the platform was until day 4 of training (compared to day 1 of 
training).  Mice were also probe tested in the Morris water maze on day 13 post-
surgery to determine if long term memory was intact.  Mice that were treated with 
CRZ before receiving Ara-C treatment (n = 12, 10) solved the maze significantly 
faster (Fig. 33A) and swam a shorter distance (Fig. 33B) than Ara-C-treated mice 
that did not receive CRZ (n = 11, 10).  To ensure treated mice were not 
swimming slower (resulting in the difference observed), their swim speed was 
determined.  No significant difference in swim speed between any of the groups 
was observed (Fig. 33C). These results indicate that CRZ-treatment, and 
activation of the α1A-AR, is neuroprotective for brain injuries (such as that 
induced by surgery) and also rescues the affect of ablating neurogenesis on 





Figure 33.  Morris water maze test results. Ara-C treated mice with CRZ treatment solved () the 
maze significantly faster than Ara-C treated mice without CRZ treatment () and vehicle mice. 
(A1) No surgery mice without CRZ treatment were learning the maze significantly faster on by day 
2 of MWM. Both vehicle (A2) and Ara-C mice (A3) without CRZ treatment did not solve the maze 
faster until day 4 of training.  (B1-3) No-surgery, vehicle and Ara-C mice treated with CRZ all 
solved the maze significantly faster by day 2 of training. (C1) No surgery (n=12) and CRZ-no 
surgery (n=12) mice, vehicle (n=10) and CRZ-vehicle (n=14) mice solved the mice in 
approximately 3 seconds. Vehicle and CRZ-Ara-C treated (n=12) mice solved the maze faster 
than mice that received Ara-C alone (n=11). (C2) Similar to C1, mice with Ara-C alone travelled 
the longest distance, significantly more than vehicle and CRZ-Ara-C treated mice. (C3) There was 
no difference in speed between any of the groups, or within groups.   Error bars represent SEM; * 
p < 0.05, ** p < 0.01, *** p < 0.001.  Ara-C, cytosine arabinoside; CRZ, cirazoline; MWM, Morris 








CYTOSINE ARABINOSIDE DISRUPTS HYPOTHALAMIC NEUROGENESIS 
AND INDUCES OBESITY IN MICE 
 
7.1. Introduction 
The different stages of adult neurogenesis (see review by Ming and Song, 
2011), and the influence of each neuron type on weight maintenance during 
those stages, remains unclear.  In this study, the aim was to clarify the effect of 
hypothalamic neurogenesis and the α1Aadrenergic receptor on weight 
maintenance in mice.  To do this, cellular proliferation was disrupted while 
simultaneously activating the α1A-adrenergic receptor with cirazoline.  To clarify 
the role of hypothalamic neurogenesis, motor activity was tested, fat deposition 
was measured, and neurons were counted in the hypothalamus of both treated 
and control groups.  The approach taken in this study specifically addresses the 
role of α1Aadrenergic receptor activation, neuronal stem cells and immature 
neurons in weight maintenance.  The results of this study help clarify how the 
various stages of neuronal development affect weight maintenance. 
7.2.  Methods 
7.2.1.  Mouse husbandry 
Cohorts of 4-wk old B6/CBA strain mice (24 male and 30 female) were 




transferred to the University of North Dakota’s animal care facility (protocol no. 
1012-1). For further details on mouse husbandry, see section 6.2.1. 
7.2.2.  Cirazoline Treatment.   
See section 6.2.2 for further details.     
7.2.3. Microinfusion Pumps & Stereotaxic Surgery.   
See section 6.2.3. for further details. 
7.2.4.  Open field.   
The open field test (43.2 x 43.2 cm, MedAssociates) was used to measure 
motor activity on day 13 post-surgery.  Mice were tested for 20 min between 
1100 h and 1400 h.  Data was automatically collected and analyzed each min by 
Activity Monitor software (MedAssociates). 
7.2.5. Weight, Food Intake, & Fat Deposition Analysis.   
Mice were weighed on days 0, 11 and 14, and food intake was measured 
by weighing food given on day 0, the day of surgery, weighing food eaten on day 
7 and replenishing the food supply (again weighing the initial food given), and 
then weighing food left on day 11 post-surgery, and day 14 post-surgery.  Fat 
deposits from gonadal (surrounding the testes/ovaries in the corresponding 
male/female), perirenal (behind the kidneys), subcutaneous (the abdomen and 
hind), and intestinal areas (surrounding the small and large intestine) were 
dissected using standard dissection tools.  Fat was placed in tared weigh boats, 





7.2.6. BrdU Injection & Cardiac Perfusion.   
To label dividing cells, mice were intraperitoneally injected once with 5-
bromo-2’-deoxyuridine (BrdU, 10 mg/mL dissolved in saline, Sigma-Aldrich) at 50 
mg/kg on day 11 post-surgery.  After three days, mice were given a lethal dose of 
pentobarbital (150 mg/kg, Euthasol, Virbac Animal Health) and perfused 
transcardially with heparinized saline.  Brains were removed and fixed with 4% 
paraformaldehyde in normal buffered PBS.  After 48 h, the right hemisphere was 
serially sectioned at 40 m.  For more procedural details, see section 6.2.6.  
7.2.7.  Immunohistochemistry.   
For BrdU-DCX details, see section 6.2.7.  For c-Fos sections, PBS was 
used to wash sections 3 times for 5 min in between the following incubations: (1) 
5% goat serum (Jackson ImmunoResearch) and 10% BSA in PBS block, 1 h at 
room temperature (RT); (2) rabbit polyclonal to c-Fos antibody (Abcam 7963, 
1:250) at 4C, 24 h; (3) biotinylated goat anti-rabbit (1:2,000) 2 h at RT; (4) 
avidin/biotin enzyme complex conjugated to horseradish peroxidase (Vector 
Laboratories), 1 h at RT; (8) Diaminobenzidine (DAB, Vector Laboratories) 3 min.  
C-fos sections were mounted and coverslipped using polyvinyl alcohol mounting 
medium (Evans et al., 2004).   
7.2.8. Stereology.   
For BrdU+, DCX+ or c-Fos+ cell counting, a 1 in 6 series between bregma -




hypothalamus, ventral medial hypothalamus (VMH) and the arcuate 
hypothalamus were identified and outlined.  c-Fos+ cells were investigated in the 
VMH only.  The observer was blinded for analysis.  Unbiased quantification of 
BrdU+/ DCX+ or c-Fos+ cells was performed by the optical fractionator method 
(West et al., 1991) using Stereoinvestigator 9.0 (Microbrightfield Inc) and an 
Olympus BX51WI microscope. Parameters were set the same as those 
mentioned in section 6.2.8, except for grid size (sites counted) which was set at 
100m x 100m for this study. For more parameter details, see section 6.2.8. 
7.2.9. Statistical Analysis.   
Physical (weight, food intake, and fat deposits), behavioral, and 
stereological data were analyzed using Prism (ver. 5.01; GraphPad, La Jolla, CA, 
USA).  Unpaired two-tailed t-test with or without Welch’s correction for unequal 
variance was used as required.  One-way analysis of variance was used with a 
Tukey post hoc test when analyzing groups of three or more.  Data are presented 
as mean  S.E.M and significance was set at p < 0.05.  
7.3. Results 
 
7.3.1.  Ara-C treatment significantly increased weight and food intake; 
cirazoline treatment had no effect.   
Mice were divided into four groups (untreated, vehicle-control, CRZ-
vehicle, CRZ-Ara-C-treated) to determine how activating the α1Aadrenergic 
receptor effects neurogenesis and weight.  Weight and food intake was 
unchanged between CRZ-vehicle (n = 12), vehicle-control (n = 12) and untreated 




weight (F (3, 50) = 32.11, p < 0.0001) and consumed less food (n = 7, F (3, 45) = 
21.79, p < 0.0001) compared with CRZ-Ara-C-treated mice (n = 14, Fig. 34A, B).  
Neither CRZ nor Ara-C treatment affected mouse motor activity when examined 
in the open field test (Fig. 34C).  These findings suggest that inhibiting cellular 
proliferation significantly increases weight and food intake, and activating the α1A-
AR has no ameliorating effect on these factors.  
Figure 34.  Exposure to antimitotic agent Ara-C caused significant increase in weight and food 
intake.  (A) Non-CRZ treated () mice in both untreated (n = 12) or vehicle-control groups (n = 
12), and CRZ-treated () vehicle mice (n = 16) showed no significant difference in weight gain 
between groups.  Ara-C treated mice (n = 14) gained significantly more weight after 2 wks of Ara-
C when compared with vehicle-control mice. (B) CRZ-treated Ara-C mice had significant 
increases in food intake compared with CRZ-treated vehicle-controls.  (C) There was no 
significant difference in motor activity between any of the groups, as measured in the open field.  
Error bars represent SEM; *** p < 0.001. Ara-C, cytosine arabinoside; CRZ, cirazoline; SEM, 
standard error of the mean. 
7.3.2.  Mice treated with Ara-C had significantly greater fat deposits.   
Fat deposits were analyzed to determine whether weight-gain in the Ara-
C-treated mice was due to increases in fat.  Significantly greater fat deposits 
were observed in Ara-C treated mice compared to vehicle-control mice in the 
gonadal (Fig. 35A, 1.215 ± 0.155 n = 14 vs. 0.407 ± 0.040, n = 16; p < 0.001), 
perirenal (Fig. 35A, 0.247 ± 0.029 vs. 0.074 ± 0.008; p < 0.001), subcutaneous 
(Fig. 35A, 0.752 ± 0.091 vs. 0.226 ± 0.017; p < 0.001), and intestinal deposits 




fat deposits increased uniformly and were proportionate with weight gained (Fig. 
35B).  
Figure 35.  Ara-C-treatment significantly increased fat deposits in mice. When Ara-C-treated mice 
were compared to CRZ-vehicle control mice (A) gonadal, perirenal, subcutaneous, and intestinal 
fat deposits were increased, but no difference was found in the distribution of fat to these regions 
between groups (B).  CRZ-vehicle (n = 16), CRZ-Ara-C-treated (n=14); Error bars represent 
SEM; *** p < 0.001. Ara-C, cytosine arabinoside; CRZ, cirazoline; SEM, standard error of the 
mean. 
7.3.3.  Treatment with Ara-C depleted neuronal and dividing cell numbers in 
the hypothalamus.   
To determine whether 2-wk Ara-C treatment effectively disrupted 
neurogenesis (20µg/µl at a flow rate of 0.25 µl/h for 14 d) and decreased cell 
populations, the number of dividing cells (BrdU) and immature neurons (DCX) 
were quantified in the hypothalamus.   After 2 wks, there was significantly 
reduced numbers of DCX+ (Fig. 36 B, C; p < 0.05) and BrdU+ cells (Fig. 36 E, F; 
p < 0.01) in CRZ-Ara-C treated mice when compared to CRZ-vehicle-controls 
(Fig. 36 A, D).  Double-labeled cells could not be counted confidently.  However, 
reduced numbers of immature neurons and dividing cells suggests that effective 





Figure 36.  Ara-C significantly reduced neurogenesis in the hypothalamus.  Representative fields 
of (A) DCX+ and (D) BrdU+ cells are shown in vehicle mice (n = 7) but are both absent in CRZ-
Ara-C-treated mice (n = 7) (B, E).  The number of DCX+ (C) and BrdU+ cells (F) were significantly 
fewer in CRZ-Ara-C-treated mice when compared with CRZ-vehicle-control mice.  Error bars 
represent SEM; * p < 0.05, ** p < 0.01. Ara-C, cytosine arabinoside; BrdU, 5-bromo-2’-
deoxyuridine; CRZ, cirazoline; DCX, doublecortin; SEM, standard error of the mean.  
7.3.4.  There was no difference in neuronal activity in the VMH of Ara-C-
treated compared to non-treated mice.   
Neuronal activity (c-Fos, Dragunow & Faull, 1989) was investigated in the 
VMH (an important hypothalamic nucleus within the satiety circuit) to determine 
whether activity changes correlated with the increased food intake resulting from 
Ara-C treatments.  No  difference (p = 0.8617) between c-Fos labeled cell 
numbers in Ara-C-treated mice (Fig. 37 B, C) and vehicle-control mice (Fig. 37 A, 
C) was observed.  This data suggests that neuronal activity in the VMH is 






Figure 37.  Ara-C did not affect hypothalamic neuronal activity.  There was no difference in 
neuronal activity between CRZ-Ara-C-treated mice and CRZ-vehicle-control mice in the ventral 
medial hypothalamus.  Representative fields showing (A) c-Fos+ cells (brown) in CRZ-vehicle-
control mice (n = 7), and (B) c-Fos+ cells in CRZ-Ara-C-treated mice (n = 5).  No statistical 
difference was seen between the CRZ-vehicle-control and CRZ-Ara-C-treated mice (C).  Error 








ROLE OF THE ALPHA1A-ADRENERGIC RECEPTOR IN EXERCISE 
INDUCED NEUROGENESIS 
8.1. Introduction 
 The influence of the α1A-AR on exercise-induced neurogenesis has not 
been investigated yet.  Therefore, the goal of this study was to clarify the role of 
the α1A-AR in exercise-induced neurogenesis.  A small pilot study was launched 
to investigate this question by using transgenic α1A-AR knock out (α1A-AR KO) 
and normal C57/B6 mice and splitting these groups into cages with free-spinning 
running wheels and cages with fixed-wheels.  After 3 wks, changes in anxiety 
were tested with the zero maze and changes in neurogenesis, using 
immunohistochemistry and stereology for unbiased quantification.  The results of 
this study will help determine whether the α1A-AR plays a role in exercise-induced 
neurogenesis, and whether further investigation is needed. 
8.2. Methods 
8.2.1.  Mouse Husbandry  
6-wk old B6/CBA strain and α1A-AR KO mice were received from Dr. 
Dianne Perez (Cleveland Clinic Foundation) and were transferred to the 
University of North Dakota’s Association for Assessment and Accreditation of 




mice were housed in pairs (sorted by sex) in 41.9 x 21.6-cm transparent, 
polycarbonate boxes containing one red mouse house, an individual water bottle 
filled with pH-adjusted water (Edstrom Industries, Inc., Waterford, WI), and a 
running wheel that was either free-moving (“running” group) or fixed and 
unmoving (“sedentary” group). For further details about food and room 
conditions, please see section 6.2.1. The experimental protocol employed in this 
study conformed to the Guide for the Care and Use of Laboratory Animals 
(Institute of Laboratory Animal Resources, 1996) and were approved by the 
Animal Care and Use Committee at the University of North Dakota (protocol 
#1109-2). 
8.2.2.  Running Apparatus 
Running wheels (Mini Silent Spinners, 11.4 cm, Super Pet, Elk Grove 
Village, IL, USA) were secured with gorilla tape at roughly 2 cm from the cage 
wall (to allow free movement).  Each wheel was equipped with a rare earth-metal 
magnet (1.9 g each) that was secured to the side of the wheel with gorilla tape 
(Fig. 38).  A bike computer (Schwinn 20-function bike computer, Vancouver WA, 
USA) was programmed as instructed and the sensor was taped to the cage wall 
about 7-8 cm from the bottom of the cage.  The sensor was placed such that if a 
mouse was running, the magnet would pass close enough to the sensor to 
trigger it.  The sensor and all wiring were covered with duct tape to ensure no 
mouse tampering.  Bedding was placed over the wheel stand to cover the tape 
and evenly spread throughout the cage.  Food was place in a suet basket (C & S 




taped to the side of the cage wall with duct tape.  Water bottles (Petco) were also 
secured in this way.  For sedentary cages with fixed-wheels, the wheel was 
disassembled and a piece of duct tape was secured to the ball bearing in the 
wheel.  The wheel was reassembled and rendered stationary.  The bike sensor 
was not in the sedentary cages, but the tape was used to mimic a sensor in the 
cage.  Cages were cleaned once a week. Food and water was monitored, 
weighed and recorded once a week. Mouse weights were recorded once a week 
and mouse miles were recorded daily (via odometer readings from the bike 
computer).   
Figure 38. Running cage set-up. The suet basket is visible on the left and the running wheel 
with bike computer/odometer on the right. Mice are seen in the picture sitting in the wheel. 
8.2.3.  Elevated Zero Maze  
The zero maze (diameter: 50 cm, height: 40 cm, Stoelting, Wood Dale, IL, 
USA) was used to test for anxiety.  Mice were placed in acclimation cages for 1 




maze for 10 min and video recorded (Logitech, Newark, CA, USA). After, mice 
were removed from the maze and placed back into their home cages.  The maze 
was cleaned with 70% ethyl alcohol in between each session.  Videos were 
analyzed for time spent in the open area (all four paws in the open) versus time 
spent in the close areas, and number of entries into the open areas versus 
closed area.   
8.2.4.  BrdU Injections & Cardiac Perfusions  
On day 20 of running, mice were given two injections of 5-bromo-2’-
deoxyuridine (BrdU, 10 mg/mL dissolved in saline, Sigma-Aldrich, St. Louis, MO, 
USA) at 50 mg/kg about 10 h apart, with the last injection occurring around 76 h 
before sacrifice.  BrdU was made immediately before the first injection to insure 
potency and integrity.  See section 6.2.6. for more procedural details. 
8.2.5.  Immunohistochemistry   
See section 6.2.7. for procedural details. 
8.2.6.  Stereology   
See section 6.2.8. for procedural details. 
8.2.7.  Statistics  
Prism Software (ver. 5.01; GraphPad, La Jolla, CA, USA) was used to 
one-way analysis of variance followed by a Tukey post hoc test when analyzing 




correction for unequal variance was used as required.  Data are presented as 
mean  S.E.M and significance was set at p < 0.05. 
8.3.  Results 
8.3.1.  Running WT mice ate more than their sedentary counterparts; there 
was no difference among α1A-AR KO mice 
 To determine differences food intake, running, and weight gain, all three 
were tracked for the duration of the pilot study.  There was no observed 
difference between any groups in any of these areas except for food consumed 
(Fig. 39A).  Among WT mice, the running group consumed significantly more 
food than the sedentary group (p < 0.01).  No difference was observed in the 
α1AAR-KO mice; this may indicate that the α1A-AR is important for appetite 
regulation during times of high activity. 
Figure 39.  WT running mice consumed significantly more food than their sedentary counterparts.  
(A) Among WT () mice groups, the running group (n = 6) ate significantly more than their 
sedentary counterparts (n = 6), while no difference was seen among the α1A-AR KO () mice 
between sedentary group (n = 6) and the running group (n = 6).  (B) No difference was observed 
between WT and α1A-AR KO mice in running.  (C) There was no difference in weight gain 
between any of the groups.  Error bars represent SEM; ** p < 0.01.  AR, adrenergic receptor; Ara-
C, cytosine arabinoside; CRZ, cirazoline; KO, knock-out; SEM, standard error of the mean; WT, 
wild type. 
8.3.2.  Running α1A-AR KO mice exhibit signs of anxiety in the last 5 min of 
zero maze 
 The zero maze test was used to determine whether exercising relieved 




between any of the groups in number of entries for the maze (Fig. 40, B1-3).  
However, when the second 5 min of time the mice spent in the open parts of the 
zero maze was examined, a significant difference between the running WT mice 
and the running α1A-AR KO mice and running α1A-AR KO mice and their 
sedentary controls was observed (Fig. 40, A2; p < 0.01).  Thus, it was concluded 
that running mice lacking the α1A-AR are more likely to exhibit signs of anxiety 
the longer they stay in the maze, whereas their sedentary and WT running 
controls are more likely to explore the maze as the test progresses. 
Figure 40.  Running α1A-AR KO mice exhibit signs of anxiety as zero maze progresses.  (A1) 
There was no difference in time spent in the open area of the maze between WT () sedentary 
(n = 6), WT running (n = 6), α1A-AR KO () sedentary (n = 6), or α1A-AR KO running (n = 6) 
groups during the first 5 min of the zero maze.  (A2) α1A-AR KO running mice spent significantly 
more time in the closed parts of the maze than either WT running mice or sedentary α1A-AR KO 
mice.  (A3) Overall time spent in open areas on the zero maze showed no difference between 
groups.   (B1-3) There was no difference between any of the groups in entries into open areas of 
the zero maze.  Error bars represent SEM; ** p < 0.01. AR, adrenergic receptor; Ara-C, cytosine 






8.3.3. Wild type running mice had significantly more dividing neurons than 
α1A-AR KO running mice 
 To determine whether running increased neurogenesis in WT and α1A-AR 
KO mice, immunohistochemistry was used to label new neurons (DCX+) and 
dividing cells (BrdU+), and dividing neurons (BrdU+/DCX+).  No difference was 
observed between WT sedentary mice (n = 6) and WT running mice (n = 6) for 
any of these cell markers. However, a significant difference was found between 
WT running mice and α1A-AR KO running mice in both total population of cells 
marked (Fig. 41A) and dividing cells (Fig. 41C).  It was concluded that mice 
lacking the α1A-AR do not have the significant increases in neurogenesis that 
typically accompany aerobic exercise. 
Figure 41.  Running mice without the α1A-AR have a lower total cell population and significantly 
less neurogenesis.  (A) There was a significant difference in total population of cells between the 
running WT mice (, n = 6) and both sedentary (n = 6) and running α1A-AR KO mice (, n = 6) 
groups.  (B) There was no difference between any of the groups in the number of immature 
neurons (DCX+).  (C) There were significantly fewer cells in the running α1A-AR KO group when 
compared to the running WT group.  Error bars represent SEM; ** p < 0.01.  AR, adrenergic 










9.1 Neurogenesis, the α1A-AR, synaptic plasticity and cognition 
9.1.1 Cognition and synaptic plasticity 
 In this study, we used two transgenic α1A-AR mouse models, the α1A-AR 
selective agonist, CRZ, and Barnes maze.  We found that chronic α1A-AR 
stimulation improved learning and memory (Figs. 17-20) as well as synaptic 
plasticity in mice.  In contrast, knocking out the α1A-AR had a negative effect on 
learning and memory.  Specifically, we found that chronic α1A-AR stimulation 
improves cognitive performance in the Barnes maze (Fig. 17). To assess 
whether the cognitive behavioral gains seen in CAM α1A-AR mice correlated with 
enhanced hippocampal plasticity, we looked at several different indicators of 
synaptic plasticity.  We found enhanced basal synaptic transmission, PPF (short-
term synaptic plasticity), and LTP in hippocampal slices prepared from aged 
CAM α1A-AR mice when compared to WT mice (Fig. 18).  Then, we treated 
normal WT mice with CRZ to determine whether we could pharmacologically 
mimic the effects observed in the CAM α1A-AR mice.  Indeed, CRZ-treated mice 
had improved cognitive function compared with normal mice (Fig. 19).  Finally, 
we next examined the effects of blocking α1A-ARs on cognitive function using a 




Barnes maze was reduced in α1A-AR KO mice (Fig. 20).  Taken together, these 
results indicate that the α1A-AR plays an essential role in learning and memory – 
though it remains to be seen how the α1A-AR is mediating this effect. 
 Synaptic plasticity is widely held as an essential component of learning 
and memory.  The hippocampus is a critical structure with respect to learning, 
memory, and synaptic plasticity.  Furthermore, it is well established that young 
neurons near the proliferative zone in the DG have a lower threshold for LTP 
than mature neurons (Ge et al., 2007; Schmidt-Hieber et al., 2004) and that 
reduction of DG stem cell proliferation selectively inhibits LTP (Snyder et al., 
2001), suggesting a relationship between the birth of new neurons and LTP.  
Within the adult hippocampus, synaptic plasticity occurs primarily in two areas: 
the perforant path and the Schaffer collaterals.  Both areas show susceptibility to 
age-related declines in LTP (Burke & Barnes, 2006; Diana, Domenici, Loizzo, 
Scotti de Carolis, & Sagratella, 1994; Froc et al., 2003; Landfield & Lynch, 1977).  
Conversely, LTD occurs more readily in aged mice, suggestive of an age-related 
increase in the susceptibility to depression in synaptic strength (Landfield & 
Lynch, 1977).  Moreover, hippocampal CA1 pyramidal neurons show age-related 
deficits in PPF (Landfield & Lynch, 1977), a form of short-term plasticity related to 
the amplitude of synaptic responses.  Each of these alterations in synaptic 
plasticity (LTP, LTD, PPF) correlates to age-related deficits in cognitive 
performance in the murine brain (Bach et al., 1999; Foster, 1999).  Alzheimer’s 
disease (AD) mouse models also show similar reductions to aged mice in long-




later in life, coinciding with considerable neuronal death.  Conversely, the present 
study shows that aged CAM α1A-AR mice possess markedly improved basal 
synaptic transmission, PPF, and LTP at the CA3-CA1 synapses (Fig. 18A-C).  
Taken together, these results may suggest a role for the α1A-AR in improving 
synaptic efficiency, possibly throughout senescence. 
The cognitive enhancements of CAM α1A-AR mice may be due to α1A-AR 
activation increasing neurogenesis (Gupta et al., 2009) or the survival of 
neurons. An important kinase in the α1A-AR second messenger pathway is ERK 
(Fig. 5; Liu et al., 2011).  ERK has neuroprotective effects in the brain (Emery et 
al., 2010) and may be involved in regulating hippocampal neurogenesis (Aberg et 
al., 2003).  One study linked ERK to cognition and found that reducing ERK 
levels in hippocampal neurons led to memory deficits (Yan, Hou, Wu, Liu, & 
Zhou, 2007).  
In summary, using a constitutively activate mutant α1A-AR mouse model 
and long-term administration of an α1A-AR agonist in normal mice, we 
demonstrated that stimulating the α1A-AR subtype enhances learning and 
memory, and synaptic plasticity in aged CAM α1A-AR mice.  Therefore, α1A-AR 
agonists may offer a potential new strategy for treating the decline in cognition 






9.1.2 Neurogenesis, the α1A-AR and cognition 
We hypothesized that α1A-AR induced neurogenesis underlies the 
enhanced learning, memory and synaptic function we previously observed (Doze 
et al., 2011).  To test this hypothesis, we activated the α1A-AR with CRZ and 
simultaneously inhibited neurogenesis with the anti-mitotic agent, Ara-C. Then, 
we measured the cognitive function of these mice with behavioral tests.  We 
found that all treatment groups remembered the location of the platform by day 2 
of Morris water maze (MWM), and mice receiving CRZ (despite Ara-C treatment 
or surgery) learned as quickly as mice that did not have Ara-C treatment or 
surgery.  Finally, mice treated with both CRZ and Ara-C performed the same as 
vehicle and no surgery mice, and significantly better than mice treated with Ara-C 
alone.  Additionally, we found that increasing concentrations of Ara-C killed 
hippocampal neurons and a lower concentration of Ara-C effectively inhibited 
hippocampal neurogenesis and depleted immature neurons (DCX+) and dividing 
neurons (BrdU+/DCX+) populations.  Ara-C treatment did not negatively affect 
motor movement and there was no difference between treatment groups in novel 
object recognition.  These data support the hypothesis  that activating the α1A-AR 
enhances learning and memory –in the absence of hippocampal neurogenesis—
protects against brain injury (induced by surgery).  This is evident in our Morris 
water maze test results (comparing the CRZ-vehicle mice, Fig. 7A2, to the 
untreated vehicle mice, Fig. 7B2) which are suggestive of a neuroprotective 
action of α1A-AR activation.  We think this novel observation may clarify the 




 Several studies have found that hippocampal neurogenesis is crucial 
component of learning (Dupret et al., 2008).  Moreover, others have shown that 
increasing hippocampal neurogenesis benefited cognition (Wong-Goodrich et al., 
2010), and decreasing or eliminating hippocampal neurogenesis was detrimental 
to cognitive function (Winocur, Wojtowicz, Sekeres, Snyder, & Wang, 2006).   
Our results support and extend these findings as mice treated with Ara-C alone 
performed worse in the probe trial of the MWM than mice that received vehicle or 
CRZ (Fig. 7C1).  Therefore, the presence of intact hippocampal neurogenesis in 
the brain is important for learning and memory.   However, there are several 
regions in the brain where neurogenesis occurs (albeit at lower rates) that may 
be involved in learning and memory.  Because the anti-mitotic agent we chose to 
inhibit neurogenesis (Ara-C) was delivered into the lateral ventricles, it was able 
to act on all dividing cells in the brain including other important, neurogenic 
learning and memory areas such as the neocortex, the striatum, and the 
amygdala (Gould, 2007).  We previously showed that chronically activating the 
α1A-AR increases hippocampal neurogenesis (Gupta et al., 2009).  The 
neocortex, striatum, and amygdala, in addition to the hippocampus, also have a 
high expression of α1A-AR (Papay et al., 2006). Thus, neurogenesis may have 
also been enhanced in these regions through the activation of the α1A-AR, which 
may also explain the cognitive enhancements seen in our previous study.  We 
tested the hypothesis that α1A-AR induced neurogenesis underlies the enhanced 
learning, memory and synaptic function. However, we found that learning and 




mechanism is responsible for enhanced learning and memory and synaptic 
function we previously observed.  Therefore, it is not the neurogenesis aspect but 
the α1A-AR activation that we will focus on here.   
To explain the mechanism behind the α1A-AR behavioral enhancements, 
and in the absence of neurogenesis, observed in this study, we hypothesize that 
NE through the actions of the α1A-AR, modulates the intrinsic properties of post-
synaptic neurons in the CA1, thus making these neurons more responsive to 
potentiation.  Subsequently, appropriate input such as theta-burst stimulation or 
the actual learning-process induces synaptic plasticity more easily and learning 
and memory improvements are the result. 
We previously showed LTP was enhanced in mice with chronically 
activated α1A-ARs (Doze et al., 2011). Others have shown that activating the α1-
AR enhances LTP (Izumi & Zorumski, 1999).  However, the mechanism 
underlying this connection is not clear. α1A-AR activation is coupled to the Gq 
protein, which increases IP3 and [Ca
2+]i levels (Hwa et al., 1996).  Further, 
blocking the IP3 receptor inhibits LTP in hippocampal CA1 neurons (Fujii, 
Matsumoto, Igarashi, Kato, & Mikoshiba, 2000), and in the presence of a Ca2+ 
chelator like EGTA, LTP is blocked (Lynch et al., 1983).  Other studies echo that 
increasing postsynaptic Ca2+concentrations is an important step for induction of 
LTP (Rose & Konnerth, 2001), and required for mossy fiber-CA3 LTP through 
Ca2+ from internal stores (Kwon & Castillo, 2008).  Gibbs and Bowser (2010) 
went one step further and showed that increases in free cytosolic Ca2+from 




important receptors that may be affected by the changes in cellular activity after 
activation of the α1A-AR, include the glutamate activated N-methyl-D-aspartate 
receptor (NMDAR) and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid receptor (AMPAR). 
Hippocampal-dependent memory is reliant on the activation of the 
NMDAR (Gilbert & Mack, 1990; Morris, 1989).  The behavioral effects of blocking 
NMDARs mimic that of a damaged hippocampus in rats (Robinson Jr., Crooks 
Jr., Shinkman, & Gallagher, 1989).  Theta-burst stimulation (TBS) is a common 
technique that induces hippocampal CA1-LTP based on the electrical signals that 
occur during the actual learning process in the rat (Otto et al., 1991).  This 
particular type of LTP is prevented when NMDARs are blocked (Bashir et al., 
1990; Coan, Saywood, & Collingridge, 1987; Collingridge, Kehl, & McLennan, 
1983).  Furthermore, LTP can be blocked if depolarization of the post-synaptic 
cell is limited (Kelso, Ganong, & Brown, 1986; Malenka, 1991).  These studies 
reveal that the temporal component of synaptic plasticity (whether post-tetanic, 
short-term or long-term) is dependent on the level of depolarization mediated by 
internal calcium [Ca2+]i levels. 
AMPARs are thought to be a key component to the induction and 
maintenance of LTP (Malinow & Malenka, 2002).  In the hippocampus, 
specifically, post-synaptic AMPARs increase after LTP is induced (Maren, Tocco, 
Standley, Baudry, & Thompson, 1993).  Additionally, the exocytosis of AMPARs 
to the synapse is critical in the induction of LTP as when exocytosis is blocked, 




et al., 2001). This exocytosis occurring in the post-synaptic dendrites of 
hippocampal neurons is also thought to be dependent on [Ca2+]i levels (Maletic-
Savatic et al., 1998).  The AMPAR is composed of four common subunits 
(GluR1-4) and in the hippocampus, the GluR1, 2 and 3 are most prevalent in 
GluR1/2 or GluR2/3 complexes (Wenthold, Petralia, Blahos J, & Niedzielski, 
1996).  And, after high frequency stimulation such as TBS, GluR1 subunits 
rapidly move to the synapse and spines of dendrites, and was NMDAR-
dependent (Shi et al., 1999).  Finally, knocking out the GluR1 subunit inhibits the 
induction of LTP (Mack et al., 2001; Zamanillo et al., 1999).  The α1A-AR 
increases [Ca2+]i levels, important for depolarization of the post-synaptic cell and 
dendritic exocytosis, and also activates phospholipase D (PLD; Parmentier et al., 
2004), known to play an important role in cellular exocytosis and endocytosis 
(Foster & Xu, 2003).  These studies support our hypothesis that NE through the 
actions of the α1A-AR, modulates the intrinsic properties of post-synaptic neurons 
in the CA1, thus making these neurons more responsive to potentiation.  
However, this does not explain how activating the α1A-AR could be 
neuroprotective. 
 As previously mentioned, CRZ is not a specific activator of just one 
receptor.  It fully activates the α1A-AR, partially-activates the α1B- and α1D-AR, and 
blocks α2-ARs (Horie et al., 1995).  What effects do these other receptors have 
on learning and memory?  Previous studies show that stimulating the α1A-AR 
specifically enhances cognition and neurogenesis (Doze et al., 2011; Gupta et 




(Yun et al., 2003; Zuscik et al., 2000).  Blocking α2-ARs, however, may also play 
a role in enhanced cognition.  One study showed that blocking α2-ARs promoted 
memory consolidation while activating it promoted memory loss (Gibbs, 
Hutchinson, & Summers, 2010). But another using Morris water maze , showed 
that younger rats showed no deficits in cognition when blocking α2-ARs, but in 
older rats it did (Sirviö et al., 1992). It seems that α2-ARs may be involved in 
learning and memory functions, but how α2-ARs have a role in cognition remains 
unclear. 
 In other areas of the brain such as the prefrontal cortex, α2-ARs and α1-
ARs appear to play a role in cognition.  When α1-ARs are activated during 
attention-switching tasks, performance is improved (Lapiz & Morilak, 2006), but 
impairs short term spatial working memory (Arnsten et al., 1999; Birnbaum, 
Gobeske, Auerbach, Taylor, & Arnsten, 1999).  One study used CRZ and tested 
spatial working memory in monkeys but found that CRZ impaired memory, and 
speculated that activating α1-ARs impairs spatial working memory while 
activating α2-ARs improves memory (Arnsten & Jentsch, 1997; Mao et al., 1999).  
These findings support the hypothesis that activating α1A-AR in the PFC is not 
responsible for the learning and memory improvements we saw in our mice.   
 The amygdala is another area of the brain shown to be involved in fear-
associated memory tasks.  One study showed that when β-ARs (not α1-ARs) 
were activated by NE, learning and memory in the basolateral amygdala were 
enhanced over untreated controls. But another study showed that blocking α1-




Cunha, LeDoux, & Cain, 2010).  And a study done by Ferry, Roozendaal, & 
McGaugh (1999) showed that activating α1-ARs enhances memory formation 
even while in the presence of an α2-AR blocker.  Additionally, this study showed 
that α1-ARs need to interact with β-ARs in order to see the beneficial effects to 
memory storage. The interaction of these receptors and the effect on cognition is 
a subject that needs further exploration. 
 Another consideration is the type of cells that may be mediating the 
responses we observed. Both neurons and astrocytes express α1- and α2-ARs. 
We have only considered neurons because of the increased neurogenesis we 
saw with this response, but gliogenesis has also been shown to be regulated by 
the α1A-AR (Gupta et al., 2009).  Memory consolidation was enhanced when 
activating α1-ARs on astrocytes, specifically (Gibbs & Bowser, 2010). Several 
studies have linked the Ca2+ levels in astrocytes to ARs and to Ca2+ levels in 
neurons. In hippocampal astrocytes from rats, activating α1-ARs inhibited the 
spread of Ca2+ waves, whereas activation of β-ARs or α2-ARs did not alter the 
waves (Muyderman et al., 1998). But another study found that activating α1-ARs 
increases astrocyte internal Ca2+ concentrations within an intact rat hippocampal 
slice, but only 5% of astrocytes responded when isolated from the slice (Duffy & 
MacVicar, 1995).  Another study showed that when α2-ARs are blocked on the 
astrocyte, Ca2+ levels increased and the astrocytes are potentiated (Bekar, He, & 
Nedergaard, 2008).  This observation is supported by a few other studies 
showing that astrocytes and neurons directly modulate Ca2+ levels of neurons, 




release of glutamate (Parpura et al., 1994). All of these studies support the idea 
that astrocytes may be just as important for information processes as neurons, 
and clearly modulate and influence neuronal activity. 
Finally, we discovered that activating the α1A-AR with CRZ protected the 
brain from surgical injury.  While CRZ is a potent α1-AR activator (a full agonist at 
the α1A-AR and only partial agonist at the α1B-AR), is it also an α2-AR blocker 
(Ruffolo & Waddell, 1982).  It has been shown that microglia express α2A- and β2-
ARs, and NE acts on the α2A-AR on activated microglia and suppresses 
microglial reactivity and motility (Gyoneva & Traynelis, 2013). And the loss of NE 
that occurs during neurodegeneration (Mann, Lincoln, Yates, Stamp, & Toper, 
1980) would disinhibit microglia, allowing them to react and be more motile in the 
event of injury.  Therefore, the presence of CRZ blocking the α2A-AR would have 
a similar effect.  We think that it is the action of CRZ through the α2-AR on 
microglia that may be mediating the neuroprotective effects in the present study. 
As a result, this study is the first to discover the behavioral and neuroprotective 
effects of CRZ. 
 Several additional confirmatory studies could be conducted to further 
support and extend our initial findings.  First, specific memory tests that target the 
PFC, amygdala or hippocampus need to be used in conjunction with cell-specific 
ablation of neurons or astrocytes.  Activation and inhibition of the α1-AR should 
be tested in this paradigm, along with activation and inhibition of the α2-AR.  
Investigation of the role of the α1- and α2-AR in brain injury and the role these 




neuroprotective effects of CRZ treatment.  Mechanistically, Ca2+ levels and 
NMDAR function need to be examined while acutely and chronically activating 
the α1A-AR in vivo and in vitro. Additionally, AMPA receptor trafficking, number 
and subunit composition could also be investigated under acute and chronic α1A-
AR activation.  Results from these experiments would further elucidate the extent 
of the involvement of the α1A-AR in synaptic plasticity. 
 The results of our study showed that activating the α1A-AR protects mice 
from the negative effects of inhibiting neurogenesis on learning and memory, as 
well as from brain injury.  The anti-mitotic agent, Ara-C, also widely known as 
cytarabine, is a common treatment for certain types of cancer, such as leukemia 
(Ogbomo, Michaelis, Klassert, Doerr, & Cinatl, 2008; Wang et al., 1997).  Up to 
50% of patients treated with chemotherapy suffer from post-chemotherapy 
cognitive impairment, also known as chemo-brain or chemo-fog (Tannock, Ahles, 
Ganz, & Van Dam, 2004).  This results in cognitive impairments such as trouble 
learning and remembering.  Therefore, activating the α1A-AR prior to and during 
treatment may help to protect patients from chemo-brain. Furthermore, blocking 
the α2-AR may also help those who have suffered from traumatic brain injuries.  
The results of our study may help elucidate the mechanism behind learning and 
memory and help those with learning and memory disorders and other 






9.2 Hypothalamic neurogenesis and metabolism 
Our results suggest that disrupting cellular proliferation in the 
hypothalamus induces obesity in mice.  This finding is supported by data 
showing that Ara-C-treated mice had significantly (1) increased weight and 
increased food intake (Fig. 34), (2) increased fat deposits (Fig. 35), and (3) fewer 
dividing cells (BrdU) and immature neurons (DCX) in the hypothalamus (Fig. 36).  
In addition, neuronal activation was not isolated to or increased in a specific 
region of the hypothalamus in either Ara-C-treated or vehicle-control mice.  
These findings suggest that cellular proliferation in the adult hypothalamus plays 
an important role in weight maintenance.  
We found Ara-C-treated mice showed significantly fewer dividing cells and 
immature neurons in the hypothalamus.  Since neurogenesis in the 
hypothalamus leads to the production of neurons important to appetite and 
satiety in the brain, we deduced that it is the disruption of neurogenesis 
specifically that plays an important role in weight maintenance.  This result is 
consistent with other studies using Ara-C to disrupt neurogenesis in the 
hypothalamus (Kokoeva et al., 2005; Pierce & Xu, 2010).  Interestingly, obesity 
caused by diet or a leptin-deficiency disrupts hypothalamic neurogenesis and 
depletes neuronal stem cell populations (McNay, Briançon, Kokoeva, Maratos-
Flier, & Flier, 2012).  Disrupting cellular proliferation (i.e., neurogenesis) in our 
mice resulted in obesity; in contrast, inducing obesity in mice resulted in 
disrupted neurogenesis.  Together, these results further support the idea that 




Several possible mechanisms exist for hypothalamic neurogenesis-related 
weight disturbances.  To explore these mechanisms, it is necessary to compare 
our results with a key study by Pierce and Xu (2010).  This study showed AgRP 
neuron-deficient mice had significantly reduced body fat mass compared to 
control mice when treated with Ara-C for 4 wks—suggesting that newly 
generated cells in the hypothalamus are required for maintaining normal appetite 
and body fat.  It is possible that a large percent of proliferating and newborn 
neurons are orexigenic AgRP neurons versus anorexigenic POMC neurons.  
AgRP neurons release GABA onto POMC neurons (Cowley et al., 2001).  Thus, 
knocking out the immature and proliferating AgRP neurons (which normally 
inhibit POMC neurons) would allow POMC neurons to fire, suppress appetite, 
and reduce body fat.  But because Ara-C is non-specific and affects all dividing 
cells in the brain—though disrupting hypothalamic neurogenesis is more likely 
the reason for weight disturbances—disrupting dividing cells in other neurogenic 
brain regions (e.g., amygdala or substantia nigra, Bernier et al., 2002; Zhao et 
al., 2003), may have contributed to the weight phenomena observed. 
Our results were similar to the Pierce and Xu study results (2010): newly 
generated cells are required for maintenance of normal body fat.  Our study – 
which used 20 times more Ara-C (2%) than Pierce and Xu’s study (0.1%) – found 
the opposite effect using Ara-C.  Whereas chronic Ara-C treatment depleted 
proliferating, early-, and late-stage immature neuron populations in the 
hypothalamus, our acute and high-concentration of Ara-C-treatment targeted 




immature hypothalamic neurons are strongly orexigenic, producing excessive 
quantities of AgRP (relative to mature and proliferating neurons) and this excess 
AgRP causes obesity in mice (Ollmann et al., 1997) – similar to our study.  
Alternatively, some newborn neurons are leptin responsive (Pierce & Xu, 2010), 
and if there are no proliferating or newborn neurons in the hypothalamus to 
receive leptin, then there is nothing to suppress appetite; weight gain results.  
One study suggests leptin acts on receptors primarily at the stem cell level yet 
does not regulate neuronal cell division or the fate of newborn neurons (McNay 
et al., 2012).  Conversely, a different study shows that leptin influences 
hypothalamic feeding circuits in newborn mice and may have long-lasting effects 
on metabolism in adults (Bouret & Simerly, 2006).  Finally, another study shows 
that newborn hypothalamic cells are adaptive and express different proteins and 
receptors depending on their environment (Pierce & Xu, 2010).  This adaptive 
hypothesis may explain why such contrasting results are observed across 
hypothalamic neurogenesis and weight studies. 
The adaptive hypothesis of newborn hypothalamic neurons may parallel 
with hippocampal newborn neurons.  Immature hippocampal neurons play a 
significantly different role in pattern separation (an important process in creating 
memories) compared with mature, integrated neurons (Aimone, Deng, & Gage, 
2011).  Even the strategic addition and removal of specific new hippocampal 
neurons influences spatial learning (Dupret et al., 2007).  Furthermore, critical 
periods  (windows in development when the neuron is especially sensitive to 




population response, and types of neurons in the DG once neurons mature 
(Tashiro, Makino, & Gage, 2007).  Therefore, hypothalamic neurons may have a 
critical period of development similar to hippocampal neurons; depending on 
environmental influences, hypothalamic neurons may contribute to opposite 
energy balance outcomes (obesity versus anorexia) when in proliferating, 
immature, and mature stages of neurogenesis. 
To understand more about the underlying mechanisms in our study, we 
investigated the neuronal activity marker c-Fos, in the ventromedial nucleus – 
just one of the important hypothalamic nuclei involved in the satiety circuit of the 
hypothalamus.  We found no difference in c-Fos+ cells in the VMH of either Ara-
C-treated or vehicle-control mice.  Our results were comparable to another study 
investigating c-Fos activity in diet-induced obesity mice and found c-Fos activity 
was also unchanged in the VMH (Lin & Huang, 1999).  The varying levels of 
neuronal activity (c-Fos) may be explained by a contrast in techniques: we used 
Ara-C to broadly deplete hypothalamic neurons whereas others used genetic 
methods to specifically target different types of hypothalamic neurons (i.e., AgRP 
vs. POMC). 
Neurogenesis in the hypothalamus is more difficult to detect than in strong 
neurogenic regions (e.g., the SGZ in the DG of the hippocampus) because 
hypothalamic neuronal stem cells tend to divide more slowly (Lee & Blackshaw, 
2012). Exposure to BrdU, the marker for dividing cells, is higher in regions like 
the hippocampus because it is surrounded by cerebrospinal fluid (Bennett, Yang, 




region exposed to cerebrospinal fluid – the arcuate nucleus and the median 
eminence, where neurogenesis is strongly detected.  Because this investigation 
of the hypothalamus was only after we observed weight gain in our mice, we did 
not design the study with hypothalamic neurogenesis in mind.  Therefore, we 
gave a single injection of BrdU to our mice and this may be the reason for our 
inability to detect dividing neurons (double labeled with both BrdU and DCX).  It 
should be noted that neurogenesis can be reliably detected by using DCX alone 
(Brown et al., 2003), as there is a high expression of DCX with BrdU only 3-4 
days after BrdU injection.  However, because hypothalamic neurogenesis is still 
a controversial neurogenic region, BrdU administration may be advisable – and 
multiple injections or central administration of BrdU would address the problem of 
low incorporation rate due to slower proliferation in this area.  
In the future, it will be important to investigate levels of hormones such as 
leptin and ghrelin, and cellular markers, such as pSTAT3 (part of the leptin 
signaling pathway), AgRP and POMC.  We agree with the authors of a recent 
review on hypothalamic neurogenesis and feeding regulation (Sousa-Ferreira, de 
Almeida, & Cavadas, 2013), and feel fate mapping of developing hypothalamic 
neurons (from birth to maturation) in the various regions of the hypothalamus 
(arcuate, ventral medial, dorsomedial nuclei, and the median eminence) is an 
essential experiment to perform.  Further, fate-mapping these neurons while 
tracking food intake and weight changes may elucidate how each phase of 




Our findings show that α1A-AR activation had no effect on weight or food 
intake, but acutely disrupting cellular proliferation (i.e. neurogenesis) in the 
hypothalamus induced obesity in mice.  These findings contribute to our 
knowledge of the hypothalamic neurons and their role in weight, metabolism and 
energy balance.  Continued research in this area is important since determining 
how and when these neurons influence weight and metabolism may lead to new 
therapeutic strategies for obesity and other weight-related disorders.  
9.3 Exercise-induced neurogenesis and the α1A-adrenergic receptor 
We hypothesized that exercise-induced neurogenesis is mediated by the 
α1A-adrenergic receptor.  To test this hypothesis, we used α1A-AR KO mice along 
with their normal WT counterparts, and split each strain into two groups: 
sedentary or running.  Then mice were allowed to run freely for 3 weeks.  Food 
consumed and miles run were tracked throughout the duration of the experiment.  
Mice were also tested using the zero maze after 3 weeks of running to determine 
whether exercise decreased anxiety, as is commonly found in exercising mice 
(Duman & Schlesinger, 2008; Salam et al., 2009).  Finally, brains were analyzed 
for levels of neurogenesis in the DG of the hippocampus (using BrdU and DCX 
as markers).  We found that: 1) sedentary WT mice ate less than their running 
counterparts – but there was no difference among α1A-AR KO mice groups (Fig. 
39); 2) Running α1A-AR KO mice had increased anxiety compared to running WT 
mice during the last 5 min of zero maze (Fig. 40); 3) there was not an increase in 
neurogenesis between running WT and sedentary WT mice, but there was a 




(Fig. 41). Though this was a pilot study, these results indicate there may be a 
connection between the α1A-AR and the anxiolytic effects of exercise, as well as 
between the α1A-AR and exercise-induced neurogenesis. 
The first result from this study is perplexing: running WT mice ate more 
than sedentary WT mice but there was no difference among the α1A-AR KO 
groups.  Of course, it is obvious in the WT mice that running mice burn more 
calories and therefore consume more calories – explaining the difference found. 
However, this difference was not found among the α1A-AR KO mice. This may be 
explained simply, in that perhaps α1A-AR KO mice ran less than the WT mice. 
Even though this was tracked and no difference was found between WT and α1A-
AR KO running groups, it is possible that there was a slight enough difference to 
affect food intake. Another explanation may be that the absence of the α1A-AR 
may affect appetite or metabolism. Though activating the α1A-AR usually 
suppresses appetite (Davies & Wellman, 1992; Morien, McMahon, & Wellman, 
1993), perhaps the absence of the α1A-AR has the opposite effect on appetite. 
Results from the zero maze showed that running α1A-AR KO mice were 
found to be more anxious during the last 5 min of the test when compared to 
running WT mice.  Since we know that exercise increases NE in the brain (Brown 
& Huss, 1973; B. Brown et al., 1979) as well as NE metabolites (Dunn & Reigle, 
1996), the adrenergic receptor system was being activated as the mice were 
running.  It is possible then that the α1A-AR may mediate, at least in part, the 
anxiolytic effects of exercise, as α1A-AR KO mice became more anxious as the 




related behavior in mice, as measured with the elevated-plus maze (Doze et al., 
2009).  Another found that the chronic activation of the α1A-AR reduces 
obsessive compulsive-type anxiety (as measured with the marble burying test) 
and anxiety-like behavior (as measured in light-dark exploration) (Doze et al., 
2011).  Experimental evidence supports the activation of the α1A-AR as an 
anxiolytic and possibly as a mediator in the anxiolytic effects of exercise, though 
to what extent remains controversial. 
A surprising result from this pilot study was that running WT mice did not 
have higher levels of neurogenesis than sedentary WT mice. The strain we used 
in this study was C57BL/6.  We were aware that this strain shows the least 
amount of reaction to exercise-induced neurogenesis when compared to other 
strains (Clark et al., 2011), however we needed to match the background of our 
α1A-AR KO mice, which were constructed on the C57BL/6 strain.  There was also 
no difference found between any groups when examining DCX+-cells, but there 
was a difference found between the running WT group and the running α1A-AR 
KO group when we examined BrdU+/DCX+-double labeled cells. We found a 
significant decrease in double labeled cells in the running α1A-AR KO group. This 
suggests that running decreases neurogenesis when the α1A-AR is not present – 
implying that the α1A-AR is offsetting a separate pathway that decreases 
neurogenesis during exercise.  This ambiguous result does not rule out the 
potential for the α1A-AR to mediate exercise-induced neurogenesis. 
There are several ways to address the ambiguity of the results in this 




each in separate cages. This would make measuring total miles run for each 
mouse easier.  Mice running significantly less or more than other mice should be 
excluded from the study.  Mice should be tested in the open field test (motor 
movement) as well to ensure they are not physically impaired.  The strain 
problem may be difficult to address as constructing transgenic mice is sometimes 
reliant on strain behavior during offspring rearing, one of the reasons the 
C57BL/6 background was chosen.  However, it may be beneficial to investigate 
whether an α1A-AR KO transgenic mouse can be constructed on a strain that is 
more responsive to exercise-induced neurogenesis, such as the AKR/J strain 
(Clark et al., 2011).  A final possibility would be to use osmotic pumps and 
cannulate mice to deliver an affective α1A-AR selective antagonist such as 5-
methylurapidil (table 2; Horie et al., 1995) during exercise. This would also isolate 
the antagonism of the α1A-AR to the CNS, as a transgenic manipulation is global 
and affects the PNS as well. A pharmacological approach would also give more 
flexibility to the experiment – as one could block the α1A-AR during exercise, and 
then unblock the α1A-AR to determine if the expected response would return.   
Discovering the mediating receptors in exercise-induced neurogenesis 
has important therapeutic implications. For instance, if we are able to pinpoint the 
receptor subtype mediating this response, such as the α1A-AR, we may be able 
to target this receptor and induce neurogenesis in physically impaired patients 
and patients with neurodegenerative disorders.  Additionally, as mentioned in 
9.1, activating the α1A-AR has neuroprotective affects during brain injury, rescues 




learning and memory in normal mice.  Activation of the α1A-AR during 
chemotherapy may protect patients from chemo-brain, and may help them 
recover the lost brain cells during chemotherapy treatment by stimulating 
neurogenesis. Though there is much left to investigate and discover with the α1A-






























Abbreviations used in text 
C   Degrees Celsius 
[Ca2+]i  Internal calcium concentration 
3V  Third ventricle 
AAALAC American Association for Accreditation of Laboratory Animal Care 
aCSF  Artificial cerebral spinal fluid 
AD  Alzheimer’s disease 
AgRP  Agouti-related peptide 
AMPA  -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ANG  Adult neurogenesis 
ANOVA Analysis of variance 
AR  Adrenergic receptor 
Ara-C  Cytosine arabinoside 
ARC  Arcuate nucleus 
B  Bregma 
BrdU  5-bromo-2’-deoxyuridine 
CA  Cornu ammonis 
CaCl2  Calcium chloride 
CAM  Constitutively activated mutant 
CNS  Central nervous system 
CO2
  Carbon dioxide 
CRZ  Cirazoline 
CS  Coronal suture 
DAG  Diacylglycerol 
DCX  Doublecortin 
DMN  Dorsal medial nucleus 
DNA  Deoxyribonucleic acid 
EC50  Effective concentration (50% maximal effect) 
EGTA  Ethylene glycol tetraacetic acid 
Emax  Maximum effect, potency 
EPI  Epinephrine 
EPSP  Excitatory post-synaptic potential 
ERK  Extracellular signal-regulated kinase 
fEPSP Field excitatory post-synaptic potential 
FX  Fornix 
GABA  -aminobutyric acid 
GFAP  Glial fibrillary acidic protein 
GPCR  G protein-coupled receptor 
h  hour(s) 
HCl  Hydrochloric acid 
IP3  Inositol 1,4,5-trisphosphate 
IUPHAR International Union of Basic Clinical Pharmacology 
JNK  c-Jun N-terminal Kinase 
KCl  Potassium chloride 
kg  kilogram (103 gram) 
KO  Knock-out130 
131 
 
L  Lambda 
LHA  Lateral hypothalamic area 
LTD  Long-term depression 
LTP  Long-term potentiation 
MAPK  Mitogen activated protein kinase 
ME  Median eminence 
MgSO4 Magnesium sulfate 
min  minute(s) 
mL  milliliter (10-3 liter) 
mm  millimeter (10-3 meter) 
MWM  Morris water maze 
n  number 
NaCl  Sodium chloride 
NaH2PO4 Sodium phosphate 
NaHCO3 Sodium bicarbonate 
NE  Norepinephrine 
NeuN  Neuron-specific neuronal peptide 
NeuroD Neuron differentiation protein 
NIH  National Institute of Health 
NMDA N-methyl-D-aspartate 
NOR  Novel object recognition 
NPY  Neuropeptide Y 
NTS  Nucleus of the solitary tract 
PFA  Parafornical area 
PIP2  Phosphatidylinositol 4,5-bisphosphate 
PKC  Protein kinase C 
PLA2  Phospholipase A2 
PLC  Phospholipase C 
PNS  Peripheral nervous system 
POMC Proopiomelanocortin 
PPF  Paired-pulse facilitation 
PSA-NCAM Polysialylated-neural cell adhesion molecule 
PTP  Post-tetanic potentiation 
PVN  Paraventricular nucleus 
RNA  Ribonucleic acid 
s  second 
SEM  Standard error of the mean 
SGZ  Subgranular zone 
STP  Short-term potentiation 
SVZ  Subventricular zone 
TBS  Theta-burst stimulation 
VMH  Ventral medial hypothalamus 
WT  Wildtype 
μA  micro amp 
μg  microgram (10-6 gram) 
μm  micrometer (10-6 meter) 
132 
 



























Aberg, M. A. I., Aberg, N. D., Palmer, T. D., Alborn, A.-M., Carlsson-Skwirut, C., 
Bang, P., Rosengren, L. E., Olsson, T., Gage, F. H., Eriksson, P. S. (2003). 
IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. 
Molecular and Cellular Neurosciences, 24(1), 23–40. doi:10.1016/S1044-
7431(03)00082-4 
Adams, M. M., Smith, T. D., Moga, D., Gallagher, M., Wang, Y., Wolfe, B. B., 
Rapp, P. R., Morrison, J. H. (2001). Hippocampal dependent learning ability 
correlates with N-methyl-D-aspartate (NMDA) receptor levels in CA3 
neurons of young and aged rats. The Journal of Comparative Neurology, 
432(2), 230–43. 
Adrenoceptors: Introduction. (n.d.) Retrieved March 4, 2014, from IUPHAR: 
International Union of Basic and Clinical Pharmacology Database website, 
http://www.iuphar-db.org/index.jsp 
Ahlquist, R. P. (1948). A study of the adrenotropic receptors. The American 
Journal of Physiology, 153(3), 586–600. 
Aimone, J. B., Deng, W., & Gage, F. H. (2011). Resolving new memories: a 
critical look at the dentate gyrus, adult neurogenesis, and pattern separation. 
Neuron, 70(4), 589–96. doi:10.1016/j.neuron.2011.05.010 
Altman, J., & Das, G. D. (1965). Autoradiographic and histological evidence of 
postnatal hippocampal neurogenesis in rats. The Journal of Comparative 
Neurology, 124(3), 319–35. 
Alvarez-Buylla, A., & Garcia-Verdugo, J. M. (2002). Neurogenesis in adult 
subventricular zone. The Journal of Neuroscience : The Official Journal of 
the Society for Neuroscience, 22(3), 629–34. 
Arch, J. R., Ainsworth, A. T., Cawthorne, M. A., Piercy, V., Sennitt, M. V, Thody, 
V. E., Wilson, C., Wilson, S. (1984). Atypical beta-adrenoceptor on brown 
adipocytes as target for anti-obesity drugs. Nature, 309(5964), 163–5. 
Arnsten, A. F., & Jentsch, J. D. (1997). The alpha-1 adrenergic agonist, 
cirazoline, impairs spatial working memory performance in aged monkeys. 
Pharmacology, Biochemistry, and Behavior, 58(1), 55–9. 
134 
 
Arnsten, A. F., Mathew, R., Ubriani, R., Taylor, J. R., & Li, B. M. (1999). Alpha-1 
noradrenergic receptor stimulation impairs prefrontal cortical cognitive 
function. Biological Psychiatry, 45(1), 26–31. 
Bach, M. E., Barad, M., Son, H., Zhuo, M., Lu, Y. F., Shih, R., Mansuy, I., 
Hawkins, R. D., Kandel, E. R. (1999). Age-related defects in spatial memory 
are correlated with defects in the late phase of hippocampal long-term 
potentiation in vitro and are attenuated by drugs that enhance the cAMP 
signaling pathway. Proceedings of the National Academy of Sciences of the 
United States of America, 96(9), 5280–5. 
Barnes, C. A. (1979). Memory deficits associated with senescence: a 
neurophysiological and behavioral study in the rat. Journal of Comparative 
and Physiological Psychology, 93(1), 74–104. 
Bashir, Z. I., Tam, B., & Collingridge, G. L. (1990). Activation of the glycine site in 
the NMDA receptor is necessary for the induction of LTP. Neuroscience 
Letters, 108(3), 261–6. 
Bauer, S., & Patterson, P. H. (2005). The cell cycle-apoptosis connection 
revisited in the adult brain. The Journal of Cell Biology, 171(4), 641–50. 
doi:10.1083/jcb.200505072 
Bédard, A., & Parent, A. (2004). Evidence of newly generated neurons in the 
human olfactory bulb. Brain Research. Developmental Brain Research, 
151(1-2), 159–68. doi:10.1016/j.devbrainres.2004.03.021 
Bekar, L. K., He, W., & Nedergaard, M. (2008). Locus coeruleus alpha-
adrenergic-mediated activation of cortical astrocytes in vivo. Cerebral Cortex 
(New York, N.Y. : 1991), 18(12), 2789–95. doi:10.1093/cercor/bhn040 
Bekinschtein, P., Oomen, C. A., Saksida, L. M., & Bussey, T. J. (2011). Effects of 
environmental enrichment and voluntary exercise on neurogenesis, learning 
and memory, and pattern separation: BDNF as a critical variable? Seminars 
in Cell & Developmental Biology, 22(5), 536–42. 
doi:10.1016/j.semcdb.2011.07.002 
Bennett, L., Yang, M., Enikolopov, G., & Iacovitti, L. (2009). Circumventricular 
organs: a novel site of neural stem cells in the adult brain. Molecular and 
Cellular Neurosciences, 41(3), 337–47. doi:10.1016/j.mcn.2009.04.007 
Bernier, P. J., Bedard, A., Vinet, J., Levesque, M., & Parent, A. (2002). Newly 
generated neurons in the amygdala and adjoining cortex of adult primates. 
Proceedings of the National Academy of Sciences of the United States of 
America, 99(17), 11464–9. doi:10.1073/pnas.172403999 
135 
 
Berridge, C. W., & Waterhouse, B. D. (2003). The locus coeruleus-noradrenergic 
system: modulation of behavioral state and state-dependent cognitive 
processes. Brain Research. Brain Research Reviews, 42(1), 33–84. 
Berthelsen, S., & Pettinger, W. A. (1977). A functional basis for classification of 
alpha-adrenergic receptors. Life Sciences, 21(5), 595–606. 
Besirli, C. G., Deckwerth, T. L., Crowder, R. J., Freeman, R. S., & Johnson, E. M. 
(2003). Cytosine arabinoside rapidly activates Bax-dependent apoptosis and 
a delayed Bax-independent death pathway in sympathetic neurons. Cell 
Death and Differentiation, 10(9), 1045–58. doi:10.1038/sj.cdd.4401259 
Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., & Arnsten, A. F. 
(1999). A role for norepinephrine in stress-induced cognitive deficits: alpha-
1-adrenoceptor mediation in the prefrontal cortex. Biological Psychiatry, 
46(9), 1266–74. 
Blackstad, T. W., Fuxe, K., & Hökfelt, T. (1967). Noradrenaline nerve terminals in 
the hippocampal region of the rat and the guinea pig. Zeitschrift Für 
Zellforschung Und Mikroskopische Anatomie (Vienna, Austria : 1948), 78(4), 
463–73. 
Bliss, T. V, & Collingridge, G. L. (1993). A synaptic model of memory: long-term 
potentiation in the hippocampus. Nature, 361(6407), 31–9. 
doi:10.1038/361031a0 
Bortolotto, Z. A., & Collingridge, G. L. (1993). Characterisation of LTP induced by 
the activation of glutamate metabotropic receptors in area CA1 of the 
hippocampus. Neuropharmacology, 32(1), 1–9. doi:10.1016/0028-
3908(93)90123-K 
Bouret, S. G., & Simerly, R. B. (2006). Developmental programming of 
hypothalamic feeding circuits. Clinical Genetics, 70(4), 295–301. 
doi:10.1111/j.1399-0004.2006.00684.x 
Braess, J., Wegendt, C., Feuring-Buske, M., Riggert, J., Kern, W., Hiddemann, 
W., & Schleyer, E. (1999). Leukaemic blasts differ from normal bone marrow 
mononuclear cells and CD34+ haemopoietic stem cells in their metabolism 
of cytosine arabinoside. British Journal of Haematology, 105(2), 388–93. 
Breton-Provencher, V., Lemasson, M., Peralta, M. R., & Saghatelyan, A. (2009). 
Interneurons produced in adulthood are required for the normal functioning 
of the olfactory bulb network and for the execution of selected olfactory 
behaviors. The Journal of Neuroscience : The Official Journal of the Society 




Brown, B., & Huss, W. Van. (1973). Exercise and rat brain catecholamines. 
Journal of Applied Physiology, 664–669. 
Brown, B., Payne, T., & Kim, C. (1979). Chronic response of rat brain 
norepinephrine and serotonin levels to endurance training. Journal of 
Applied Physiology, 46, 19–23. 
Brown, J. P., Couillard-Després, S., Cooper-Kuhn, C. M., Winkler, J., Aigner, L., 
& Kuhn, H. G. (2003). Transient expression of doublecortin during adult 
neurogenesis. The Journal of Comparative Neurology, 467(1), 1–10. 
doi:10.1002/cne.10874 
Bruel-Jungerman, E., Laroche, S., & Rampon, C. (2005). New neurons in the 
dentate gyrus are involved in the expression of enhanced long-term memory 
following environmental enrichment. The European Journal of Neuroscience, 
21(2), 513–21. doi:10.1111/j.1460-9568.2005.03875.x 
Burch, R. M., Luini, A., Mais, D. E., Corda, D., Vanderhoek, J. Y., Kohn, L. D., & 
Axelrod, J. (1986). Alpha 1-adrenergic stimulation of arachidonic acid 
release and metabolism in a rat thyroid cell line. Mediation of cell replication 
by prostaglandin E2. The Journal of Biological Chemistry, 261(24), 11236–
41. 
Burke, S. N., & Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nature 
Reviews. Neuroscience, 7(1), 30–40. doi:10.1038/nrn1809 
Bylund, D. B. (1985). Heterogeneity of alpha-2 adrenergic receptors. 
Pharmacology, Biochemistry, and Behavior, 22(5), 835–43. 
doi:10.1016/0091-3057(85)90536-2 
Bylund, D. B. (1988). Subtypes of alpha 2-adrenoceptors: pharmacological and 
molecular biological evidence converge. Trends in Pharmacological 
Sciences, 9(10), 356–61. 
Bylund, D. B. (2007). Alpha- and beta-adrenergic receptors: Ahlquist’s landmark 
hypothesis of a single mediator with two receptors. American Journal of 
Physiology. Endocrinology and Metabolism, 293(6), E1479–81. 
doi:10.1152/ajpendo.00664.2007 
Cahill, L., & McGaugh, J. L. (1995). A novel demonstration of enhanced memory 





Cameron, H. A., McEwen, B. S., & Gould, E. (1995). Regulation of adult 
neurogenesis by excitatory input and NMDA receptor activation in the 
dentate gyrus. The Journal of Neuroscience : The Official Journal of the 
Society for Neuroscience, 15(6), 4687–92. 
Cameron, H., & McKay, R. D. (2001). Adult neurogenesis produces a large pool 
of new granule cells in the dentate gyrus. The Journal of Comparative 
Neurology, 435(4), 406–17. 
Campeau, S., Nyhuis, T. J., Kryskow, E. M., Masini, C. V, Babb, J. a, Sasse, S. 
K., Greenwood, B. N., Fleshner, M., Day, H. E. W. (2010). Stress rapidly 
increases alpha 1d adrenergic receptor mRNA in the rat dentate gyrus. Brain 
Research, 1323, 109–18. doi:10.1016/j.brainres.2010.01.084 
Castilla-Ortega, E., Rosell-Valle, C., Blanco, E., Pedraza, C., Chun, J., de 
Fonseca, F. R., Estivill-Torrus, Santín, L. J. (2013). Reduced wheel running 
and blunted effects of voluntary exercise in LPA1-null mice: The importance 
of assessing the amount of running in transgenic mice studies. 
Neuroscience Research, 1–10. doi:10.1016/j.neures.2013.09.004 
Chen, M. J., & Russo-Neustadt, A. A. (2005). Exercise activates the 
phosphatidylinositol 3-kinase pathway. Brain Research. Molecular Brain 
Research, 135(1-2), 181–93. doi:10.1016/j.molbrainres.2004.12.001 
Clark, P. J., Kohman, R. a, Miller, D. S., Bhattacharya, T. K., Brzezinska, W. J., & 
Rhodes, J. S. (2011). Genetic influences on exercise-induced adult 
hippocampal neurogenesis across 12 divergent mouse strains. Genes, 
Brain, and Behavior, 10(3), 345–53. doi:10.1111/j.1601-183X.2010.00674.x 
Clark, R. E., Zola, S. M., & Squire, L. R. (2000). Impaired recognition memory in 
rats after damage to the hippocampus. The Journal of Neuroscience : The 
Official Journal of the Society for Neuroscience, 20(23), 8853–60. 
Clelland, C. D., Choi, M., Romberg, C., Clemenson, G. D., Fragniere, A., Tyers, 
P., Jessberger, S., Saksida, L. M., Barker, R. A., Gage, F. H., Bussey, T. J. 
(2009). A functional role for adult hippocampal neurogenesis in spatial 
pattern separation. Science (New York, N.Y.), 325(5937), 210–3. 
doi:10.1126/science.1173215 
Coan, E. J., Irving, A. J., & Collingridge, G. L. (1989). Low-frequency activation of 
the NMDA receptor system can prevent the induction of LTP. Neuroscience 
Letters, 105(1-2), 205–10. 
Coan, E. J., Saywood, W., & Collingridge, G. L. (1987). MK-801 blocks NMDA 
receptor-mediated synaptic transmission and long term potentiation in rat 
hippocampal slices. Neuroscience Letters, 80(1), 111–4. 
138 
 
Collingridge, G. L., Kehl, S. J., & McLennan, H. (1983). Excitatory amino acids in 
synaptic transmission in the Schaffer collateral-commissural pathway of the 
rat hippocampus. The Journal of Physiology, 334, 33–46. 
Cooper-Kuhn, C. M., & Kuhn, H. G. (2002). Is it all DNA repair? Methodological 
considerations for detecting neurogenesis in the adult brain. Brain Research. 
Developmental Brain Research, 134(1-2), 13–21. 
Costafreda, S. G., Brammer, M. J., David, A. S., & Fu, C. H. Y. (2008). Predictors 
of amygdala activation during the processing of emotional stimuli: a meta-
analysis of 385 PET and fMRI studies. Brain Research Reviews, 58(1), 57–
70. doi:10.1016/j.brainresrev.2007.10.012 
Couillard-Despres, S., Winner, B., Karl, C., Lindemann, G., Schmid, P., Aigner, 
R., Laemke, J., Bogdahn, U., Winkler, J., Bischofberger, J., Aigner, L. 
(2006). Targeted transgene expression in neuronal precursors: watching 
young neurons in the old brain. The European Journal of Neuroscience, 
24(6), 1535–45. doi:10.1111/j.1460-9568.2006.05039.x 
Couillard-Despres, S., Winner, B., Schaubeck, S., Aigner, R., Vroemen, M., 
Weidner, N., Bogdahn, U., Winkler, J., Kuhn, H. G., Aigner, L. (2005). 
Doublecortin expression levels in adult brain reflect neurogenesis. The 
European Journal of Neuroscience, 21(1), 1–14. doi:10.1111/j.1460-
9568.2004.03813.x 
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. 
L., Cone, R. D., Low, M. J. (2001). Leptin activates anorexigenic POMC 
neurons through a neural network in the arcuate nucleus. Nature, 411(6836), 
480–4. doi:10.1038/35078085 
Curet, O., & de Montigny, C. (1988). Electrophysiological characterization of 
adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the 
effect of synaptically released norepinephrine. Brain Research, 475(1), 47–
57. 
Davenport, H. W. (1982). Epinephrin(e). The Physiologist, 25(2), 76–82. 
Davies, B. T., & Wellman, P. J. (1992). Effects on ingestive behavior in rats of the 
alpha 1-adrenoceptor agonist cirazoline. European Journal of 
Pharmacology, 210(1), 11–6. 
Deng, W., Aimone, J. B., & Gage, F. H. (2010). New neurons and new memories: 
how does adult hippocampal neurogenesis affect learning and memory? 
Nature Reviews. Neuroscience, 11, 339. 
139 
 
Deupree, D. L., Turner, D. A., & Watters, C. L. (1991). Spatial performance 
correlates with in vitro potentiation in young and aged Fischer 244 rats. Brain 
Research, 554, 1–9. 
Diana, G., Domenici, M. R., Loizzo, A., Scotti de Carolis, A., & Sagratella, S. 
(1994). Age and strain differences in rat place learning and hippocampal 
dentate gyrus frequency-potentiation. Neuroscience Letters, 171(1-2), 113–
6. 
Doetsch, F., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999). Regeneration of 
a germinal layer in the adult mammalian brain. Proceedings of the National 
Academy of Sciences of the United States of America, 96(20), 11619–24. 
Doze, V. A., Handel, E. M., Jensen, K. A., Darsie, B., Luger, E. J., Haselton, J. 
R., Talbot, J. N., Rorabaugh, B. R. (2009). alpha(1A)- and alpha(1B)-
adrenergic receptors differentially modulate antidepressant-like behavior in 
the mouse. Brain Research, 1285, 148–57. 
doi:10.1016/j.brainres.2009.06.035 
Doze, V. A., Papay, R. S., Goldenstein, B. L., Gupta, M. K., Collette, K. M., 
Nelson, B. W., Lyons, M. J., Davis, B. A., Luger, E. J., Wood, S. G., 
Haselton, J. R., Simpson, P. C., Perez, D. M. (2011). Long-term α1A-
adrenergic receptor stimulation improves synaptic plasticity, cognitive 
function, mood, and longevity. Molecular Pharmacology, 80(4), 747–58. 
doi:10.1124/mol.111.073734 
Dragunow, M., & Faull, R. (1989). The use of c-fos as a metabolic marker in 
neuronal pathway tracing. Journal of Neuroscience Methods, 29(3), 261–5. 
Drapeau, E., Mayo, W., Aurousseau, C., Le Moal, M., Piazza, P.-V., & Abrous, D. 
N. (2003). Spatial memory performances of aged rats in the water maze 
predict levels of hippocampal neurogenesis. Proceedings of the National 
Academy of Sciences of the United States of America, 100(24), 14385–90. 
doi:10.1073/pnas.2334169100 
Duffy, S., & MacVicar, B. A. (1995). Adrenergic calcium signaling in astrocyte 
networks within the hippocampal slice. The Journal of Neuroscience : The 
Official Journal of the Society for Neuroscience, 15(8), 5535–50. 
Duman, C., & Schlesinger, L. (2008). Voluntary exercise produces 
antidepressant and anxiolytic behavioral effects in mice. Brain Research, 
148–158. 
Dunn, A., & Reigle, T. (1996). Brain norepinephrine and metabolites after 
treadmill training and wheel running in rats. Medicine & Science in Sports & 
Exercise, 28(2), 204–209. 
140 
 
Dupret, D., Fabre, A., Döbrössy, M. D., Panatier, A., Rodríguez, J. J., Lamarque, 
S., Oliet, S. H. R., Piazza, P.-V., Abrous, D. N. (2007). Spatial learning 
depends on both the addition and removal of new hippocampal neurons. 
PLoS Biology, 5(8), e214. doi:10.1371/journal.pbio.0050214 
Dupret, D., Revest, J.-M., Koehl, M., Ichas, F., De Giorgi, F., Costet, P., Djoher, 
N. A., Piazza, P. V. (2008). Spatial relational memory requires hippocampal 
adult neurogenesis. PloS One, 3(4), e1959. 
doi:10.1371/journal.pone.0001959 
Eckenhoff, M. F., & Rakic, P. (1988). Nature and fate of proliferative cells in the 
hippocampal dentate gyrus during the life span of the rhesus monkey. The 
Journal of Neuroscience : The Official Journal of the Society for 
Neuroscience, 8(8), 2729–47. 
Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W., & Nestler, E. J. (2000). Opiates 
inhibit neurogenesis in the adult rat hippocampus. Proceedings of the 
National Academy of Sciences of the United States of America, 97(13), 
7579–84. doi:10.1073/pnas.120552597 
Elmquist, J. K., Elias, C. F., & Saper, C. B. (1999). From lesions to leptin: 
hypothalamic control of food intake and body weight. Neuron, 22(2), 221–32. 
Emery, A. C., Pshenichkin, S., Takoudjou, G. R., Grajkowska, E., Wolfe, B. B., & 
Wroblewski, J. T. (2010). The protective signaling of metabotropic glutamate 
receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK 
phosphorylation. The Journal of Biological Chemistry, 285(34), 26041–8. 
doi:10.1074/jbc.M110.139899 
Emorine, L. J., Marullo, S., Briend-Sutren, M. M., Patey, G., Tate, K., Delavier-
Klutchko, C., & Strosberg, A. D. (1989). Molecular characterization of the 
human beta 3-adrenergic receptor. Science (New York, N.Y.), 245(4922), 
1118–21. 
Ennaceur, A., & Delacour, J. (1988). A new one-trial test for neurobiological 
studies of memory in rats. 1: Behavrioal data. Laboratoire de 
Psychophysiologie, 31, 47–59. 
Ennaceur, A., & Meliani, K. (1992). A new one-trial test for neurobiological 
studies of memory in rats. III. Spatial vs. non-spatial working memory. 
Behavioural Brain Research, 51(1), 83–92. 
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A. M., Nordborg, C., 
Peterson, D. A., & Gage, F. H. (1998). Neurogenesis in the adult human 
hippocampus. Nature Medicine, 4(11), 1313–1317. doi:10.1038/3305 
141 
 
Evans, S., Janson, A., & Nyengaard, J. (Eds.). (2004). Quantitative Methods in 
Neuroscience: A Neuroanatomical Approach. Oxford: Oxford University 
Press. 
Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., & Chambon, P. 
(1996). Ligand-activated site-specific recombination in mice. Proceedings of 
the National Academy of Sciences of the United States of America, 93(20), 
10887–90. 
Fernández, A., Radmilovich, M., & Trujillo-Cenóz, O. (2002). Neurogenesis and 
gliogenesis in the spinal cord of turtles. The Journal of Comparative 
Neurology, 453(2), 131–44. doi:10.1002/cne.10388 
Ferry, B., Roozendaal, B., & McGaugh, J. L. (1999). Involvement of alpha1-
adrenoceptors in the basolateral amygdala in modulation of memory 
storage. European Journal of Pharmacology, 372(1), 9–16. 
Filipkowski, R. K., Kiryk, A., Kowalczyk, A., & Kaczmarek, L. (2005). Genetic 
models to study adult neurogenesis. Acta Biochimica Polonica, 52(2), 359–
72. 
Floresco, S. B., Seamans, J. K., & Phillips, A. G. (1997). Selective roles for 
hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm 
maze tasks with or without a delay. The Journal of Neuroscience : The 
Official Journal of the Society for Neuroscience, 17(5), 1880–90. 
Ford, A. P., Daniels, D. V, Chang, D. J., Gever, J. R., Jasper, J. R., Lesnick, J. 
D., & Clarke, D. E. (1997). Pharmacological pleiotropism of the human 
recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor 
classification. British Journal of Pharmacology, 121(6), 1127–35. 
doi:10.1038/sj.bjp.0701207 
Ford, A. P., Williams, T. J., Blue, D. R., & Clarke, D. E. (1994). Alpha 1-
adrenoceptor classification: sharpening Occam’s razor. Trends in 
Pharmacological Sciences, 15(6), 167–70. 
Foster, D. A., & Xu, L. (2003). Phospholipase D in cell proliferation and cancer. 
Molecular Cancer Research : MCR, 1(11), 789–800. 
Foster, T. C. (1999). Involvement of hippocampal synaptic plasticity in age-
related memory decline. Brain Research. Brain Research Reviews, 30(3), 
236–49. 
Fowler, C. D., Liu, Y., & Wang, Z. (2008). Estrogen and adult neurogenesis in the 




Froc, D. J., Eadie, B., Li, A. M., Wodtke, K., Tse, M., & Christie, B. R. (2003). 
Reduced Synaptic Plasticity in the Lateral Perforant Path Input to the 
Dentate Gyrus of Aged C57BL/6 Mice. Journal of Neurophysiology, 90, 32–
38. 
Fujii, S., Matsumoto, M., Igarashi, K., Kato, H., & Mikoshiba, K. (2000). Synaptic 
plasticity in hippocampal CA1 neurons of mice lacking type 1 inositol-1,4,5-
trisphosphate receptors. Learning & Memory (Cold Spring Harbor, N.Y.), 
7(5), 312–20. doi:10.1101/lm.34100 
Gage, F. H., Kempermann, G., Song, H. (2008) Adult Neurogenesis, Methods for 
Labeling and Mutation of Postnatal NPCs (pp. 62). Cold Spring Harbor, NY: 
Cold Spring Harbor Laboratory Press. 
Ge, S., Yang, C.-H., Hsu, K.-S., Ming, G.-L., & Song, H. (2007). A critical period 
for enhanced synaptic plasticity in newly generated neurons of the adult 
brain. Neuron, 54(4), 559–66. doi:10.1016/j.neuron.2007.05.002 
Gibbs, M. E., & Bowser, D. N. (2010). Astrocytic adrenoceptors and learning: 
alpha1-adrenoceptors. Neurochemistry International, 57(4), 404–10. 
doi:10.1016/j.neuint.2010.03.020 
Gibbs, M. E., Hutchinson, D. S., & Summers, R. J. (2010). Noradrenaline release 
in the locus coeruleus modulates memory formation and consolidation; roles 
for α- and β-adrenergic receptors. Neuroscience, 170(4), 1209–22. 
doi:10.1016/j.neuroscience.2010.07.052 
Gibbs, M. E., & Summers, R. J. (2001). Stimulation of alpha1-adrenoceptors 
inhibits memory consolidation in the chick. The European Journal of 
Neuroscience, 14(8), 1369–76. 
Gilbert, M. E., & Mack, C. M. (1990). The NMDA antagonist, MK-801, suppresses 
long-term potentiation, kindling, and kindling-induced potentiation in the 
perforant path of the unanesthetized rat. Brain Research, 519(1-2), 89–96. 
Gleeson, J. G., Lin, P. T., Flanagan, L. A., & Walsh, C. A. (1999). Doublecortin is 
a microtubule-associated protein and is expressed widely by migrating 
neurons. Neuron, 23(2), 257–71. 
Goldman, C. K., Marino, L., & Leibowitz, S. F. (1985). Postsynaptic alpha 2-
noradrenergic receptors mediate feeding induced by paraventricular nucleus 
injection of norepinephrine and clonidine. European Journal of 
Pharmacology, 115(1), 11–9. 
143 
 
Goldman-Rakic, P. S. (1987). Circuitry of the frontal association cortex and its 
relevance to dementia. Archives of Gerontology and Geriatrics, 6(3), 299–
309. 
Gould, E. (2007). How widespread is adult neurogenesis in mammals? Nature 
Reviews. Neuroscience, 8(6), 481–8. doi:10.1038/nrn2147 
Gould, E., Beylin, A., Tanapat, P., Reeves, A., & Shors, T. J. (1999). Learning 
enhances adult neurogenesis in the hippocampal formation. Nature 
Neuroscience, 2(3), 260–5. doi:10.1038/6365 
Gould, E., Cameron, H. A., Daniels, D. C., Woolley, C. S., & McEwen, B. S. 
(1992). Adrenal hormones suppress cell division in the adult rat dentate 
gyrus. The Journal of Neuroscience : The Official Journal of the Society for 
Neuroscience, 12(9), 3642–50. 
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998). 
Proliferation of granule cell precursors in the dentate gyrus of adult monkeys 
is diminished by stress. Proceedings of the National Academy of Sciences of 
the United States of America, 95(6), 3168–71. 
Gropp, E., Shanabrough, M., Borok, E., Xu, A. W., Janoschek, R., Buch, T., 
Plum, L., Balthasar, N., Hampel, B., Waisma, A., Barsh, G. S., Horvath, T. 
L., Brüning, J. C. (2005). Agouti-related peptide-expressing neurons are 
mandatory for feeding. Nature Neuroscience, 8(10), 1289–91. 
doi:10.1038/nn1548 
Gross, C. G. (2000). Neurogenesis in the adult brain: death of a dogma. Nature 
Reviews. Neuroscience, 1(1), 67–73. doi:10.1038/35036235 
Guan, X. M., Yu, H., Palyha, O. C., McKee, K. K., Feighner, S. D., Sirinathsinghji, 
D. J., Smith., R. G., Van der Ploeg, L. H. T., Howard, A. D. (1997). 
Distribution of mRNA encoding the growth hormone secretagogue receptor 
in brain and peripheral tissues. Brain Research. Molecular Brain Research, 
48(1), 23–9. 
Gupta, M. K., Papay, R. S., Jurgens, C. W. D., Gaivin, R. J., Shi, T., Doze, V. A., 
& Perez, D. M. (2009). alpha1-Adrenergic Receptors Regulate Neurogenesis 
and Gliogenesis. Cell, 76(2), 314–326. 
doi:10.1124/mol.109.057307.ventricles 
Gutkind, J. S. (1998). The pathways connecting G protein-coupled receptors to 
the nucleus through divergent mitogen-activated protein kinase cascades. 
The Journal of Biological Chemistry, 273(4), 1839–42. 
144 
 
Gyoneva, S., & Traynelis, S. F. (2013). Norepinephrine modulates the motility of 
resting and activated microglia via different adrenergic receptors. The 
Journal of Biological Chemistry, 288(21), 15291–302. 
doi:10.1074/jbc.M113.458901 
Hâkansson, M. L., Brown, H., Ghilardi, N., Skoda, R. C., & Meister, B. (1998). 
Leptin receptor immunoreactivity in chemically defined target neurons of the 
hypothalamus. The Journal of Neuroscience : The Official Journal of the 
Society for Neuroscience, 18(1), 559–72. 
Hammond, R. S., Tull, L. E., & Stackman, R. W. (2004). On the delay-dependent 
involvement of the hippocampus in object recognition memory. Neurobiology 
of Learning and Memory, 82(1), 26–34. doi:10.1016/j.nlm.2004.03.005 
Harrison, F. E., Hosseini, A. H., & McDonald, M. P. (2009). Endogenous anxiety 
and stress responses in water maze and Barnes maze spatial memory 
tasks. Behavioural Brain Research, 198(1), 247–51. 
doi:10.1016/j.bbr.2008.10.015 
Harrison, F. E., Reiserer, R. S., Tomarken, A. J., & McDonald, M. P. (2006). 
Spatial and nonspatial escape strategies in the Barnes maze. Learning & 
Memory (Cold Spring Harbor, N.Y.), 13(6), 809–19. doi:10.1101/lm.334306 
Harvey, J., & Collingridge, G. L. (1992). Thapsigargin blocks the induction of 
long-term potentiation in rat hippocampal slices. Neuroscience Letters, 
139(2), 197–200. 
Hein, L., Altman, J. D., & Kobilka, B. K. (1999). Two functionally distinct alpha2-
adrenergic receptors regulate sympathetic neurotransmission. Nature, 
402(6758), 181–4. doi:10.1038/46040 
Horie, K., Obika, K., Foglar, R., & Tsujimoto, G. (1995). Selectivity of the 
imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for 
human cloned alpha 1-adrenoceptor subtypes. British Journal of 
Pharmacology, 116(1), 1611–8. 
Hwa, J., Graham, R. M., & Perez, D. M. (1996). Chimeras of alpha1-adrenergic 
receptor subtypes identify critical residues that modulate active state 
isomerization. The Journal of Biological Chemistry, 271(14), 7956–64. 
Iivonen, H., Nurminen, L., Harri, M., Tanila, H., & Puoliväli, J. (2003). 
Hypothermia in mice tested in Morris water maze. Behavioural Brain 
Research, 141(2), 207–13. 
145 
 
Insel, P. A., Weiss, B. A., Slivka, S. R., Howard, M. J., Waite, J. J., & Godson, C. 
A. (1991). Regulation of phospholipase A2 by receptors in MDCK-Dl cells. 
Biochemical Society Transactions, 19(2), 329–33. 
Izumi, Y., Clifford, D. B., & Zorumski, C. F. (1992). Norepinephrine reverses N-
methyl-D-aspartate-mediated inhibition of long-term potentiation in rat 
hippocampal slices. Neuroscience Letters, 142(2), 163–6. 
Izumi, Y., & Zorumski, C. F. (1999). Norepinephrine promotes long-term 
potentiation in the adult rat hippocampus in vitro. Synapse (New York, N.Y.), 
31(3), 196–202. doi:10.1002/(SICI)1098-2396(19990301)31:3<196::AID-
SYN4>3.0.CO;2-K 
Jacobsen, C. F., & Nissen, H. W. (1937). Studies of cerebral function in primates. 
IV. The effects of frontal lobe lesions on the delayed alternation habit in 
monkeys. Journal of Comparative Psychology, 23(1), 101–112. 
Jähkel, M., Rilke, O., Koch, R., & Oehler, J. (2000). Open field locomotion and 
neurotransmission in mice evaluated by principal component factor analysis-
effects of housing condition, individual activity disposition and psychotropic 
drugs. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 
24(1), 61–84. 
Jhaveri, D., Mackay, E. W., Hamlin, A. S., Marathe, S. V, Nandam, L. S., Vaidya, 
V. A., & Bartlett, P. F. (2010). Norepinephrine Directly Activates Adult 
Hippocampal Precursors via ß3-Adrenergic Receptors. The Journal of 
Neuroscience, 30(7), 2795–2806. 
Kandel, E. R., Schwartz, J. H., Jessell, T. M. (2000) Principles of Neural Science 
(Ed. 4), Cellular Mechanisms of Learning and the Biological Basis of 
Individuality (pp. 1261). New York, NY: McGraw Hill. 
Kandel, E. R., Schwartz, J. H., Jessell, T. M. (2000) Principles of Neural Science 
(Ed. 4), Learning and Memory (pp. 1231). New York, NY: McGraw Hill. 
Kava, M. S., Blue, D. R., Vimont, R. L., Clarke, D. E., & Ford, A. P. (1998). 
Alpha1L-adrenoceptor mediation of smooth muscle contraction in rabbit 
bladder neck: a model for lower urinary tract tissues of man. British Journal 
of Pharmacology, 123(7), 1359–66. doi:10.1038/sj.bjp.0701748 
Kelso, S. R., Ganong, A. H., & Brown, T. H. (1986). Hebbian synapses in 
hippocampus. Proceedings of the National Academy of Sciences of the 
United States of America, 83(14), 5326–30. 
Kempermann, G., Jessberger, S., Steiner, B., & Kronenberg, G. (2004). 
Milestones of neuronal development in the adult hippocampus. Trends in 
Neurosciences, 27(8), 447–52. doi:10.1016/j.tins.2004.05.013 
146 
 
Klaus, F., & Amrein, I. (2012). Running in laboratory and wild rodents: differences 
in context sensitivity and plasticity of hippocampal neurogenesis. 
Behavioural Brain Research, 227(2), 363–70. doi:10.1016/j.bbr.2011.04.027 
Ko, H.-G., Jang, D.-J., Son, J., Kwak, C., Choi, J.-H., Ji, Y.-H., Lee, Y.-S., Son, 
H., Kaang, B.-K. (2009). Effect of ablated hippocampal neurogenesis on the 
formation and extinction of contextual fear memory. Molecular Brain, 2, 1. 
doi:10.1186/1756-6606-2-1 
Kobilka, B. K., Matsui, H., Kobilka, T. S., Yang-Feng, T. L., Francke, U., Caron, 
M. G., Llefkowitz, R. J., Regan, J. W. (1987). Cloning, sequencing, and 
expression of the gene coding for the human platelet alpha 2-adrenergic 
receptor. Science (New York, N.Y.), 238(4827), 650–6. 
Kobori, N., Hu, B., & Dash, P. K. (2011). Altered adrenergic receptor signaling 
following traumatic brain injury contributes to working memory dysfunction. 
Neuroscience, 172, 293–302. doi:10.1016/j.neuroscience.2010.10.048 
Kohman, R. A., DeYoung, E. K., Bhattacharya, T. K., Peterson, L. N., & Rhodes, 
J. S. (2012). Wheel running attenuates microglia proliferation and increases 
expression of a proneurogenic phenotype in the hippocampus of aged mice. 
Brain, Behavior, and Immunity, 26(5), 803–10. doi:10.1016/j.bbi.2011.10.006 
Kokoeva, M. M. V, Yin, H., & Flier, J. S. (2005). Neurogenesis in the 
Hypothalamus of Adult Mice: Potential Role in Energy Balance. Science 
(New York, N.Y.), 310(5748), 679–83. doi:10.1126/science.1115360 
Kokoeva, M. V, Yin, H., & Flier, J. S. (2007). Evidence for constitutive neural cell 
proliferation in the adult murine hypothalamus. The Journal of Comparative 
Neurology, 505(2), 209–20. doi:10.1002/cne.21492 
Kulkarni, V. A., Jha, S., & Vaidya, V. A. (2002). Depletion of norepinephrine 
decreases the proliferation, but does not influence the survival and 
differentiation, of granule cell progenitors in the adult rat hippocampus. 
European Journal of Neuroscience, 16(10), 2008–2012. doi:10.1046/j.1460-
9568.2002.02268.x 
Kwon, H.-B., & Castillo, P. E. (2008). Long-term potentiation selectively 
expressed by NMDA receptors at hippocampal mossy fiber synapses. 
Neuron, 57(1), 108–20. doi:10.1016/j.neuron.2007.11.024 
Lakhlani, P. P., Amenta, F., Napoleone, P., Felici, L., & Eikenburg, D. C. (1994). 
Pharmacological characterization and anatomical localization of 
prejunctional beta-adrenoceptors in the rat kidney. British Journal of 
Pharmacology, 111(4), 1296–308. 
147 
 
Landfield, P. W., & Lynch, G. (1977). Impaired monosynaptic potentiation in in 
vitro hippocampal slices from aged, memory-deficient rats. Journal of 
Gerontology, 32(5), 523–33. 
Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P., & Brown, T. G. (1967). 
Differentiation of receptor systems activated by sympathomimetic amines. 
Nature, 214(5088), 597–8. 
Langer, S. Z. (1974). Presynaptic regulation of catecholamine release. 
Biochemical Pharmacology, 23(13), 1793–800. 
Lapiz, M. D. S., & Morilak, D. A. (2006). Noradrenergic modulation of cognitive 
function in rat medial prefrontal cortex as measured by attentional set 
shifting capability. Neuroscience, 137(3), 1039–49. 
doi:10.1016/j.neuroscience.2005.09.031 
Lazzaro, S. C., Hou, M., Cunha, C., LeDoux, J. E., & Cain, C. K. (2010). 
Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear 
conditioning and long-term potentiation. Learning & Memory (Cold Spring 
Harbor, N.Y.), 17(10), 489–93. doi:10.1101/lm.1918210 
Lee, D. A., & Blackshaw, S. (2012). Functional implications of hypothalamic 
neurogenesis in the adult mammalian brain. International Journal of 
Developmental Neuroscience : The Official Journal of the International 
Society for Developmental Neuroscience, 30(8), 615–21. 
doi:10.1016/j.ijdevneu.2012.07.003 
Lee, J. E., Hollenberg, S. M., Snider, L., Turner, D. L., Lipnick, N., & Weintraub, 
H. (1995). Conversion of Xenopus ectoderm into neurons by NeuroD, a 
basic helix-loop-helix protein. Science (New York, N.Y.), 268(5212), 836–44. 
Lee, M. C., Inoue, K., Okamoto, M., Liu, Y. F., Matsui, T., Yook, J. S., & Soya, H. 
(2013). Voluntary resistance running induces increased hippocampal 
neurogenesis in rats comparable to load-free running. Neuroscience Letters, 
537, 6–10. doi:10.1016/j.neulet.2013.01.005 
Leibowitz, S. F. (1988). Hypothalamic paraventricular nucleus: interaction 
between alpha 2-noradrenergic system and circulating hormones and 
nutrients in relation to energy balance. Neuroscience and Biobehavioral 
Reviews, 12(2), 101–9. 
Lemaire, V., Koehl, M., Le Moal, M., & Abrous, D. N. (2000). Prenatal stress 
produces learning deficits associated with an inhibition of neurogenesis in 
the hippocampus. Proceedings of the National Academy of Sciences of the 
United States of America, 97(20), 11032–7. 
148 
 
Lewis, P. D., Patel, A. J., Béndek, G., & Balázs, R. (1977). Effect of reserpine on 
cell proliferation in the developing rat brain: a quantivative histological study. 
Brain Research, 129(2), 299–308. 
Li, C.-Q., Liu, D., Huang, L., Wang, H., Zhang, J.-Y., & Luo, X.-G. (2008). 
Cytosine arabinoside treatment impairs the remote spatial memory function 
and induces dendritic retraction in the anterior cingulate cortex of rats. Brain 
Research Bulletin, 77(5), 237–40. doi:10.1016/j.brainresbull.2008.07.010 
Lin, S., & Huang, X. F. (1999). Altered hypothalamic c-Fos-like immunoreactivity 
in diet-induced obese mice. Brain Research Bulletin, 49(3), 215–9. 
Liu, F., He, K., Yang, X., Xu, N., Liang, Z., Xu, M., Zhao, X., Han, Q., Zhang, Y. 
(2011). α1A-adrenergic receptor induces activation of extracellular signal-
regulated kinase 1/2 through endocytic pathway. PloS One, 6(6), e21520. 
doi:10.1371/journal.pone.0021520 
Lledo, P. M., Zhang, X., Südhof, T. C., Malenka, R. C., & Nicoll, R. A. (1998). 
Postsynaptic membrane fusion and long-term potentiation. Science (New 
York, N.Y.), 279(5349), 399–403. doi:10.1126/science.279.5349.399 
Lledo, P.-M., Alonso, M., & Grubb, M. S. (2006). Adult neurogenesis and 
functional plasticity in neuronal circuits. Nature Reviews. Neuroscience, 7(3), 
179–93. doi:10.1038/nrn1867 
Lois, C., & Alvarez-Buylla, A. (1994). Long-distance neuronal migration in the 
adult mammalian brain. Science (New York, N.Y.), 264(5162), 1145–8. 
Lomasney, J. W., Cotecchia, S., Lorenz, W., Leung, W. Y., Schwinn, D. A., 
Yang-Feng, T. L., Brownstein, M., Lefkowitz, R. J., Caron, M. G. (1991). 
Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic 
receptor. The gene for which is located on human chromosome 5. The 
Journal of Biological Chemistry, 266(10), 6365–9. 
Lovinger, B. Y. D. M., Routtenbergt, A., Lovinger, D. M., & Routtenberg, A. 
(1988). Synapse-specific protein kinase C activation enhances maintenance 
of long-term potentiation in rat hippocampus. The Journal of Physiology, 
400, 321–33. 
Loy, R., Koziell, D. A., Lindsey, J. D., & Moore, R. Y. (1980). Noradrenergic 
innervation of the adult rat hippocampal formation. The Journal of 




Lu, W., Man, H., Ju, W., Trimble, W. S., MacDonald, J. F., & Wang, Y. T. (2001). 
Activation of synaptic NMDA receptors induces membrane insertion of new 
AMPA receptors and LTP in cultured hippocampal neurons. Neuron, 29(1), 
243–54. 
Luquet, S., Perez, F. A., Hnasko, T. S., & Palmiter, R. D. (2005). NPY/AgRP 
neurons are essential for feeding in adult mice but can be ablated in 
neonates. Science (New York, N.Y.), 310(5748), 683–5. 
doi:10.1126/science.1115524 
Lynch, G., Larson, J., Kelso, S., Barrionuevo, G., & Schottler, F. (1983). 
Intracellular injections of EGTA block induction of hippocampal long-term 
potentiation. Nature, 305(5936), 719–21. 
Ma, Q. (2008). Beneficial effects of moderate voluntary physical exercise and its 
biological mechanisms on brain health. Neuroscience Bulletin, 4(4), 265–
270. doi:10.1007/s12264-008-0402-1 
Mack, V., Burnashev, N., Kaiser, K. M., Rozov, A., Jensen, V., Hvalby, O., 
Seeburg, P. H., Sakmann, B., Sprengel, R. (2001). Conditional restoration of 
hippocampal synaptic potentiation in Glur-A-deficient mice. Science (New 
York, N.Y.), 292(5526), 2501–4. doi:10.1126/science.1059365 
Madsen, T. M., Treschow, a, Bengzon, J., Bolwig, T. G., Lindvall, O., & 
Tingström, A. (2000). Increased neurogenesis in a model of 
electroconvulsive therapy. Biological Psychiatry, 47(12), 1043–9. 
Malenka, R. C. (1991). Postsynaptic factors control the duration of synaptic 
enhancement in area CA1 of the hippocampus. Neuron, 6(1), 53–60. 
doi:10.1016/0896-6273(91)90121-F 
Maletic-Savatic, M., Koothan, T., & Malinow, R. (1998). Calcium-evoked dendritic 
exocytosis in cultured hippocampal neurons. Part II: mediation by 
calcium/calmodulin-dependent protein kinase II. The Journal of 
Neuroscience : The Official Journal of the Society for Neuroscience, 18(17), 
6814–21. 
Malinow, R., & Malenka, R. C. (2002). AMPA receptor trafficking and synaptic 
plasticity. Annual Review of Neuroscience, 25, 103–26. 
doi:10.1146/annurev.neuro.25.112701.142758 
Mann, D. M., Lincoln, J., Yates, P. O., Stamp, J. E., & Toper, S. (1980). Changes 
in the monoamine containing neurones of the human CNS in senile 




Mao, Z. M., Arnsten, A. F., & Li, B. M. (1999). Local infusion of an alpha-1 
adrenergic agonist into the prefrontal cortex impairs spatial working memory 
performance in monkeys. Biological Psychiatry, 46(9), 1259–65. 
Maren, S., Tocco, G., Standley, S., Baudry, M., & Thompson, R. F. (1993). 
Postsynaptic factors in the expression of long-term potentiation (LTP): 
increased glutamate receptor binding following LTP induction in vivo. 
Proceedings of the National Academy of Sciences of the United States of 
America, 90(20), 9654–8. 
Masuda, T., Nakagawa, S., Boku, S., Nishikawa, H., Takamura, N., Kato, A., 
Inoue, T., Koyama, T. (2012). Noradrenaline increases neural precursor 
cells derived from adult rat dentate gyrus through β2 receptor. Progress in 
Neuro-Psychopharmacology & Biological Psychiatry, 36(1), 44–51. 
doi:10.1016/j.pnpbp.2011.08.019 
McGaugh, J. L., & Cahill, L. (1997). Interaction of neuromodulatory systems in 
modulating memory storage. Behavioural Brain Research, 83(1-2), 31–8. 
McNay, D. E. G., Briançon, N., Kokoeva, M. V, Maratos-Flier, E., & Flier, J. S. 
(2012). Remodeling of the arcuate nucleus energy-balance circuit is inhibited 
in obese mice. The Journal of Clinical Investigation, 122(1), 142–52. 
doi:10.1172/JCI43134 
Messam, C. A., Hou, J., & Major, E. O. (2000). Coexpression of nestin in neural 
and glial cells in the developing human CNS defined by a human-specific 
anti-nestin antibody. Experimental Neurology, 161(2), 585–96. 
doi:10.1006/exnr.1999.7319 
Miller, M. W., & Nowakowski, R. S. (1988). Use of bromodeoxyuridine-
immunohistochemistry to examine the proliferation, migration and time of 
origin of cells in the central nervous system. Brain Research, 457(1), 44–52. 
Ming, G., & Song, H. (2005). Adult neurogenesis in the mammalian central 
nervous system. Annual Review of Neuroscience, 28, 223–50. 
doi:10.1146/annurev.neuro.28.051804.101459 
Ming, G.-L., & Song, H. (2011). Adult neurogenesis in the mammalian brain: 
significant answers and significant questions. Neuron, 70(4), 687–702. 
doi:10.1016/j.neuron.2011.05.001 
Minneman, K. P., Han, C., & Abel, P. W. (1988). Comparison of alpha 1-
adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 
4101. Molecular Pharmacology, 33(5), 509–14. 
151 
 
Miyaki, T., Fujikawa, T., Kitaoka, R., Hirano, N., Matsumura, S., Fushiki, T., & 
Inoue, K. (2011). Noradrenergic projections to the ventromedial 
hypothalamus regulate fat metabolism during endurance exercise. 
Neuroscience, 190, 239–50. doi:10.1016/j.neuroscience.2011.05.051 
Morien, A., McMahon, L., & Wellman, P. J. (1993). Effects on food and water 
intake of the alpha 1-adrenoceptor agonists amidephrine and SK&F-89748. 
Life Sciences, 53(2), 169–74. 
Morris, R. (1984). Developments of a water-maze procedure for studying spatial 
learning in the rat. Journal of Neuroscience Methods, 11(1), 47–60. 
Morris, R. G. (1989). Synaptic plasticity and learning: selective impairment of 
learning rats and blockade of long-term potentiation in vivo by the N-methyl-
D-aspartate receptor antagonist AP5. The Journal of Neuroscience : The 
Official Journal of the Society for Neuroscience, 9(9), 3040–57. 
Morrow, A. L., & Creese, I. (1986). Characterization of alpha 1-adrenergic 
receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and 
[3H]prazosin binding. Molecular Pharmacology, 29(4), 321–30. 
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., & Schwartz, M. W. 
(2006). Central nervous system control of food intake and body weight. 
Nature, 443(7109), 289–95. doi:10.1038/nature05026 
Muyderman, H., Nilsson, M., Blomstrand, F., Khatibi, S., Olsson, T., Hansson, E., 
& Rönnbäck, L. (1998). Modulation of mechanically induced calcium waves 
in hippocampal astroglial cells. Inhibitory effects of alpha 1-adrenergic 
stimulation. Brain Research, 793(1-2), 127–35. 
Mynlieff, M., & Dunwiddie, T. V. (1988). Noradrenergic depression of synaptic 
responses in hippocampus of rat: evidence for mediation by alpha 1-
receptors. Neuropharmacology, 27(4), 391–8. 
Nacher, J., & McEwen, B. S. (2006). The role of N-methyl-D-asparate receptors 
in neurogenesis. Hippocampus, 16(3), 267–70. doi:10.1002/hipo.20160 
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & 
Matsukura, S. (2001). A role for ghrelin in the central regulation of feeding. 
Nature, 409(6817), 194–8. doi:10.1038/35051587 
Nedergaard, M. (1994). Direct signaling from astrocytes to neurons in cultures of 
mammalian brain cells. Science (New York, N.Y.), 263(5154), 1768–71. 
152 
 
Neylan, T. C., Scoville, W. B., & Milner, B. (2000). Memory and the Medial 
Temporal Lobe : Patient H . M . Loss of Recent Memory After Bilateral 
Hippocampal Lesions. Journal Of Neuropsychiatry, 253(5026), 1380–1386. 
Nowakowski, R. S., & Hayes, N. L. (2000). New neurons: extraordinary evidence 
or extraordinary conclusion? Science (New York, N.Y.), 288(5467), 771. 
doi:10.1126/science.288.5467.771a 
Obenaus, A., Mody, I., & Baimbridge, K. G. (1989). Dantrolene-Na (Dantrium) 
blocks induction of long-term potentiation in hippocampal slices. 
Neuroscience Letters, 98(2), 172–8. 
Offermanns, S., & Simon, M. I. (1998). Genetic analysis of mammalian G-protein 
signalling. Oncogene, 17(11 Reviews), 1375–81. 
doi:10.1038/sj.onc.1202173 
Ogbomo, H., Michaelis, M., Klassert, D., Doerr, H. W., & Cinatl, J. (2008). 
Resistance to cytarabine induces the up-regulation of NKG2D ligands and 
enhances natural killer cell lysis of leukemic cells. Neoplasia (New York, 
N.Y.), 10(12), 1402–10. doi:10.1593/neo.08972 
Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I., & 
Barsh, G. S. (1997). Antagonism of central melanocortin receptors in vitro 
and in vivo by agouti-related protein. Science (New York, N.Y.), 278(5335), 
135–8. doi:10.1126/science.278.5335.135 
Olton, D. S., & Papas, B. C. (1979). Spatial memory and hippocampal function. 
Neuropsychologia, 17(6), 669–82. 
Otto, T., Eichenbaum, H., Wiener, S. I., & Wible, C. G. (1991). Learning-related 
patterns of CA1 spike trains parallel stimulation parameters optimal for 
inducing hippocampal long-term potentiation. Hippocampus, 1(2), 181–92. 
doi:10.1002/hipo.450010206 
Pang, K., & Rose, G. M. (1987). Differential effects of norepinephrine on 
hippocampal complex-spike and theta-neurons. Brain Research, 425(1), 
146–58. 
Papay, R., Gaivin, R., Jha, A., McCune, D. F., McGrath, J. C., Rodrigo, M. C., 
Simpson, P. C., Doze, V. A., Perez, D. M. (2006). Localization of the mouse 
alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in 
neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. 




Papay, R. S., Shi, T., Piascik, M. T., Naga Prasad, S. V, & Perez, D. M. (2013). 
α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through 
interleukin-6 secretion. Molecular Pharmacology, 83(5), 939–48. 
doi:10.1124/mol.112.084483 
Park, J. J., Baum, M. J., Paredes, R. G., & Tobet, S. A. (1996). Neurogenesis 
and cell migration into the sexually dimorphic preoptic area/anterior 
hypothalamus of the fetal ferret. Journal of Neurobiology, 30(3), 315–28. 
doi:10.1002/(SICI)1097-4695(199607)30:3&lt;315::AID-NEU1&gt;3.0.CO;2-7 
Parmentier, J.-H., Gandhi, G. K., Wiggins, M. T., Saeed, A. E., Bourgoin, S. G., & 
Malik, K. U. (2004). Protein kinase Czeta regulates phospholipase D activity 
in rat-1 fibroblasts expressing the alpha1A adrenergic receptor. BMC Cell 
Biology, 5, 4. doi:10.1186/1471-2121-5-4 
Parpura, V., Basarsky, T. A., Liu, F., Jeftinija, K., Jeftinija, S., & Haydon, P. G. 
(1994). Glutamate-mediated astrocyte-neuron signalling. Nature, 369(6483), 
744–7. doi:10.1038/369744a0 
Pencea, V., Bingaman, K. D., Wiegand, S. J., & Luskin, M. B. (2001). Infusion of 
brain-derived neurotrophic factor into the lateral ventricle of the adult rat 
leads to new neurons in the parenchyma of the striatum, septum, thalamus, 
and hypothalamus. The Journal of Neuroscience : The Official Journal of the 
Society for Neuroscience, 21(17), 6706–17. 
Perez, D. M. (2006). The Adrenergic Receptors: In the 21st Century. Totowa, NJ: 
Human Press. 
Perez, D. M. (2006). The Adrenergic Receptors: In the 21st Century, AR 
Localization with ISH and Autoradiography (pp. 176-177). Totowa, NJ: 
Human Press. 
Perez, D. M. (2006). The Adrenergic Receptors: In the 21st Century, Historical 
Perspectives (pp. 5). Totowa, NJ: Human Press. 
Perez, D. M. (2006). The Adrenergic Receptors: In the 21st Century, Ligand 
Binding, Activation, and Agonist Trafficking (pp. 26-27, 54, 55). Totowa, NJ: 
Human Press. 
Perez, D. M., DeYoung, M. B., & Graham, R. M. (1993). Coupling of expressed 
alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways 
is both G protein and cell type specific. Molecular Pharmacology, 44(4), 
784–95. 
Perez, D. M., Piascik, M. T., & Graham, R. M. (1991). Solution-phase library 
screening for the identification of rare clones: isolation of an alpha 1D-
adrenergic receptor cDNA. Molecular Pharmacology, 40(6), 876–83. 
154 
 
Perez, D. M., Piascik, M. T., Malik, N., Gaivin, R., & Graham, R. M. (1994). 
Cloning, expression, and tissue distribution of the rat homolog of the bovine 
alpha 1C-adrenergic receptor provide evidence for its classification as the 
alpha 1A subtype. Molecular Pharmacology, 46(5), 823–31. 
Pergola, G., & Suchan, B. (2013). Associative Learning Beyond the Medial 
Temporal Lobe: Many Actors on the Memory Stage. Frontiers in Behavioral 
Neuroscience, 7(November), 162. doi:10.3389/fnbeh.2013.00162 
Pierce, A. A., & Xu, A. W. (2010). De novo neurogenesis in adult hypothalamus 
as a compensatory mechanism to regulate energy balance. The Journal of 
Neuroscience : The Official Journal of the Society for Neuroscience, 30(2), 
723–30. doi:10.1523/JNEUROSCI.2479-09.2010 
Pupo, A. S., & Minneman, K. P. (2001). Adrenergic pharmacology: focus on the 
central nervous system. CNS Spectrums, 6(8), 656–62. 
Pussinen, R., Nieminen, S., Koivisto, E., Haapalinna, A., Riekkinen, P., & Sirvio, 
J. (1997). Enhancement of intermediate-term memory by an alpha-1 agonist 
or a partial agonist at the glycine site of the NMDA receptor. Neurobiology of 
Learning and Memory, 67(1), 69–74. doi:10.1006/nlme.1996.3738 
Pussinen, R., & Sirviö, J. (1998). Minor role for alpha1-adrenoceptors in the 
facilitation of induction and early maintenance of long-term potentiation in 
the CA1 field of the hippocampus. Journal of Neuroscience Research, 51(3), 
309–15. 
Puumala, T., Greijus, S., Narinen, K., Haapalinna, A., Riekkinen, P., & Sirviö, J. 
(1998). Stimulation of alpha-1 adrenergic receptors facilitates spatial 
learning in rats. European Neuropsychopharmacology : The Journal of the 
European College of Neuropsychopharmacology, 8(1), 17–26. 
Puumala, T., Sirviö, J., Ruotsalainen, S., & Riekkinen, P. (1996). Effects of St-
587 and prazosin on water maze and passive avoidance performance of 
scopolamine-treated rats. Pharmacology, Biochemistry, and Behavior, 55(1), 
107–15. 
Racotta, R., & Soto-Mora, L. M. (1993). Specificity of alpha- and beta-adrenergic 
inhibition of water and food intake. Physiology & Behavior, 53(2), 361–5. 
Rao, M. S., & Shetty, A. K. (2004). Efficacy of doublecortin as a marker to 
analyse the absolute number and dendritic growth of newly generated 
neurons in the adult dentate gyrus. The European Journal of Neuroscience, 
19(2), 234–46. doi:10.1111/j.1460-9568.2003.03123.x 
155 
 
Regan, J. W., Kobilka, T. S., Yang-Feng, T. L., Caron, M. G., Lefkowitz, R. J., & 
Kobilka, B. K. (1988). Cloning and expression of a human kidney cDNA for 
an alpha 2-adrenergic receptor subtype. Proceedings of the National 
Academy of Sciences of the United States of America, 85(17), 6301–5. 
Reynolds, B. A., & Weiss, S. (1992). Generation of neurons and astrocytes from 
isolated cells of the adult mammalian central nervous system. Science (New 
York, N.Y.), 255(5052), 1707–10. 
Rhodes, J. S., Gammie, S. C., & Garland, T. (2005). Neurobiology of Mice 
Selected for High Voluntary Wheel-running Activity. Integrative and 
Comparative Biology, 45(3), 438–55. doi:10.1093/icb/45.3.438 
Riekkinen, M., Kemppainen, S., & Riekkinen, P. (1997). Effects of stimulation of 
alpha 1-adrenergic and NMDA/glycine-B receptors on learning defects in 
aged rats. Psychopharmacology, 131(1), 49–56. 
Riekkinen, M., Stefanski, R., Kuitunen, J., & Riekkinen, P. (1996). Effects of 
combined block of alpha 1-adrenoceptors and NMDA receptors on spatial 
and passive avoidance behavior in rats. European Journal of Pharmacology, 
300(1-2), 9–16. 
Rizk, P., Salazar, J., Raisman-Vozari, R., Marien, M., Ruberg, M., Colpaert, F., & 
Debeir, T. (2006). The alpha2-adrenoceptor antagonist dexefaroxan 
enhances hippocampal neurogenesis by increasing the survival and 
differentiation of new granule cells. Neuropsychopharmacology : Official 
Publication of the American College of Neuropsychopharmacology, 31(6), 
1146–57. doi:10.1038/sj.npp.1300954 
Robinson Jr., G. S., Crooks Jr., G. B., Shinkman, P. G., & Gallagher, M. (1989). 
Behavioral effects of MK-801 mimic deficits associated with hippocampal 
damage. Psychobiology, 17(2), 156–164. doi:10.3758/BF03337831 
Rose, C. R., & Konnerth, A. (2001). Stores not just for storage. intracellular 
calcium release and synaptic plasticity. Neuron, 31(4), 519–22. 
Rossi, R., & Scharrer, E. (1994). Inhibitory effect of the alpha 1-adrenergic 
antagonist prazosin on food intake in pygmy goats. Pharmacology, 
Biochemistry, and Behavior, 47(4), 851–6. 
Ruffolo, R. R., & Waddell, J. E. (1982). Receptor interactions of imidazolines. IX. 
Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic 




Salam, J. N., Fox, J. H., Detroy, E. M., Guignon, M. H., Wohl, D. F., & Falls, W. 
A. (2009). Voluntary exercise in C57 mice is anxiolytic across several 
measures of anxiety. Behavioural Brain Research, 197(1), 31–40. 
doi:10.1016/j.bbr.2008.07.036 
Scanziani, M., Gähwiler, B. H., & Thompson, S. M. (1993). Presynaptic inhibition 
of excitatory synaptic transmission mediated by alpha adrenergic receptors 
in area CA3 of the rat hippocampus in vitro. The Journal of Neuroscience : 
The Official Journal of the Society for Neuroscience, 13(12), 5393–401. 
Scheiderer, C. L., Dobrunz, L. E., & McMahon, L. L. (2004). Novel form of long-
term synaptic depression in rat hippocampus induced by activation of alpha 
1 adrenergic receptors. Journal of Neurophysiology, 91(2), 1071–7. 
doi:10.1152/jn.00420.2003 
Schmidt-Hieber, C., Jonas, P., & Bischofberger, J. (2004). Enhanced synaptic 
plasticity in newly generated granule cells of the adult hippocampus. Nature, 
429(6988), 184–7. doi:10.1038/nature02553 
Seki, T. (2002). Hippocampal adult neurogenesis occurs in a microenvironment 
provided by PSA-NCAM-expressing immature neurons. Journal of 
Neuroscience Research, 69(6), 772–83. doi:10.1002/jnr.10366 
Seri, B., Herrera, D. G., Gritti, A., Ferron, S., Collado, L., Vescovi, A., Garcia-
Verdugo, J. M., Alvarez-Buylla, A. (2006). Composition and organization of 
the SCZ: a large germinal layer containing neural stem cells in the adult 
mammalian brain. Cerebral Cortex (New York, N.Y. : 1991), 16 Suppl 1, 
i103–11. doi:10.1093/cercor/bhk027 
Shi, S. H., Hayashi, Y., Petralia, R. S., Zaman, S. H., Wenthold, R. J., Svoboda, 
K., & Malinow, R. (1999). Rapid spine delivery and redistribution of AMPA 
receptors after synaptic NMDA receptor activation. Science (New York, 
N.Y.), 284(5421), 1811–6. doi:10.1126/science.284.5421.1811 
Shors, T. J., Miesegaes, G., Beylin, A., Zhao, M., Rydel, T., & Gould, E. (2001). 
Neurogenesis in the adult is involved in the formation of trace memories. 
Nature, 410(6826), 372–6. doi:10.1038/35066584 
Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y., & Gould, E. (2002). 
Neurogenesis may relate to some but not all types of hippocampal-
dependent learning. Hippocampus, 12(5), 578–84. doi:10.1002/hipo.10103 
Sirviö, J., & MacDonald, E. (1999). Central alpha1-adrenoceptors: their role in 
the modulation of attention and memory formation. Pharmacology & 
Therapeutics, 83(1), 49–65. 
157 
 
Sirviö, J., Riekkinen, P., MacDonald, E., Airaksinen, M., Lammintausta, R., & 
Riekkinen, P. J. (1992). The effects of alpha-2 adrenoceptor antagonist, 
atipamezole, on spatial learning in scopolamine-treated and aged rats. 
Journal of Neural Transmission. Parkinson’s Disease and Dementia Section, 
4(2), 99–106. 
Snyder, J., Kee, N., & Wojtowicz, J. (2001). Effects of adult neurogenesis on 
synaptic plasticity in the rat dentate gyrus. Journal of Neurophysiology, 
85(6), 2423–31. 
Snyder, J. S., Glover, L. R., Sanzone, K. M., Kamhi, J. F., & Cameron, H. A. 
(2009). The effects of exercise and stress on the survival and maturation of 
adult-generated granule cells. Hippocampus, 19(10), 898–906. 
doi:10.1002/hipo.20552 
Snyder, J. S., Hong, N. S., McDonald, R. J., & Wojtowicz, J. M. (2005, January). 
A role for adult neurogenesis in spatial long-term memory. Neuroscience. 
doi:10.1016/j.neuroscience.2004.10.009 
Sousa-Ferreira, L., de Almeida, L. P., & Cavadas, C. (2013). Role of 
hypothalamic neurogenesis in feeding regulation. Trends in Endocrinology 
and Metabolism: TEM, 1–9. doi:10.1016/j.tem.2013.10.005 
Squire, L. R. (1992). Memory and the hippocampus: a synthesis from findings 
with rats, monkeys, and humans. Psychological Review, 99(2), 195–231. 
Squire, L. R., & Zola, S. M. (1996). Structure and function of declarative and 
nondeclarative memory systems. Proceedings of the National Academy of 
Sciences of the United States of America, 93(24), 13515–22. 
Sreenivasan, Y., Sarkar, A., & Manna, S. K. (2003). Mechanism of cytosine 
arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation. 
Oncogene, 22(28), 4356–69. doi:10.1038/sj.onc.1206486 
Stanton, P. K., & Sarvey, J. M. (1985). Depletion of norepinephrine, but not 
serotonin, reduces long-term potentiation in the dentate gyrus of rat 
hippocampal slices. The Journal of Neuroscience : The Official Journal of the 
Society for Neuroscience, 5(8), 2169–76. 
Sutherland, R. J., & McDonald, R. J. (1990). Hippocampus, amygdala, and 
memory deficits in rats. Behavioural Brain Research, 37(1), 57–79. 
Tanapat, P., Hastings, N. B., Reeves, A. J., & Gould, E. (1999). Estrogen 
stimulates a transient increase in the number of new neurons in the dentate 
gyrus of the adult female rat. The Journal of Neuroscience : The Official 
Journal of the Society for Neuroscience, 19(14), 5792–801. 
158 
 
Tannock, I. F., Ahles, T. A., Ganz, P. A., & Van Dam, F. S. (2004). Cognitive 
impairment associated with chemotherapy for cancer: report of a workshop. 
Journal of Clinical Oncology : Official Journal of the American Society of 
Clinical Oncology, 22(11), 2233–9. doi:10.1200/JCO.2004.08.094 
Tashiro, A., Makino, H., & Gage, F. H. (2007). Experience-specific functional 
modification of the dentate gyrus through adult neurogenesis: a critical 
period during an immature stage. The Journal of Neuroscience : The Official 
Journal of the Society for Neuroscience, 27(12), 3252–9. 
doi:10.1523/JNEUROSCI.4941-06.2007 
Taupin, P. (2007). BrdU immunohistochemistry for studying adult neurogenesis: 
paradigms, pitfalls, limitations, and validation. Brain Research Reviews, 
53(1), 198–214. doi:10.1016/j.brainresrev.2006.08.002 
Van Pelt, K., de Haan, G., Vellenga, E., & Daenen, S. M. G. J. (2005). 
Administration of low-dose cytarabine results in immediate S-phase arrest 
and subsequent activation of cell cycling in murine stem cells. Experimental 
Hematology, 33(2), 226–31. doi:10.1016/j.exphem.2004.10.013 
Van Praag, H., Christie, B. R., Sejnowski, T. J., & Gage, F. H. (1999). Running 
enhances neurogenesis, learning, and long-term potentiation in mice. 
Proceedings of the National Academy of Sciences of the United States of 
America, 96(23), 13427–31. 
Van Praag, H., Kempermann, G., & Gage, F. H. (1999). Running increases cell 
proliferation and neurogenesis in the adult mouse dentate gyrus. Nature 
Neuroscience, 2(3), 266–70. doi:10.1038/6368 
Van Praag, H., Shubert, T., Zhao, C., & Gage, F. H. (2005). Exercise enhances 
learning and hippocampal neurogenesis in aged mice. The Journal of 
Neuroscience : The Official Journal of the Society for Neuroscience, 25(38), 
8680–5. doi:10.1523/JNEUROSCI.1731-05.2005 
Veyrac, A., Didier, A., Colpaert, F., Jourdan, F., & Marien, M. (2005). Activation 
of noradrenergic transmission by alpha2-adrenoceptor antagonists 
counteracts deafferentation-induced neuronal death and cell proliferation in 
the adult mouse olfactory bulb. Experimental Neurology, 194(2), 444–56. 
doi:10.1016/j.expneurol.2005.03.004 
Von Bohlen und Halbach, O. (2007). Immunohistological markers for staging 




Von Bohlen Und Halbach, O. (2011). Immunohistological markers for proliferative 
events, gliogenesis, and neurogenesis within the adult hippocampus. Cell 
and Tissue Research, 345, 1–19. doi:10.1007/s00441-011-1196-4 
Von Euler, U. S. (1951). The nature of adrenergic nerve mediators. 
Pharmacological Reviews, 3(3), 247–77. 
Vorhees, C. V, & Williams, M. T. (2006). Morris water maze: procedures for 
assessing spatial and related forms of learning and memory. Nature 
Protocols, 1(2), 848–58. doi:10.1038/nprot.2006.116 
Wang, W. S., Tzeng, C. H., Chiou, T. J., Liu, J. H., Hsieh, R. K., Yen, C. C., & 
Chen, P. M. (1997). High-dose cytarabine and mitoxantrone as salvage 
therapy for refractory non-Hodgkin’s lymphoma. Japanese Journal of Clinical 
Oncology, 27(3), 154–7. 
Wellman, P. J., & Davies, B. T. (1992). Reversal of cirazoline- and 
phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist 
prazosin. Pharmacology, Biochemistry, and Behavior, 42(1), 97–100. 
Wenk, G. L. (2004). Assessment of spatial memory using the radial arm maze 
and Morris water maze. Current Protocols in Neuroscience, Chapter 8, Unit 
8.5A. doi:10.1002/0471142301.ns0805as26 
Wenthold, R. J., Petralia, R. S., Blahos J, I. I., & Niedzielski, A. S. (1996). 
Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 
neurons. The Journal of Neuroscience : The Official Journal of the Society 
for Neuroscience, 16(6), 1982–9. 
Wess, J. (1998). Molecular basis of receptor/G-protein-coupling selectivity. 
Pharmacology & Therapeutics, 80(3), 231–64. 
West, M. J., Slomianka, L., & Gundersen, H. J. (1991). Unbiased stereological 
estimation of the total number of neurons in thesubdivisions of the rat 
hippocampus using the optical fractionator. The Anatomical Record, 231(4), 
482–97. doi:10.1002/ar.1092310411 
Wilson, R. C., Vacek, T., Lanier, D. L., & Dewsbury, D. A. (1976). Open-field 
behavior in muroid rodents. Behavioral Biology, 17(4), 495–506. 
Winocur, G., Wojtowicz, J. M., Sekeres, M., Snyder, J. S., & Wang, S. (2006). 
Inhibition of neurogenesis interferes with hippocampus-dependent memory 




Wong-Goodrich, S. J. E., Pfau, M. L., Flores, C. T., Fraser, J. A., Williams, C. L., 
& Jones, L. W. (2010). Voluntary running prevents progressive memory 
decline and increases adult hippocampal neurogenesis and growth factor 
expression after whole-brain irradiation. Cancer Research, 70(22), 9329–38. 
doi:10.1158/0008-5472.CAN-10-1854 
Wu, D., Jiang, H., & Simon, M. I. (1995). Different alpha 1-adrenergic receptor 
sequences required for activating different G alpha subunits of Gq class of G 
proteins. The Journal of Biological Chemistry, 270(17), 9828–32. 
Wu, D., Katz, A., Lee, C. H., & Simon, M. I. (1992). Activation of phospholipase C 
by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq 
family. The Journal of Biological Chemistry, 267(36), 25798–802. 
Xing, M., & Insel, P. A. (1996). Protein kinase C-dependent activation of cytosolic 
phospholipase A2 and mitogen-activated protein kinase by alpha 1-
adrenergic receptors in Madin-Darby canine kidney cells. The Journal of 
Clinical Investigation, 97(5), 1302–10. doi:10.1172/JCI118546 
Yan, X.-B., Hou, H.-L., Wu, L.-M., Liu, J., & Zhou, J.-N. (2007). Lithium regulates 
hippocampal neurogenesis by ERK pathway and facilitates recovery of 
spatial learning and memory in rats after transient global cerebral ischemia. 
Neuropharmacology, 53(4), 487–95. doi:10.1016/j.neuropharm.2007.06.020 
Yanpallewar, S. U., Fernandes, K., Marathe, S. V, Vadodaria, K. C., Jhaveri, D., 
Rommelfanger, K., Ladiwala, U., Jha, S., Muthig, V., Hein, L., Bartlett, P., 
Winshenker, D., Vaidya, V. A. (2010). Alpha2-adrenoceptor blockade 
accelerates the neurogenic, neurotrophic, and behavioral effects of chronic 
antidepressant treatment. The Journal of Neuroscience : The Official Journal 
of the Society for Neuroscience, 30(3), 1096–109. 
doi:10.1523/JNEUROSCI.2309-09.2010 
Yun, J., Gaivin, R. J., McCune, D. F., Boongird, A., Papay, R. S., Ying, Z., 
Gonzalez-Cabrera, J., Najm, I., Perez, D. M. (2003). Gene expression profile 
of neurodegeneration induced by alpha1B-adrenergic receptor overactivity: 
NMDA/GABAA dysregulation and apoptosis. Brain : A Journal of Neurology, 
126(Pt 12), 2667–81. doi:10.1093/brain/awg277 
Zamanillo, D., Sprengel, R., Hvalby, O., Jensen, V., Burnashev, N., Rozov, A., 
Kaiser, K. M. M., Koster, H. J., Borchardt, T., Worley, P., Lubke, J., 
Frotscher, M., Kelly, P. H., Sommer, B., ANdersen, P., Seeburg, P. H., 
Sakmann, B. (1999). Importance of AMPA receptors for hippocampal 
synaptic plasticity but not for spatial learning. Science (New York, N.Y.), 
284(5421), 1805–11. doi:10.1126/science.284.5421.1805 
161 
 
Zeng, D. W., Harrison, J. K., D’Angelo, D. D., Barber, C. M., Tucker, A. L., Lu, Z. 
H., & Lynch, K. R. (1990). Molecular characterization of a rat alpha 2B-
adrenergic receptor. Proceedings of the National Academy of Sciences of 
the United States of America, 87(8), 3102–6. 
Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R. M., Johansson, C. B., 
Brismar, H., Shupliakov, O., Frisen, J., Janson, A. M. (2003). Evidence for 
neurogenesis in the adult mammalian substantia nigra. Proceedings of the 
National Academy of Sciences of the United States of America, 100(13), 
7925–30. doi:10.1073/pnas.1131955100 
Zhong, H., & Minneman, K. P. (1999). Alpha1-adrenoceptor subtypes. European 
Journal of Pharmacology, 375(1-3), 261–76. 
Zuscik, M. J., Sands, S., Ross, S. A., Waugh, D. J., Gaivin, R. J., Morilak, D., & 
Perez, D. M. (2000). Overexpression of the alpha1B-adrenergic receptor 
causes apoptotic neurodegeneration: multiple system atrophy. Nature 
Medicine, 6(12), 1388–94. doi:10.1038/82207 
 
